id	sid	tid	token	lemma	pos
aji-163	1	1	_	_	PUNCT
aji-163	2	1	_	_	PUNCT
aji-163	3	1	_	_	PUNCT
aji-163	4	1	_	_	PUNCT
aji-163	5	1	_	_	PUNCT
aji-163	6	1	_	_	PUNCT
aji-163	7	1	_	_	PUNCT
aji-163	8	1	_	_	PUNCT
aji-163	9	1	_	_	PUNCT
aji-163	10	1	_	_	PUNCT
aji-163	11	1	_	_	PUNCT
aji-163	12	1	_	_	PUNCT
aji-163	13	1	_	_	PUNCT
aji-163	14	1	_	_	PUNCT
aji-163	15	1	_	_	PUNCT
aji-163	16	1	_	_	PUNCT
aji-163	17	1	_	_	PUNCT
aji-163	18	1	_	_	PUNCT
aji-163	19	1	_	_	PUNCT
aji-163	20	1	_	_	PUNCT
aji-163	21	1	_	_	PUNCT
aji-163	22	1	_	_	PUNCT
aji-163	23	1	_	_	PUNCT
aji-163	24	1	_	_	PUNCT
aji-163	25	1	_	_	PUNCT
aji-163	26	1	_	_	PUNCT
aji-163	27	1	_	_	PUNCT
aji-163	28	1	_	_	PUNCT
aji-163	29	1	_	_	PUNCT
aji-163	30	1	_	_	PUNCT
aji-163	31	1	_	_	PUNCT
aji-163	32	1	_	_	PUNCT
aji-163	33	1	_	_	PUNCT
aji-163	34	1	_	_	PUNCT
aji-163	35	1	_	_	PUNCT
aji-163	36	1	_	_	PUNCT
aji-163	37	1	_	_	PUNCT
aji-163	38	1	_	_	PUNCT
aji-163	39	1	_	_	PUNCT
aji-163	40	1	_	_	PUNCT
aji-163	41	1	_	_	PUNCT
aji-163	42	1	_	_	PUNCT
aji-163	43	1	_	_	PUNCT
aji-163	44	1	_	_	PUNCT
aji-163	45	1	_	_	PUNCT
aji-163	46	1	_	_	PUNCT
aji-163	47	1	_	_	PUNCT
aji-163	48	1	_	_	PUNCT
aji-163	49	1	_	_	PUNCT
aji-163	50	1	_	_	PUNCT
aji-163	51	1	_	_	PUNCT
aji-163	52	1	_	_	PUNCT
aji-163	53	1	_	_	PUNCT
aji-163	54	1	_	_	PUNCT
aji-163	55	1	_	_	PUNCT
aji-163	56	1	_	_	PUNCT
aji-163	57	1	_	_	PUNCT
aji-163	58	1	_	_	PUNCT
aji-163	59	1	_	_	PUNCT
aji-163	60	1	_	_	PUNCT
aji-163	61	1	_	_	PUNCT
aji-163	62	1	_	_	PUNCT
aji-163	63	1	_	_	PUNCT
aji-163	64	1	_	_	PUNCT
aji-163	65	1	_	_	PUNCT
aji-163	66	1	_	_	PUNCT
aji-163	67	1	_	_	PUNCT
aji-163	68	1	_	_	PUNCT
aji-163	69	1	_	_	PUNCT
aji-163	70	1	_	_	PUNCT
aji-163	71	1	_	_	PUNCT
aji-163	72	1	_	_	PUNCT
aji-163	73	1	_	_	PUNCT
aji-163	74	1	_	_	PUNCT
aji-163	75	1	_	_	PUNCT
aji-163	76	1	_	_	PUNCT
aji-163	77	1	_	_	PUNCT
aji-163	78	1	_	_	PUNCT
aji-163	79	1	_	_	PUNCT
aji-163	80	1	_	_	PUNCT
aji-163	81	1	_	_	PUNCT
aji-163	82	1	_	_	PUNCT
aji-163	83	1	_	_	PUNCT
aji-163	84	1	_	_	PUNCT
aji-163	85	1	_	_	PUNCT
aji-163	86	1	_	_	PUNCT
aji-163	87	1	_	_	PUNCT
aji-163	88	1	_	_	PUNCT
aji-163	89	1	_	_	PUNCT
aji-163	90	1	_	_	PUNCT
aji-163	91	1	_	_	PUNCT
aji-163	92	1	_	_	PUNCT
aji-163	93	1	_	_	PUNCT
aji-163	94	1	_	_	PUNCT
aji-163	95	1	_	_	PUNCT
aji-163	96	1	_	_	PUNCT
aji-163	97	1	_	_	PUNCT
aji-163	98	1	_	_	PUNCT
aji-163	99	1	_	_	PUNCT
aji-163	100	1	_	_	PUNCT
aji-163	101	1	_	_	PUNCT
aji-163	102	1	*	*	PUNCT
aji-163	102	2	corresponding	correspond	VERB
aji-163	102	3	author	author	NOUN
aji-163	102	4	:	:	PUNCT
aji-163	102	5	e	e	NOUN
aji-163	102	6	-	-	NOUN
aji-163	102	7	mail	mail	NOUN
aji-163	102	8	:	:	PUNCT
aji-163	102	9	lucyjanefrancisokolie@gmail.com	lucyjanefrancisokolie@gmail.com	X
aji-163	102	10	;	;	PUNCT
aji-163	102	11	cite	cite	VERB
aji-163	102	12	as	as	ADP
aji-163	102	13	:	:	PUNCT
aji-163	102	14	janefrancis	janefrancis	PROPN
aji-163	102	15	,	,	PUNCT
aji-163	102	16	okolie	okolie	PROPN
aji-163	102	17	lucy	lucy	PROPN
aji-163	102	18	,	,	PUNCT
aji-163	102	19	maduka	maduka	PROPN
aji-163	102	20	amuche	amuche	NOUN
aji-163	102	21	stella	stella	NOUN
aji-163	102	22	,	,	PUNCT
aji-163	102	23	ojeniran	ojeniran	NOUN
aji-163	102	24	taiwo	taiwo	PROPN
aji-163	102	25	paul	paul	PROPN
aji-163	102	26	,	,	PUNCT
aji-163	102	27	yahaya	yahaya	PROPN
aji-163	102	28	imran	imran	PROPN
aji-163	102	29	umar	umar	PROPN
aji-163	102	30	,	,	PUNCT
aji-163	102	31	lawal	lawal	PROPN
aji-163	102	32	mustapha	mustapha	PROPN
aji-163	102	33	,	,	PUNCT
aji-163	102	34	oniye	oniye	ADP
aji-163	102	35	mariam	mariam	PROPN
aji-163	102	36	masud	masud	PROPN
aji-163	102	37	,	,	PUNCT
aji-163	102	38	and	and	CCONJ
aji-163	102	39	umar	umar	PROPN
aji-163	102	40	muhammad	muhammad	PROPN
aji-163	102	41	muhsin	muhsin	PROPN
aji-163	102	42	.	.	PUNCT
aji-163	102	43	2025	2025	NUM
aji-163	102	44	.	.	PUNCT
aji-163	103	1	“	"	PUNCT
aji-163	103	2	the	the	DET
aji-163	103	3	role	role	NOUN
aji-163	103	4	of	of	ADP
aji-163	103	5	trained	train	VERB
aji-163	103	6	immunity	immunity	NOUN
aji-163	103	7	in	in	ADP
aji-163	103	8	protection	protection	NOUN
aji-163	103	9	against	against	ADP
aji-163	103	10	infectious	infectious	ADJ
aji-163	103	11	diseases	disease	NOUN
aji-163	103	12	:	:	PUNCT
aji-163	103	13	epigenetic	epigenetic	ADJ
aji-163	103	14	reprogramming	reprogramming	NOUN
aji-163	103	15	and	and	CCONJ
aji-163	103	16	long	long	ADJ
aji-163	103	17	-	-	PUNCT
aji-163	103	18	term	term	NOUN
aji-163	103	19	immune	immune	ADJ
aji-163	103	20	responses	response	NOUN
aji-163	103	21	”	"	PUNCT
aji-163	103	22	.	.	PUNCT
aji-163	104	1	asian	asian	ADJ
aji-163	104	2	journal	journal	NOUN
aji-163	104	3	of	of	ADP
aji-163	104	4	immunology	immunology	NOUN
aji-163	104	5	8	8	NUM
aji-163	104	6	(	(	PUNCT
aji-163	104	7	1):86	1):86	NUM
aji-163	104	8	-	-	SYM
aji-163	104	9	96	96	NUM
aji-163	104	10	.	.	PUNCT
aji-163	105	1	https://doi.org/10.9734/aji/2025/v8i1163	https://doi.org/10.9734/aji/2025/v8i1163	PROPN
aji-163	105	2	.	.	PUNCT
aji-163	106	1	asian	asian	ADJ
aji-163	106	2	journal	journal	PROPN
aji-163	106	3	of	of	ADP
aji-163	106	4	immunology	immunology	NOUN
aji-163	106	5	volume	volume	NOUN
aji-163	106	6	8	8	NUM
aji-163	106	7	,	,	PUNCT
aji-163	106	8	issue	issue	NOUN
aji-163	106	9	1	1	NUM
aji-163	106	10	,	,	PUNCT
aji-163	106	11	page	page	NOUN
aji-163	106	12	86	86	NUM
aji-163	106	13	-	-	SYM
aji-163	106	14	96	96	NUM
aji-163	106	15	,	,	PUNCT
aji-163	106	16	2025	2025	NUM
aji-163	106	17	;	;	PUNCT
aji-163	106	18	article	article	NOUN
aji-163	106	19	no.aji.134904	no.aji.134904	VERB
aji-163	106	20	the	the	DET
aji-163	106	21	role	role	NOUN
aji-163	106	22	of	of	ADP
aji-163	106	23	trained	train	VERB
aji-163	106	24	immunity	immunity	NOUN
aji-163	106	25	in	in	ADP
aji-163	106	26	protection	protection	NOUN
aji-163	106	27	against	against	ADP
aji-163	106	28	infectious	infectious	ADJ
aji-163	106	29	diseases	disease	NOUN
aji-163	106	30	:	:	PUNCT
aji-163	106	31	epigenetic	epigenetic	ADJ
aji-163	106	32	reprogramming	reprogramming	NOUN
aji-163	106	33	and	and	CCONJ
aji-163	106	34	longterm	longterm	ADJ
aji-163	106	35	immune	immune	ADJ
aji-163	106	36	responses	response	NOUN
aji-163	106	37	okolie	okolie	PROPN
aji-163	106	38	lucy	lucy	PROPN
aji-163	106	39	janefrancis	janefrancis	PROPN
aji-163	107	1	a	a	PROPN
aji-163	107	2	*	*	PROPN
aji-163	107	3	,	,	PUNCT
aji-163	107	4	maduka	maduka	ADJ
aji-163	107	5	amuche	amuche	PROPN
aji-163	107	6	stella	stella	PROPN
aji-163	107	7	b	b	PROPN
aji-163	107	8	,	,	PUNCT
aji-163	107	9	ojeniran	ojeniran	NOUN
aji-163	107	10	taiwo	taiwo	PROPN
aji-163	107	11	paul	paul	PROPN
aji-163	107	12	c	c	PROPN
aji-163	107	13	,	,	PUNCT
aji-163	107	14	yahaya	yahaya	PROPN
aji-163	107	15	imran	imran	PROPN
aji-163	107	16	umar	umar	PROPN
aji-163	107	17	d	d	PROPN
aji-163	107	18	,	,	PUNCT
aji-163	107	19	lawal	lawal	PROPN
aji-163	107	20	mustapha	mustapha	PROPN
aji-163	107	21	e	e	PROPN
aji-163	107	22	,	,	PUNCT
aji-163	107	23	oniye	oniye	PROPN
aji-163	107	24	mariam	mariam	PROPN
aji-163	107	25	masud	masud	PROPN
aji-163	107	26	f	f	PROPN
aji-163	107	27	and	and	CCONJ
aji-163	107	28	umar	umar	PROPN
aji-163	107	29	muhammad	muhammad	PROPN
aji-163	107	30	muhsin	muhsin	PROPN
aji-163	107	31	g	g	PROPN
aji-163	107	32	a	a	DET
aji-163	107	33	department	department	NOUN
aji-163	107	34	of	of	ADP
aji-163	107	35	microbiology	microbiology	NOUN
aji-163	107	36	,	,	PUNCT
aji-163	107	37	alex	alex	PROPN
aji-163	107	38	ekwueme	ekwueme	PROPN
aji-163	107	39	federal	federal	PROPN
aji-163	107	40	university	university	PROPN
aji-163	107	41	ndufu	ndufu	PROPN
aji-163	107	42	-	-	PUNCT
aji-163	107	43	alike	alike	ADV
aji-163	107	44	,	,	PUNCT
aji-163	107	45	nigeria	nigeria	PROPN
aji-163	107	46	.	.	PUNCT
aji-163	108	1	b	b	X
aji-163	108	2	department	department	PROPN
aji-163	108	3	of	of	ADP
aji-163	108	4	science	science	PROPN
aji-163	108	5	education	education	NOUN
aji-163	108	6	,	,	PUNCT
aji-163	108	7	nnamdi	nnamdi	PROPN
aji-163	108	8	azikiwe	azikiwe	PROPN
aji-163	108	9	university	university	NOUN
aji-163	108	10	awka	awka	NOUN
aji-163	108	11	,	,	PUNCT
aji-163	108	12	nigeria	nigeria	PROPN
aji-163	108	13	.	.	PUNCT
aji-163	109	1	c	c	PROPN
aji-163	109	2	alex	alex	PROPN
aji-163	109	3	ekwueme	ekwueme	PROPN
aji-163	109	4	federal	federal	PROPN
aji-163	109	5	university	university	PROPN
aji-163	109	6	teaching	teaching	NOUN
aji-163	109	7	hospital	hospital	NOUN
aji-163	109	8	,	,	PUNCT
aji-163	109	9	abakaliki	abakaliki	ADJ
aji-163	109	10	,	,	PUNCT
aji-163	109	11	ebonyi	ebonyi	PROPN
aji-163	109	12	state	state	PROPN
aji-163	109	13	,	,	PUNCT
aji-163	109	14	nigeria	nigeria	PROPN
aji-163	109	15	.	.	PUNCT
aji-163	110	1	d	d	DET
aji-163	110	2	department	department	PROPN
aji-163	110	3	of	of	ADP
aji-163	110	4	biochemistry	biochemistry	NOUN
aji-163	110	5	,	,	PUNCT
aji-163	110	6	bayero	bayero	PROPN
aji-163	110	7	university	university	PROPN
aji-163	110	8	kano	kano	PROPN
aji-163	110	9	,	,	PUNCT
aji-163	110	10	nigeria	nigeria	PROPN
aji-163	110	11	.	.	PUNCT
aji-163	111	1	e	e	PROPN
aji-163	111	2	department	department	PROPN
aji-163	111	3	of	of	ADP
aji-163	111	4	microbiology	microbiology	NOUN
aji-163	111	5	,	,	PUNCT
aji-163	111	6	kebbi	kebbi	PROPN
aji-163	111	7	state	state	PROPN
aji-163	111	8	university	university	PROPN
aji-163	111	9	of	of	ADP
aji-163	111	10	science	science	NOUN
aji-163	111	11	and	and	CCONJ
aji-163	111	12	technology	technology	NOUN
aji-163	111	13	,	,	PUNCT
aji-163	111	14	aleiro	aleiro	NOUN
aji-163	111	15	,	,	PUNCT
aji-163	111	16	nigeria	nigeria	PROPN
aji-163	111	17	.	.	PUNCT
aji-163	112	1	f	f	PROPN
aji-163	112	2	department	department	PROPN
aji-163	112	3	of	of	ADP
aji-163	112	4	environmental	environmental	ADJ
aji-163	112	5	biology	biology	NOUN
aji-163	112	6	,	,	PUNCT
aji-163	112	7	kwara	kwara	PROPN
aji-163	112	8	state	state	PROPN
aji-163	112	9	polytechnic	polytechnic	ADJ
aji-163	112	10	/	/	SYM
aji-163	112	11	science	science	NOUN
aji-163	112	12	laboratory	laboratory	NOUN
aji-163	112	13	technology	technology	NOUN
aji-163	112	14	,	,	PUNCT
aji-163	112	15	nigeria	nigeria	PROPN
aji-163	112	16	.	.	PUNCT
aji-163	113	1	g	g	PROPN
aji-163	113	2	department	department	PROPN
aji-163	113	3	of	of	ADP
aji-163	113	4	microbiology	microbiology	NOUN
aji-163	113	5	,	,	PUNCT
aji-163	113	6	bayero	bayero	PROPN
aji-163	113	7	university	university	PROPN
aji-163	113	8	kano	kano	PROPN
aji-163	113	9	,	,	PUNCT
aji-163	113	10	nigeria	nigeria	PROPN
aji-163	113	11	.	.	PUNCT
aji-163	114	1	authors	author	NOUN
aji-163	114	2	’	'	PUNCT
aji-163	114	3	contributions	contribution	NOUN
aji-163	114	4	this	this	DET
aji-163	114	5	work	work	NOUN
aji-163	114	6	was	be	AUX
aji-163	114	7	carried	carry	VERB
aji-163	114	8	out	out	ADP
aji-163	114	9	in	in	ADP
aji-163	114	10	collaboration	collaboration	NOUN
aji-163	114	11	among	among	ADP
aji-163	114	12	all	all	DET
aji-163	114	13	authors	author	NOUN
aji-163	114	14	.	.	PUNCT
aji-163	115	1	all	all	DET
aji-163	115	2	authors	author	NOUN
aji-163	115	3	read	read	VERB
aji-163	115	4	and	and	CCONJ
aji-163	115	5	approved	approve	VERB
aji-163	115	6	the	the	DET
aji-163	115	7	final	final	ADJ
aji-163	115	8	manuscript	manuscript	NOUN
aji-163	115	9	.	.	PUNCT
aji-163	116	1	article	article	NOUN
aji-163	116	2	information	information	PROPN
aji-163	116	3	doi	doi	PROPN
aji-163	116	4	:	:	PUNCT
aji-163	116	5	https://doi.org/10.9734/aji/2025/v8i1163	https://doi.org/10.9734/aji/2025/v8i1163	PROPN
aji-163	116	6	open	open	ADJ
aji-163	116	7	peer	peer	NOUN
aji-163	116	8	review	review	NOUN
aji-163	116	9	history	history	NOUN
aji-163	116	10	:	:	PUNCT
aji-163	116	11	this	this	DET
aji-163	116	12	journal	journal	NOUN
aji-163	116	13	follows	follow	VERB
aji-163	116	14	the	the	DET
aji-163	116	15	advanced	advance	VERB
aji-163	116	16	open	open	ADJ
aji-163	116	17	peer	peer	NOUN
aji-163	116	18	review	review	NOUN
aji-163	116	19	policy	policy	NOUN
aji-163	116	20	.	.	PUNCT
aji-163	117	1	identity	identity	NOUN
aji-163	117	2	of	of	ADP
aji-163	117	3	the	the	DET
aji-163	117	4	reviewers	reviewer	NOUN
aji-163	117	5	,	,	PUNCT
aji-163	117	6	editor(s	editor(s	NOUN
aji-163	117	7	)	)	PUNCT
aji-163	117	8	and	and	CCONJ
aji-163	117	9	additional	additional	ADJ
aji-163	117	10	reviewers	reviewer	NOUN
aji-163	117	11	,	,	PUNCT
aji-163	117	12	peer	peer	NOUN
aji-163	117	13	review	review	NOUN
aji-163	117	14	comments	comment	NOUN
aji-163	117	15	,	,	PUNCT
aji-163	117	16	different	different	ADJ
aji-163	117	17	versions	version	NOUN
aji-163	117	18	of	of	ADP
aji-163	117	19	the	the	DET
aji-163	117	20	manuscript	manuscript	NOUN
aji-163	117	21	,	,	PUNCT
aji-163	117	22	comments	comment	NOUN
aji-163	117	23	of	of	ADP
aji-163	117	24	the	the	DET
aji-163	117	25	editors	editor	NOUN
aji-163	117	26	,	,	PUNCT
aji-163	117	27	etc	etc	X
aji-163	117	28	are	be	AUX
aji-163	117	29	available	available	ADJ
aji-163	117	30	here	here	ADV
aji-163	117	31	:	:	PUNCT
aji-163	117	32	https://pr.sdiarticle5.com/review-history/134904	https://pr.sdiarticle5.com/review-history/134904	NOUN
aji-163	117	33	received	receive	VERB
aji-163	117	34	:	:	PUNCT
aji-163	117	35	26/02/2025	26/02/2025	NUM
aji-163	117	36	published	publish	VERB
aji-163	117	37	:	:	PUNCT
aji-163	117	38	03/05/2025	03/05/2025	NUM
aji-163	117	39	minireview	minireview	NOUN
aji-163	117	40	article	article	NOUN
aji-163	117	41	https://doi.org/10.9734/aji/2025/v8i1163	https://doi.org/10.9734/aji/2025/v8i1163	PROPN
aji-163	117	42	https://pr.sdiarticle5.com/review-history/134904	https://pr.sdiarticle5.com/review-history/134904	VERB
aji-163	117	43	janefrancis	janefrancis	PROPN
aji-163	117	44	et	et	PROPN
aji-163	117	45	al	al	PROPN
aji-163	117	46	.	.	PROPN
aji-163	117	47	;	;	PUNCT
aji-163	117	48	asian	asian	PROPN
aji-163	117	49	j.	j.	PROPN
aji-163	117	50	immunol	immunol	PROPN
aji-163	117	51	.	.	PROPN
aji-163	117	52	,	,	PUNCT
aji-163	117	53	vol	vol	NOUN
aji-163	117	54	.	.	PROPN
aji-163	117	55	8	8	NUM
aji-163	117	56	,	,	PUNCT
aji-163	117	57	no	no	INTJ
aji-163	117	58	.	.	NOUN
aji-163	117	59	1	1	NUM
aji-163	117	60	,	,	PUNCT
aji-163	117	61	pp	pp	ADJ
aji-163	117	62	.	.	PUNCT
aji-163	118	1	86	86	NUM
aji-163	118	2	-	-	SYM
aji-163	118	3	96	96	NUM
aji-163	118	4	,	,	PUNCT
aji-163	118	5	2025	2025	NUM
aji-163	118	6	;	;	PUNCT
aji-163	118	7	article	article	NOUN
aji-163	118	8	no.aji.134904	no.aji.134904	VERB
aji-163	118	9	87	87	NUM
aji-163	118	10	abstract	abstract	ADJ
aji-163	118	11	trained	train	VERB
aji-163	118	12	immunity	immunity	NOUN
aji-163	118	13	,	,	PUNCT
aji-163	118	14	a	a	DET
aji-163	118	15	concept	concept	NOUN
aji-163	118	16	introduced	introduce	VERB
aji-163	118	17	more	more	ADJ
aji-163	118	18	than	than	ADP
aji-163	118	19	a	a	DET
aji-163	118	20	decade	decade	NOUN
aji-163	118	21	ago	ago	ADV
aji-163	118	22	,	,	PUNCT
aji-163	118	23	defines	define	VERB
aji-163	118	24	the	the	DET
aji-163	118	25	non	non	ADJ
aji-163	118	26	-	-	ADJ
aji-163	118	27	specific	specific	ADJ
aji-163	118	28	memory	memory	NOUN
aji-163	118	29	capacity	capacity	NOUN
aji-163	118	30	of	of	ADP
aji-163	118	31	innate	innate	ADJ
aji-163	118	32	immunity	immunity	NOUN
aji-163	118	33	by	by	ADP
aji-163	118	34	epigenetic	epigenetic	ADJ
aji-163	118	35	and	and	CCONJ
aji-163	118	36	metabolic	metabolic	NOUN
aji-163	118	37	reprogramming	reprogramme	VERB
aji-163	118	38	.	.	PUNCT
aji-163	119	1	it	it	PRON
aji-163	119	2	involves	involve	VERB
aji-163	119	3	features	feature	NOUN
aji-163	119	4	of	of	ADP
aji-163	119	5	epigenetic	epigenetic	ADJ
aji-163	119	6	and	and	CCONJ
aji-163	119	7	metabolic	metabolic	NOUN
aji-163	119	8	reprogramming	reprogramming	NOUN
aji-163	119	9	of	of	ADP
aji-163	119	10	innate	innate	ADJ
aji-163	119	11	immune	immune	ADJ
aji-163	119	12	cells	cell	NOUN
aji-163	119	13	that	that	PRON
aji-163	119	14	induce	induce	VERB
aji-163	119	15	long	long	ADJ
aji-163	119	16	-	-	PUNCT
aji-163	119	17	term	term	NOUN
aji-163	119	18	functional	functional	ADJ
aji-163	119	19	changes	change	NOUN
aji-163	119	20	in	in	ADP
aji-163	119	21	host	host	NOUN
aji-163	119	22	defense	defense	NOUN
aji-163	119	23	.	.	PUNCT
aji-163	120	1	this	this	DET
aji-163	120	2	review	review	NOUN
aji-163	120	3	explores	explore	VERB
aji-163	120	4	the	the	DET
aji-163	120	5	mechanisms	mechanism	NOUN
aji-163	120	6	and	and	CCONJ
aji-163	120	7	duration	duration	NOUN
aji-163	120	8	of	of	ADP
aji-163	120	9	trained	train	VERB
aji-163	120	10	immunity	immunity	NOUN
aji-163	120	11	,	,	PUNCT
aji-163	120	12	as	as	ADV
aji-163	120	13	well	well	ADV
aji-163	120	14	as	as	ADP
aji-163	120	15	the	the	DET
aji-163	120	16	therapies	therapy	NOUN
aji-163	120	17	related	relate	VERB
aji-163	120	18	to	to	ADP
aji-163	120	19	its	its	PRON
aji-163	120	20	potential	potential	NOUN
aji-163	120	21	in	in	ADP
aji-163	120	22	infectious	infectious	ADJ
aji-163	120	23	diseases	disease	NOUN
aji-163	120	24	.	.	PUNCT
aji-163	121	1	a	a	DET
aji-163	121	2	systematic	systematic	ADJ
aji-163	121	3	literature	literature	NOUN
aji-163	121	4	search	search	NOUN
aji-163	121	5	was	be	AUX
aji-163	121	6	conducted	conduct	VERB
aji-163	121	7	across	across	ADP
aji-163	121	8	pubmed	pubmed	PROPN
aji-163	121	9	,	,	PUNCT
aji-163	121	10	google	google	NOUN
aji-163	121	11	scholar	scholar	NOUN
aji-163	121	12	,	,	PUNCT
aji-163	121	13	and	and	CCONJ
aji-163	121	14	web	web	NOUN
aji-163	121	15	of	of	ADP
aji-163	121	16	science	science	NOUN
aji-163	121	17	for	for	ADP
aji-163	121	18	studies	study	NOUN
aji-163	121	19	published	publish	VERB
aji-163	121	20	between	between	ADP
aji-163	121	21	2019	2019	NUM
aji-163	121	22	and	and	CCONJ
aji-163	121	23	2025	2025	NUM
aji-163	121	24	.	.	PUNCT
aji-163	122	1	experimental	experimental	ADJ
aji-163	122	2	and	and	CCONJ
aji-163	122	3	clinical	clinical	ADJ
aji-163	122	4	studies	study	NOUN
aji-163	122	5	on	on	ADP
aji-163	122	6	innate	innate	ADJ
aji-163	122	7	immune	immune	ADJ
aji-163	122	8	memory	memory	NOUN
aji-163	122	9	,	,	PUNCT
aji-163	122	10	epigenetic	epigenetic	ADJ
aji-163	122	11	modifications	modification	NOUN
aji-163	122	12	,	,	PUNCT
aji-163	122	13	and	and	CCONJ
aji-163	122	14	metabolic	metabolic	NOUN
aji-163	122	15	pathways	pathway	NOUN
aji-163	122	16	associated	associate	VERB
aji-163	122	17	with	with	ADP
aji-163	122	18	long	long	ADJ
aji-163	122	19	-	-	PUNCT
aji-163	122	20	term	term	NOUN
aji-163	122	21	immune	immune	ADJ
aji-163	122	22	responses	response	NOUN
aji-163	122	23	were	be	AUX
aji-163	122	24	selected	select	VERB
aji-163	122	25	as	as	ADP
aji-163	122	26	study	study	NOUN
aji-163	122	27	criteria	criterion	NOUN
aji-163	122	28	.	.	PUNCT
aji-163	123	1	the	the	DET
aji-163	123	2	synthesized	synthesize	VERB
aji-163	123	3	data	datum	NOUN
aji-163	123	4	was	be	AUX
aji-163	123	5	narratively	narratively	ADV
aji-163	123	6	summarized	summarize	VERB
aji-163	123	7	to	to	PART
aji-163	123	8	assess	assess	VERB
aji-163	123	9	key	key	ADJ
aji-163	123	10	themes	theme	NOUN
aji-163	123	11	,	,	PUNCT
aji-163	123	12	including	include	VERB
aji-163	123	13	molecular	molecular	ADJ
aji-163	123	14	mechanisms	mechanism	NOUN
aji-163	123	15	,	,	PUNCT
aji-163	123	16	sustainability	sustainability	NOUN
aji-163	123	17	,	,	PUNCT
aji-163	123	18	and	and	CCONJ
aji-163	123	19	translational	translational	ADJ
aji-163	123	20	applications	application	NOUN
aji-163	123	21	.	.	PUNCT
aji-163	124	1	a	a	DET
aji-163	124	2	total	total	NOUN
aji-163	124	3	of	of	ADP
aji-163	124	4	eight	eight	NUM
aji-163	124	5	studies	study	NOUN
aji-163	124	6	were	be	AUX
aji-163	124	7	included	include	VERB
aji-163	124	8	in	in	ADP
aji-163	124	9	this	this	DET
aji-163	124	10	review	review	NOUN
aji-163	124	11	.	.	PUNCT
aji-163	125	1	the	the	DET
aji-163	125	2	findings	finding	NOUN
aji-163	125	3	revealed	reveal	VERB
aji-163	125	4	that	that	SCONJ
aji-163	125	5	trained	train	VERB
aji-163	125	6	immunity	immunity	NOUN
aji-163	125	7	is	be	AUX
aji-163	125	8	mediated	mediate	VERB
aji-163	125	9	by	by	ADP
aji-163	125	10	histone	histone	NOUN
aji-163	125	11	modifications	modification	NOUN
aji-163	125	12	,	,	PUNCT
aji-163	125	13	metabolic	metabolic	NOUN
aji-163	125	14	changes	change	NOUN
aji-163	125	15	,	,	PUNCT
aji-163	125	16	and	and	CCONJ
aji-163	125	17	long	long	ADJ
aji-163	125	18	-	-	PUNCT
aji-163	125	19	term	term	NOUN
aji-163	125	20	myelopoiesis	myelopoiesis	NOUN
aji-163	125	21	.	.	PUNCT
aji-163	126	1	studies	study	NOUN
aji-163	126	2	also	also	ADV
aji-163	126	3	show	show	VERB
aji-163	126	4	that	that	SCONJ
aji-163	126	5	immune	immune	ADJ
aji-163	126	6	training	training	NOUN
aji-163	126	7	has	have	VERB
aji-163	126	8	varying	vary	VERB
aji-163	126	9	durations	duration	NOUN
aji-163	126	10	,	,	PUNCT
aji-163	126	11	with	with	ADP
aji-163	126	12	effects	effect	NOUN
aji-163	126	13	lasting	last	VERB
aji-163	126	14	from	from	ADP
aji-163	126	15	weeks	week	NOUN
aji-163	126	16	to	to	ADP
aji-163	126	17	months	month	NOUN
aji-163	126	18	.	.	PUNCT
aji-163	127	1	emerging	emerge	VERB
aji-163	127	2	therapeutic	therapeutic	ADJ
aji-163	127	3	strategies	strategy	NOUN
aji-163	127	4	will	will	AUX
aji-163	127	5	focus	focus	VERB
aji-163	127	6	on	on	ADP
aji-163	127	7	vaccine	vaccine	NOUN
aji-163	127	8	enhancement	enhancement	NOUN
aji-163	127	9	,	,	PUNCT
aji-163	127	10	cancer	cancer	NOUN
aji-163	127	11	immunotherapy	immunotherapy	NOUN
aji-163	127	12	,	,	PUNCT
aji-163	127	13	and	and	CCONJ
aji-163	127	14	sepsis	sepsis	NOUN
aji-163	127	15	management	management	NOUN
aji-163	127	16	.	.	PUNCT
aji-163	128	1	however	however	ADV
aji-163	128	2	,	,	PUNCT
aji-163	128	3	challenges	challenge	NOUN
aji-163	128	4	remain	remain	VERB
aji-163	128	5	,	,	PUNCT
aji-163	128	6	including	include	VERB
aji-163	128	7	a	a	DET
aji-163	128	8	lack	lack	NOUN
aji-163	128	9	of	of	ADP
aji-163	128	10	clinical	clinical	ADJ
aji-163	128	11	validation	validation	NOUN
aji-163	128	12	,	,	PUNCT
aji-163	128	13	incomplete	incomplete	ADJ
aji-163	128	14	mechanistic	mechanistic	ADJ
aji-163	128	15	understanding	understanding	NOUN
aji-163	128	16	,	,	PUNCT
aji-163	128	17	and	and	CCONJ
aji-163	128	18	ethical	ethical	ADJ
aji-163	128	19	concerns	concern	NOUN
aji-163	128	20	.	.	PUNCT
aji-163	129	1	trained	train	VERB
aji-163	129	2	immunity	immunity	NOUN
aji-163	129	3	is	be	AUX
aji-163	129	4	a	a	DET
aji-163	129	5	promising	promising	ADJ
aji-163	129	6	approach	approach	NOUN
aji-163	129	7	to	to	ADP
aji-163	129	8	immunomodulation	immunomodulation	NOUN
aji-163	129	9	between	between	ADP
aji-163	129	10	innate	innate	ADJ
aji-163	129	11	and	and	CCONJ
aji-163	129	12	adaptive	adaptive	ADJ
aji-163	129	13	immunity	immunity	NOUN
aji-163	129	14	.	.	PUNCT
aji-163	130	1	future	future	ADJ
aji-163	130	2	research	research	NOUN
aji-163	130	3	should	should	AUX
aji-163	130	4	aim	aim	VERB
aji-163	130	5	to	to	PART
aji-163	130	6	conduct	conduct	VERB
aji-163	130	7	clinical	clinical	ADJ
aji-163	130	8	trials	trial	NOUN
aji-163	130	9	,	,	PUNCT
aji-163	130	10	assess	assess	NOUN
aji-163	130	11	safety	safety	NOUN
aji-163	130	12	,	,	PUNCT
aji-163	130	13	and	and	CCONJ
aji-163	130	14	develop	develop	VERB
aji-163	130	15	precision	precision	NOUN
aji-163	130	16	medicine	medicine	NOUN
aji-163	130	17	approaches	approach	NOUN
aji-163	130	18	to	to	PART
aji-163	130	19	efficiently	efficiently	ADV
aji-163	130	20	utilize	utilize	VERB
aji-163	130	21	this	this	DET
aji-163	130	22	concept	concept	NOUN
aji-163	130	23	in	in	ADP
aji-163	130	24	therapeutic	therapeutic	ADJ
aji-163	130	25	applications	application	NOUN
aji-163	130	26	.	.	PUNCT
aji-163	131	1	keywords	keyword	NOUN
aji-163	131	2	:	:	PUNCT
aji-163	131	3	trained	train	VERB
aji-163	131	4	immunity	immunity	NOUN
aji-163	131	5	;	;	PUNCT
aji-163	131	6	innate	innate	ADJ
aji-163	131	7	immune	immune	ADJ
aji-163	131	8	memory	memory	NOUN
aji-163	131	9	;	;	PUNCT
aji-163	131	10	infectious	infectious	ADJ
aji-163	131	11	diseases	disease	NOUN
aji-163	131	12	;	;	PUNCT
aji-163	131	13	metabolic	metabolic	NOUN
aji-163	131	14	reprogramming	reprogramming	NOUN
aji-163	131	15	;	;	PUNCT
aji-163	131	16	epigenetics	epigenetic	NOUN
aji-163	131	17	.	.	PUNCT
aji-163	132	1	abbreviations	abbreviation	NOUN
aji-163	132	2	bcg	bcg	PROPN
aji-163	132	3	:	:	PUNCT
aji-163	132	4	bacillus	bacillus	NOUN
aji-163	132	5	calmette	calmette	NOUN
aji-163	132	6	-	-	PUNCT
aji-163	132	7	guérin	guérin	PROPN
aji-163	132	8	hand	hand	NOUN
aji-163	132	9	:	:	PUNCT
aji-163	132	10	hiv	hiv	PROPN
aji-163	132	11	-	-	PUNCT
aji-163	132	12	associated	associate	VERB
aji-163	132	13	neurocognitive	neurocognitive	ADJ
aji-163	132	14	disorders	disorder	NOUN
aji-163	132	15	lncrna	lncrna	NOUN
aji-163	132	16	:	:	PUNCT
aji-163	132	17	long	long	ADJ
aji-163	132	18	non	non	ADJ
aji-163	132	19	-	-	ADJ
aji-163	132	20	coding	code	VERB
aji-163	132	21	rna	rna	NOUN
aji-163	132	22	mesh	mesh	NOUN
aji-163	132	23	:	:	PUNCT
aji-163	132	24	medical	medical	ADJ
aji-163	132	25	subject	subject	NOUN
aji-163	132	26	headings	heading	NOUN
aji-163	132	27	nk	nk	PROPN
aji-163	132	28	:	:	PUNCT
aji-163	132	29	natural	natural	ADJ
aji-163	132	30	killer	killer	NOUN
aji-163	132	31	prrs	prr	NOUN
aji-163	132	32	:	:	PUNCT
aji-163	132	33	pattern	pattern	NOUN
aji-163	132	34	recognition	recognition	NOUN
aji-163	132	35	receptors	receptor	NOUN
aji-163	132	36	tiis	tiis	NOUN
aji-163	132	37	:	:	PUNCT
aji-163	132	38	trained	train	VERB
aji-163	132	39	immunity	immunity	NOUN
aji-163	132	40	-	-	PUNCT
aji-163	132	41	inducing	induce	VERB
aji-163	132	42	agents	agent	NOUN
aji-163	132	43	tlr	tlr	PROPN
aji-163	132	44	:	:	PUNCT
aji-163	132	45	toll	toll	NOUN
aji-163	132	46	-	-	PUNCT
aji-163	132	47	like	like	ADJ
aji-163	132	48	receptors	receptor	NOUN
aji-163	132	49	1	1	NUM
aji-163	132	50	.	.	PUNCT
aji-163	133	1	introduction	introduction	NOUN
aji-163	133	2	trained	train	VERB
aji-163	133	3	immunity	immunity	NOUN
aji-163	133	4	,	,	PUNCT
aji-163	133	5	referred	refer	VERB
aji-163	133	6	to	to	ADP
aji-163	133	7	as	as	ADP
aji-163	133	8	innate	innate	ADJ
aji-163	133	9	immune	immune	ADJ
aji-163	133	10	memory	memory	NOUN
aji-163	133	11	,	,	PUNCT
aji-163	133	12	is	be	AUX
aji-163	133	13	an	an	DET
aji-163	133	14	inherent	inherent	ADJ
aji-163	133	15	capability	capability	NOUN
aji-163	133	16	of	of	ADP
aji-163	133	17	innate	innate	ADJ
aji-163	133	18	immune	immune	ADJ
aji-163	133	19	cells	cell	NOUN
aji-163	133	20	to	to	PART
aji-163	133	21	mount	mount	VERB
aji-163	133	22	enhanced	enhanced	ADJ
aji-163	133	23	response	response	NOUN
aji-163	133	24	to	to	ADP
aji-163	133	25	secondary	secondary	ADJ
aji-163	133	26	infections	infection	NOUN
aji-163	133	27	after	after	ADP
aji-163	133	28	an	an	DET
aji-163	133	29	initial	initial	ADJ
aji-163	133	30	exposure	exposure	NOUN
aji-163	133	31	.	.	PUNCT
aji-163	134	1	in	in	ADP
aji-163	134	2	contrast	contrast	NOUN
aji-163	134	3	to	to	ADP
aji-163	134	4	adaptive	adaptive	ADJ
aji-163	134	5	immunity	immunity	NOUN
aji-163	134	6	where	where	SCONJ
aji-163	134	7	memory	memory	NOUN
aji-163	134	8	cells	cell	NOUN
aji-163	134	9	are	be	AUX
aji-163	134	10	antigen	antigen	NOUN
aji-163	134	11	-	-	PUNCT
aji-163	134	12	specific	specific	ADJ
aji-163	134	13	,	,	PUNCT
aji-163	134	14	trained	train	VERB
aji-163	134	15	immunity	immunity	NOUN
aji-163	134	16	relies	rely	VERB
aji-163	134	17	on	on	ADP
aji-163	134	18	functional	functional	ADJ
aji-163	134	19	reprogramming	reprogramming	NOUN
aji-163	134	20	of	of	ADP
aji-163	134	21	the	the	DET
aji-163	134	22	innate	innate	ADJ
aji-163	134	23	immune	immune	ADJ
aji-163	134	24	cells	cell	NOUN
aji-163	134	25	,	,	PUNCT
aji-163	134	26	mainly	mainly	ADV
aji-163	134	27	monocytes	monocyte	NOUN
aji-163	134	28	,	,	PUNCT
aji-163	134	29	macrophages	macrophage	NOUN
aji-163	134	30	,	,	PUNCT
aji-163	134	31	and	and	CCONJ
aji-163	134	32	natural	natural	ADJ
aji-163	134	33	killer	killer	NOUN
aji-163	134	34	cells	cell	NOUN
aji-163	134	35	by	by	ADP
aji-163	134	36	epigenetic	epigenetic	ADJ
aji-163	134	37	and	and	CCONJ
aji-163	134	38	metabolic	metabolic	NOUN
aji-163	134	39	modifications	modification	NOUN
aji-163	134	40	(	(	PUNCT
aji-163	134	41	dulfer	dulfer	PROPN
aji-163	134	42	&	&	CCONJ
aji-163	134	43	domínguezandrés	domínguezandrés	PROPN
aji-163	134	44	,	,	PUNCT
aji-163	134	45	2024	2024	NUM
aji-163	134	46	)	)	PUNCT
aji-163	134	47	.	.	PUNCT
aji-163	135	1	this	this	PRON
aji-163	135	2	is	be	AUX
aji-163	135	3	a	a	DET
aji-163	135	4	phenomenon	phenomenon	NOUN
aji-163	135	5	shown	show	VERB
aji-163	135	6	previously	previously	ADV
aji-163	135	7	in	in	ADP
aji-163	135	8	invertebrates	invertebrate	NOUN
aji-163	135	9	without	without	ADP
aji-163	135	10	an	an	DET
aji-163	135	11	adaptive	adaptive	ADJ
aji-163	135	12	immune	immune	ADJ
aji-163	135	13	system	system	NOUN
aji-163	135	14	suggesting	suggest	VERB
aji-163	135	15	that	that	SCONJ
aji-163	135	16	innate	innate	ADJ
aji-163	135	17	immune	immune	ADJ
aji-163	135	18	memory	memory	NOUN
aji-163	135	19	has	have	AUX
aji-163	135	20	provided	provide	VERB
aji-163	135	21	a	a	DET
aji-163	135	22	fundamental	fundamental	ADJ
aji-163	135	23	evolutionary	evolutionary	ADJ
aji-163	135	24	advantage	advantage	NOUN
aji-163	135	25	(	(	PUNCT
aji-163	135	26	netea	netea	NOUN
aji-163	135	27	et	et	PROPN
aji-163	135	28	al	al	PROPN
aji-163	135	29	.	.	PROPN
aji-163	135	30	,	,	PUNCT
aji-163	135	31	2020	2020	NUM
aji-163	135	32	)	)	PUNCT
aji-163	135	33	.	.	PUNCT
aji-163	136	1	trained	train	VERB
aji-163	136	2	immunity	immunity	NOUN
aji-163	136	3	has	have	VERB
aji-163	136	4	its	its	PRON
aji-163	136	5	historical	historical	ADJ
aji-163	136	6	basis	basis	NOUN
aji-163	136	7	as	as	ADV
aji-163	136	8	early	early	ADV
aji-163	136	9	as	as	ADP
aji-163	136	10	its	its	PRON
aji-163	136	11	prolific	prolific	ADJ
aji-163	136	12	documentation	documentation	NOUN
aji-163	136	13	in	in	ADP
aji-163	136	14	the	the	DET
aji-163	136	15	nonspecific	nonspecific	ADJ
aji-163	136	16	protective	protective	ADJ
aji-163	136	17	effects	effect	NOUN
aji-163	136	18	of	of	ADP
aji-163	136	19	vaccines	vaccine	NOUN
aji-163	136	20	.	.	PUNCT
aji-163	137	1	for	for	ADP
aji-163	137	2	example	example	NOUN
aji-163	137	3	,	,	PUNCT
aji-163	137	4	the	the	DET
aji-163	137	5	bacillus	bacillus	NOUN
aji-163	137	6	calmette	calmette	NOUN
aji-163	137	7	-	-	PUNCT
aji-163	137	8	guérin	guérin	PROPN
aji-163	137	9	(	(	PUNCT
aji-163	137	10	bcg	bcg	PROPN
aji-163	137	11	)	)	PUNCT
aji-163	137	12	vaccine	vaccine	NOUN
aji-163	137	13	used	use	VERB
aji-163	137	14	for	for	ADP
aji-163	137	15	tuberculosis	tuberculosis	NOUN
aji-163	137	16	has	have	AUX
aji-163	137	17	been	be	AUX
aji-163	137	18	shown	show	VERB
aji-163	137	19	to	to	PART
aji-163	137	20	boost	boost	VERB
aji-163	137	21	resistance	resistance	NOUN
aji-163	137	22	to	to	ADP
aji-163	137	23	unrelated	unrelated	ADJ
aji-163	137	24	infections	infection	NOUN
aji-163	137	25	and	and	CCONJ
aji-163	137	26	is	be	AUX
aji-163	137	27	contrary	contrary	ADJ
aji-163	137	28	to	to	ADP
aji-163	137	29	the	the	DET
aji-163	137	30	prevailing	prevail	VERB
aji-163	137	31	separation	separation	NOUN
aji-163	137	32	of	of	ADP
aji-163	137	33	innate	innate	ADJ
aji-163	137	34	and	and	CCONJ
aji-163	137	35	adaptive	adaptive	ADJ
aji-163	137	36	immunity	immunity	NOUN
aji-163	137	37	(	(	PUNCT
aji-163	137	38	berendsen	berendsen	PROPN
aji-163	137	39	et	et	PROPN
aji-163	137	40	al	al	PROPN
aji-163	137	41	.	.	PROPN
aji-163	137	42	,	,	PUNCT
aji-163	137	43	2021	2021	NUM
aji-163	137	44	;	;	PUNCT
aji-163	137	45	ciarlo	ciarlo	PROPN
aji-163	137	46	et	et	PROPN
aji-163	137	47	al	al	PROPN
aji-163	137	48	.	.	PROPN
aji-163	137	49	,	,	PUNCT
aji-163	137	50	2020	2020	NUM
aji-163	137	51	)	)	PUNCT
aji-163	137	52	.	.	PUNCT
aji-163	138	1	further	further	ADJ
aji-163	138	2	studies	study	NOUN
aji-163	138	3	have	have	AUX
aji-163	138	4	demonstrated	demonstrate	VERB
aji-163	138	5	that	that	SCONJ
aji-163	138	6	long	long	ADV
aji-163	138	7	-	-	PUNCT
aji-163	138	8	lasting	last	VERB
aji-163	138	9	changes	change	NOUN
aji-163	138	10	in	in	ADP
aji-163	138	11	innate	innate	ADJ
aji-163	138	12	immune	immune	ADJ
aji-163	138	13	function	function	NOUN
aji-163	138	14	can	can	AUX
aji-163	138	15	be	be	AUX
aji-163	138	16	induced	induce	VERB
aji-163	138	17	by	by	ADP
aji-163	138	18	microbial	microbial	ADJ
aji-163	138	19	components	component	NOUN
aji-163	138	20	like	like	ADP
aji-163	138	21	β	β	X
aji-163	138	22	glucans	glucan	NOUN
aji-163	138	23	and	and	CCONJ
aji-163	138	24	lipopolysaccharides	lipopolysaccharide	NOUN
aji-163	138	25	,	,	PUNCT
aji-163	138	26	mediated	mediate	VERB
aji-163	138	27	by	by	ADP
aji-163	138	28	epigenetic	epigenetic	ADJ
aji-163	138	29	modifications	modification	NOUN
aji-163	138	30	e.g.	e.g.	ADV
aji-163	138	31	histone	histone	NOUN
aji-163	138	32	methylation	methylation	NOUN
aji-163	138	33	and	and	CCONJ
aji-163	138	34	acetylation	acetylation	NOUN
aji-163	138	35	in	in	ADP
aji-163	138	36	particular	particular	ADJ
aji-163	138	37	to	to	ADP
aji-163	138	38	inflammatory	inflammatory	ADJ
aji-163	138	39	response	response	NOUN
aji-163	138	40	gene	gene	NOUN
aji-163	138	41	(	(	PUNCT
aji-163	138	42	bomans	boman	NOUN
aji-163	138	43	et	et	PROPN
aji-163	138	44	al	al	PROPN
aji-163	138	45	.	.	PROPN
aji-163	138	46	,	,	PUNCT
aji-163	138	47	2018	2018	NUM
aji-163	138	48	;	;	PUNCT
aji-163	138	49	sánchezramón	sánchezramón	PROPN
aji-163	138	50	et	et	PROPN
aji-163	138	51	al	al	PROPN
aji-163	138	52	.	.	PROPN
aji-163	138	53	,	,	PUNCT
aji-163	138	54	2018	2018	NUM
aji-163	138	55	)	)	PUNCT
aji-163	138	56	.	.	PUNCT
aji-163	139	1	trained	train	VERB
aji-163	139	2	immunity	immunity	NOUN
aji-163	139	3	is	be	AUX
aji-163	139	4	mediated	mediate	VERB
aji-163	139	5	through	through	ADP
aji-163	139	6	changes	change	NOUN
aji-163	139	7	in	in	ADP
aji-163	139	8	metabolism	metabolism	NOUN
aji-163	139	9	including	include	VERB
aji-163	139	10	the	the	DET
aji-163	139	11	reprogramming	reprogramming	NOUN
aji-163	139	12	of	of	ADP
aji-163	139	13	immune	immune	ADJ
aji-163	139	14	progenitor	progenitor	NOUN
aji-163	139	15	cells	cell	NOUN
aji-163	139	16	from	from	ADP
aji-163	139	17	the	the	DET
aji-163	139	18	bone	bone	NOUN
aji-163	139	19	marrow	marrow	NOUN
aji-163	139	20	to	to	PART
aji-163	139	21	convert	convert	VERB
aji-163	139	22	to	to	ADP
aji-163	139	23	aerobic	aerobic	ADJ
aji-163	139	24	glycolysis	glycolysis	NOUN
aji-163	139	25	.	.	PUNCT
aji-163	140	1	however	however	ADV
aji-163	140	2	,	,	PUNCT
aji-163	140	3	it	it	PRON
aji-163	140	4	has	have	AUX
aji-163	140	5	been	be	AUX
aji-163	140	6	shown	show	VERB
aji-163	140	7	that	that	SCONJ
aji-163	140	8	histone	histone	NOUN
aji-163	140	9	modifications	modification	NOUN
aji-163	140	10	,	,	PUNCT
aji-163	140	11	such	such	ADJ
aji-163	140	12	as	as	ADP
aji-163	140	13	h3k4me3	h3k4me3	NOUN
aji-163	140	14	and	and	CCONJ
aji-163	140	15	h3k27ac	h3k27ac	PROPN
aji-163	140	16	,	,	PUNCT
aji-163	140	17	are	be	AUX
aji-163	140	18	associated	associate	VERB
aji-163	140	19	with	with	ADP
aji-163	140	20	a	a	DET
aji-163	140	21	heightened	heighten	VERB
aji-163	140	22	inflammatory	inflammatory	ADJ
aji-163	140	23	response	response	NOUN
aji-163	140	24	on	on	ADP
aji-163	140	25	reinfection	reinfection	NOUN
aji-163	140	26	(	(	PUNCT
aji-163	140	27	katzmarski	katzmarski	NOUN
aji-163	140	28	et	et	PROPN
aji-163	140	29	al	al	PROPN
aji-163	140	30	.	.	PROPN
aji-163	140	31	,	,	PUNCT
aji-163	140	32	2021	2021	NUM
aji-163	140	33	)	)	PUNCT
aji-163	140	34	.	.	PUNCT
aji-163	141	1	in	in	ADP
aji-163	141	2	addition	addition	NOUN
aji-163	141	3	,	,	PUNCT
aji-163	141	4	evidence	evidence	NOUN
aji-163	141	5	shows	show	VERB
aji-163	141	6	that	that	SCONJ
aji-163	141	7	trained	train	VERB
aji-163	141	8	immunity	immunity	NOUN
aji-163	141	9	is	be	AUX
aji-163	141	10	inherited	inherit	VERB
aji-163	141	11	transgenerationally	transgenerationally	ADV
aji-163	141	12	by	by	ADP
aji-163	141	13	germ	germ	NOUN
aji-163	141	14	cell	cell	NOUN
aji-163	141	15	epigenetic	epigenetic	ADJ
aji-163	141	16	modifications	modification	NOUN
aji-163	141	17	and	and	CCONJ
aji-163	141	18	shapes	shape	NOUN
aji-163	141	19	immune	immune	ADJ
aji-163	141	20	responses	response	NOUN
aji-163	141	21	in	in	ADP
aji-163	141	22	the	the	DET
aji-163	141	23	offspring	offspring	NOUN
aji-163	141	24	(	(	PUNCT
aji-163	141	25	kaufmann	kaufmann	PROPN
aji-163	141	26	et	et	PROPN
aji-163	141	27	al	al	PROPN
aji-163	141	28	.	.	PROPN
aji-163	141	29	,	,	PUNCT
aji-163	141	30	2022	2022	NUM
aji-163	141	31	)	)	PUNCT
aji-163	141	32	.	.	PUNCT
aji-163	142	1	two	two	NUM
aji-163	142	2	differing	differ	VERB
aji-163	142	3	mechanisms	mechanism	NOUN
aji-163	142	4	of	of	ADP
aji-163	142	5	immunological	immunological	ADJ
aji-163	142	6	memory	memory	NOUN
aji-163	142	7	,	,	PUNCT
aji-163	142	8	namely	namely	ADV
aji-163	142	9	trained	train	VERB
aji-163	142	10	immunity	immunity	NOUN
aji-163	142	11	and	and	CCONJ
aji-163	142	12	adaptive	adaptive	ADJ
aji-163	142	13	immune	immune	ADJ
aji-163	142	14	memory	memory	NOUN
aji-163	142	15	,	,	PUNCT
aji-163	142	16	have	have	VERB
aji-163	142	17	a	a	DET
aji-163	142	18	distinct	distinct	ADJ
aji-163	142	19	cellular	cellular	ADJ
aji-163	142	20	basis	basis	NOUN
aji-163	142	21	,	,	PUNCT
aji-163	142	22	specificity	specificity	NOUN
aji-163	142	23	,	,	PUNCT
aji-163	142	24	duration	duration	NOUN
aji-163	142	25	,	,	PUNCT
aji-163	142	26	and	and	CCONJ
aji-163	142	27	underlying	underlie	VERB
aji-163	142	28	molecular	molecular	ADJ
aji-163	142	29	janefrancis	janefrancis	NOUN
aji-163	142	30	et	et	PROPN
aji-163	142	31	al	al	PROPN
aji-163	142	32	.	.	PROPN
aji-163	142	33	;	;	PUNCT
aji-163	143	1	asian	asian	PROPN
aji-163	143	2	j.	j.	PROPN
aji-163	143	3	immunol	immunol	PROPN
aji-163	143	4	.	.	PROPN
aji-163	143	5	,	,	PUNCT
aji-163	143	6	vol	vol	NOUN
aji-163	143	7	.	.	PROPN
aji-163	143	8	8	8	NUM
aji-163	143	9	,	,	PUNCT
aji-163	143	10	no	no	INTJ
aji-163	143	11	.	.	NOUN
aji-163	143	12	1	1	NUM
aji-163	143	13	,	,	PUNCT
aji-163	143	14	pp	pp	ADJ
aji-163	143	15	.	.	PUNCT
aji-163	144	1	86	86	NUM
aji-163	144	2	-	-	SYM
aji-163	144	3	96	96	NUM
aji-163	144	4	,	,	PUNCT
aji-163	144	5	2025	2025	NUM
aji-163	144	6	;	;	PUNCT
aji-163	144	7	article	article	NOUN
aji-163	144	8	no.aji.134904	no.aji.134904	VERB
aji-163	144	9	88	88	NUM
aji-163	144	10	fig	fig	NOUN
aji-163	144	11	.	.	PUNCT
aji-163	145	1	1	1	X
aji-163	145	2	.	.	X
aji-163	145	3	conceptual	conceptual	ADJ
aji-163	145	4	framework	framework	NOUN
aji-163	145	5	of	of	ADP
aji-163	145	6	the	the	DET
aji-163	145	7	study	study	NOUN
aji-163	145	8	mechanisms	mechanism	NOUN
aji-163	145	9	.	.	PUNCT
aji-163	146	1	training	training	NOUN
aji-163	146	2	immunity	immunity	NOUN
aji-163	146	3	involves	involve	VERB
aji-163	146	4	the	the	DET
aji-163	146	5	innate	innate	ADJ
aji-163	146	6	immune	immune	ADJ
aji-163	146	7	cells	cell	NOUN
aji-163	146	8	such	such	ADJ
aji-163	146	9	as	as	ADP
aji-163	146	10	monocytes	monocyte	NOUN
aji-163	146	11	,	,	PUNCT
aji-163	146	12	macrophages	macrophage	NOUN
aji-163	146	13	,	,	PUNCT
aji-163	146	14	and	and	CCONJ
aji-163	146	15	nk	nk	PROPN
aji-163	146	16	cells	cell	NOUN
aji-163	146	17	,	,	PUNCT
aji-163	146	18	while	while	SCONJ
aji-163	146	19	adaptation	adaptation	NOUN
aji-163	146	20	immune	immune	ADJ
aji-163	146	21	memory	memory	NOUN
aji-163	146	22	is	be	AUX
aji-163	146	23	dependent	dependent	ADJ
aji-163	146	24	on	on	ADP
aji-163	146	25	antigenspecific	antigenspecific	PROPN
aji-163	146	26	t	t	PROPN
aji-163	146	27	and	and	CCONJ
aji-163	146	28	b	b	PROPN
aji-163	146	29	lymphocytes	lymphocyte	NOUN
aji-163	146	30	which	which	PRON
aji-163	146	31	get	get	AUX
aji-163	146	32	clonally	clonally	ADV
aji-163	146	33	expanded	expand	VERB
aji-163	146	34	and	and	CCONJ
aji-163	146	35	persist	persist	VERB
aji-163	146	36	for	for	ADP
aji-163	146	37	a	a	DET
aji-163	146	38	long	long	ADJ
aji-163	146	39	period	period	NOUN
aji-163	146	40	(	(	PUNCT
aji-163	146	41	netea	netea	NOUN
aji-163	146	42	et	et	PROPN
aji-163	146	43	al	al	PROPN
aji-163	146	44	.	.	PROPN
aji-163	146	45	,	,	PUNCT
aji-163	146	46	2020	2020	NUM
aji-163	146	47	)	)	PUNCT
aji-163	146	48	.	.	PUNCT
aji-163	147	1	in	in	ADP
aji-163	147	2	contrast	contrast	NOUN
aji-163	147	3	to	to	ADP
aji-163	147	4	adaptive	adaptive	ADJ
aji-163	147	5	immunity	immunity	NOUN
aji-163	147	6	,	,	PUNCT
aji-163	147	7	which	which	PRON
aji-163	147	8	works	work	VERB
aji-163	147	9	via	via	ADP
aji-163	147	10	highly	highly	ADV
aji-163	147	11	specific	specific	ADJ
aji-163	147	12	somatically	somatically	ADV
aji-163	147	13	revisers	reviser	NOUN
aji-163	147	14	in	in	ADP
aji-163	147	15	antigen	antigen	ADJ
aji-163	147	16	receptors	receptor	NOUN
aji-163	147	17	to	to	PART
aji-163	147	18	encounter	encounter	VERB
aji-163	147	19	antigens	antigen	NOUN
aji-163	147	20	previously	previously	ADV
aji-163	147	21	exposed	expose	VERB
aji-163	147	22	,	,	PUNCT
aji-163	147	23	trained	train	VERB
aji-163	147	24	immunity	immunity	NOUN
aji-163	147	25	based	base	VERB
aji-163	147	26	on	on	ADP
aji-163	147	27	broad	broad	ADJ
aji-163	147	28	pattern	pattern	NOUN
aji-163	147	29	recognition	recognition	NOUN
aji-163	147	30	receptors	receptor	NOUN
aji-163	147	31	(	(	PUNCT
aji-163	147	32	prrs	prr	NOUN
aji-163	147	33	)	)	PUNCT
aji-163	147	34	,	,	PUNCT
aji-163	147	35	like	like	ADP
aji-163	147	36	toll	toll	NOUN
aji-163	147	37	-	-	PUNCT
aji-163	147	38	like	like	ADJ
aji-163	147	39	receptors	receptor	NOUN
aji-163	147	40	(	(	PUNCT
aji-163	147	41	tlrs	tlrs	NOUN
aji-163	147	42	)	)	PUNCT
aji-163	147	43	,	,	PUNCT
aji-163	147	44	to	to	PART
aji-163	147	45	detect	detect	VERB
aji-163	147	46	conserved	conserved	ADJ
aji-163	147	47	microbial	microbial	ADJ
aji-163	147	48	components	component	NOUN
aji-163	147	49	(	(	PUNCT
aji-163	147	50	mulder	mulder	X
aji-163	147	51	et	et	PROPN
aji-163	147	52	al	al	PROPN
aji-163	147	53	.	.	PROPN
aji-163	147	54	2019	2019	NUM
aji-163	147	55	)	)	PUNCT
aji-163	147	56	.	.	PUNCT
aji-163	148	1	the	the	DET
aji-163	148	2	length	length	NOUN
aji-163	148	3	of	of	ADP
aji-163	148	4	immune	immune	ADJ
aji-163	148	5	memory	memory	NOUN
aji-163	148	6	is	be	AUX
aji-163	148	7	otherwise	otherwise	ADV
aji-163	148	8	very	very	ADV
aji-163	148	9	different	different	ADJ
aji-163	148	10	in	in	ADP
aji-163	148	11	these	these	DET
aji-163	148	12	two	two	NUM
aji-163	148	13	systems	system	NOUN
aji-163	148	14	.	.	PUNCT
aji-163	149	1	adaptive	adaptive	ADJ
aji-163	149	2	immune	immune	ADJ
aji-163	149	3	memory	memory	NOUN
aji-163	149	4	does	do	AUX
aji-163	149	5	persist	persist	VERB
aji-163	149	6	for	for	ADP
aji-163	149	7	years	year	NOUN
aji-163	149	8	or	or	CCONJ
aji-163	149	9	even	even	ADV
aji-163	149	10	a	a	DET
aji-163	149	11	lifetime	lifetime	NOUN
aji-163	149	12	,	,	PUNCT
aji-163	149	13	as	as	ADP
aji-163	149	14	the	the	DET
aji-163	149	15	presence	presence	NOUN
aji-163	149	16	of	of	ADP
aji-163	149	17	long	long	ADV
aji-163	149	18	-	-	PUNCT
aji-163	149	19	lived	live	VERB
aji-163	149	20	memory	memory	NOUN
aji-163	149	21	t	t	PROPN
aji-163	149	22	and	and	CCONJ
aji-163	149	23	b	b	PROPN
aji-163	149	24	cells	cell	NOUN
aji-163	149	25	(	(	PUNCT
aji-163	149	26	bekkering	bekkere	VERB
aji-163	149	27	et	et	PROPN
aji-163	149	28	al	al	PROPN
aji-163	149	29	.	.	PROPN
aji-163	149	30	,	,	PUNCT
aji-163	149	31	2021	2021	NUM
aji-163	149	32	)	)	PUNCT
aji-163	149	33	.	.	PUNCT
aji-163	150	1	these	these	DET
aji-163	150	2	epigenetic	epigenetic	ADJ
aji-163	150	3	and	and	CCONJ
aji-163	150	4	metabolic	metabolic	NOUN
aji-163	150	5	reprogramming	reprogramme	VERB
aji-163	150	6	programs	program	NOUN
aji-163	150	7	that	that	PRON
aji-163	150	8	train	train	VERB
aji-163	150	9	immunity	immunity	NOUN
aji-163	150	10	tend	tend	VERB
aji-163	150	11	to	to	PART
aji-163	150	12	be	be	AUX
aji-163	150	13	at	at	ADP
aji-163	150	14	the	the	DET
aji-163	150	15	molecular	molecular	ADJ
aji-163	150	16	level	level	NOUN
aji-163	150	17	and	and	CCONJ
aji-163	150	18	include	include	VERB
aji-163	150	19	histone	histone	NOUN
aji-163	150	20	modifications	modification	NOUN
aji-163	150	21	and	and	CCONJ
aji-163	150	22	shifts	shift	NOUN
aji-163	150	23	in	in	ADP
aji-163	150	24	glycolytic	glycolytic	ADJ
aji-163	150	25	metabolism	metabolism	NOUN
aji-163	150	26	to	to	PART
aji-163	150	27	enhance	enhance	VERB
aji-163	150	28	the	the	DET
aji-163	150	29	responsiveness	responsiveness	NOUN
aji-163	150	30	of	of	ADP
aji-163	150	31	innate	innate	ADJ
aji-163	150	32	immune	immune	ADJ
aji-163	150	33	cells	cell	NOUN
aji-163	150	34	to	to	ADP
aji-163	150	35	reinfection	reinfection	NOUN
aji-163	150	36	(	(	PUNCT
aji-163	150	37	saeed	saeed	PROPN
aji-163	150	38	et	et	PROPN
aji-163	150	39	al	al	PROPN
aji-163	150	40	.	.	PROPN
aji-163	150	41	,	,	PUNCT
aji-163	150	42	2014	2014	NUM
aji-163	150	43	)	)	PUNCT
aji-163	150	44	.	.	PUNCT
aji-163	151	1	adaptive	adaptive	ADJ
aji-163	151	2	immune	immune	ADJ
aji-163	151	3	memory	memory	NOUN
aji-163	151	4	,	,	PUNCT
aji-163	151	5	however	however	ADV
aji-163	151	6	,	,	PUNCT
aji-163	151	7	is	be	AUX
aji-163	151	8	sustained	sustain	VERB
aji-163	151	9	through	through	ADP
aji-163	151	10	clonal	clonal	ADJ
aji-163	151	11	expansion	expansion	NOUN
aji-163	151	12	,	,	PUNCT
aji-163	151	13	long	long	ADV
aji-163	151	14	-	-	PUNCT
aji-163	151	15	lived	live	VERB
aji-163	151	16	plasma	plasma	NOUN
aji-163	151	17	cells	cell	NOUN
aji-163	151	18	and	and	CCONJ
aji-163	151	19	memory	memory	NOUN
aji-163	151	20	t	t	NOUN
aji-163	151	21	cells	cell	NOUN
aji-163	151	22	upon	upon	SCONJ
aji-163	151	23	receipt	receipt	NOUN
aji-163	151	24	of	of	ADP
aji-163	151	25	antigens	antigen	NOUN
aji-163	151	26	with	with	ADP
aji-163	151	27	specialized	specialized	ADJ
aji-163	151	28	effector	effector	NOUN
aji-163	151	29	functions	function	NOUN
aji-163	151	30	(	(	PUNCT
aji-163	151	31	sallusto	sallusto	PROPN
aji-163	151	32	et	et	PROPN
aji-163	151	33	al	al	PROPN
aji-163	151	34	.	.	PROPN
aji-163	151	35	,	,	PUNCT
aji-163	151	36	2010	2010	NUM
aji-163	151	37	)	)	PUNCT
aji-163	151	38	.	.	PUNCT
aji-163	152	1	these	these	DET
aji-163	152	2	immune	immune	ADJ
aji-163	152	3	strategies	strategy	NOUN
aji-163	152	4	also	also	ADV
aji-163	152	5	form	form	VERB
aji-163	152	6	an	an	DET
aji-163	152	7	important	important	ADJ
aji-163	152	8	distinction	distinction	NOUN
aji-163	152	9	in	in	ADP
aji-163	152	10	terms	term	NOUN
aji-163	152	11	of	of	ADP
aji-163	152	12	their	their	PRON
aji-163	152	13	evolutionary	evolutionary	ADJ
aji-163	152	14	origin	origin	NOUN
aji-163	152	15	.	.	PUNCT
aji-163	153	1	conserved	conserve	VERB
aji-163	153	2	across	across	ADP
aji-163	153	3	the	the	DET
aji-163	153	4	wide	wide	ADJ
aji-163	153	5	spectrum	spectrum	NOUN
aji-163	153	6	of	of	ADP
aji-163	153	7	diverse	diverse	ADJ
aji-163	153	8	species	specie	NOUN
aji-163	153	9	ranging	range	VERB
aji-163	153	10	from	from	ADP
aji-163	153	11	plants	plant	NOUN
aji-163	153	12	and	and	CCONJ
aji-163	153	13	invertebrates	invertebrate	NOUN
aji-163	153	14	,	,	PUNCT
aji-163	153	15	this	this	DET
aji-163	153	16	ancient	ancient	ADJ
aji-163	153	17	type	type	NOUN
aji-163	153	18	of	of	ADP
aji-163	153	19	immunity	immunity	NOUN
aji-163	153	20	definitely	definitely	ADV
aji-163	153	21	plays	play	VERB
aji-163	153	22	a	a	DET
aji-163	153	23	selective	selective	ADJ
aji-163	153	24	role	role	NOUN
aji-163	153	25	in	in	ADP
aji-163	153	26	the	the	DET
aji-163	153	27	host	host	NOUN
aji-163	153	28	defense	defense	NOUN
aji-163	153	29	(	(	PUNCT
aji-163	153	30	duggan	duggan	PROPN
aji-163	153	31	et	et	PROPN
aji-163	153	32	al	al	PROPN
aji-163	153	33	.	.	PROPN
aji-163	153	34	,	,	PUNCT
aji-163	153	35	2023	2023	NUM
aji-163	153	36	)	)	PUNCT
aji-163	153	37	.	.	PUNCT
aji-163	154	1	in	in	ADP
aji-163	154	2	contrast	contrast	NOUN
aji-163	154	3	to	to	ADP
aji-163	154	4	adaptive	adaptive	ADJ
aji-163	154	5	immunity	immunity	NOUN
aji-163	154	6	,	,	PUNCT
aji-163	154	7	this	this	PRON
aji-163	154	8	is	be	AUX
aji-163	154	9	unique	unique	ADJ
aji-163	154	10	to	to	ADP
aji-163	154	11	the	the	DET
aji-163	154	12	vertebrates	vertebrate	NOUN
aji-163	154	13	and	and	CCONJ
aji-163	154	14	gives	give	VERB
aji-163	154	15	highly	highly	ADV
aji-163	154	16	refined	refined	ADJ
aji-163	154	17	and	and	CCONJ
aji-163	154	18	longlasting	longlaste	VERB
aji-163	154	19	protection	protection	NOUN
aji-163	154	20	against	against	ADP
aji-163	154	21	pathogens	pathogen	NOUN
aji-163	154	22	(	(	PUNCT
aji-163	154	23	sun	sun	PROPN
aji-163	154	24	&	&	CCONJ
aji-163	154	25	lanier	lanier	PROPN
aji-163	154	26	,	,	PUNCT
aji-163	154	27	2021	2021	NUM
aji-163	154	28	)	)	PUNCT
aji-163	154	29	.	.	PUNCT
aji-163	155	1	the	the	DET
aji-163	155	2	aim	aim	NOUN
aji-163	155	3	of	of	ADP
aji-163	155	4	this	this	DET
aji-163	155	5	review	review	NOUN
aji-163	155	6	was	be	AUX
aji-163	155	7	to	to	PART
aji-163	155	8	investigate	investigate	VERB
aji-163	155	9	the	the	DET
aji-163	155	10	complete	complete	ADJ
aji-163	155	11	analysis	analysis	NOUN
aji-163	155	12	of	of	ADP
aji-163	155	13	protective	protective	ADJ
aji-163	155	14	mechanisms	mechanism	NOUN
aji-163	155	15	in	in	ADP
aji-163	155	16	infectious	infectious	ADJ
aji-163	155	17	diseases	disease	NOUN
aji-163	155	18	through	through	ADP
aji-163	155	19	the	the	DET
aji-163	155	20	synthesis	synthesis	NOUN
aji-163	155	21	of	of	ADP
aji-163	155	22	contemporary	contemporary	ADJ
aji-163	155	23	evidence	evidence	NOUN
aji-163	155	24	on	on	ADP
aji-163	155	25	molecular	molecular	ADJ
aji-163	155	26	processes	process	NOUN
aji-163	155	27	and	and	CCONJ
aji-163	155	28	duration	duration	NOUN
aji-163	155	29	of	of	ADP
aji-163	155	30	effect	effect	NOUN
aji-163	155	31	and	and	CCONJ
aji-163	155	32	therapeutic	therapeutic	ADJ
aji-163	155	33	possibilities	possibility	NOUN
aji-163	155	34	of	of	ADP
aji-163	155	35	trained	train	VERB
aji-163	155	36	immunity	immunity	NOUN
aji-163	155	37	.	.	PUNCT
aji-163	156	1	fig	fig	NOUN
aji-163	156	2	.	.	PUNCT
aji-163	157	1	1	1	NUM
aji-163	157	2	illustrates	illustrate	VERB
aji-163	157	3	the	the	DET
aji-163	157	4	conceptual	conceptual	ADJ
aji-163	157	5	framework	framework	NOUN
aji-163	157	6	of	of	ADP
aji-163	157	7	the	the	DET
aji-163	157	8	study	study	NOUN
aji-163	157	9	.	.	PUNCT
aji-163	158	1	2	2	X
aji-163	158	2	.	.	X
aji-163	158	3	methodology	methodology	NOUN
aji-163	158	4	2.1	2.1	NUM
aji-163	158	5	literature	literature	NOUN
aji-163	158	6	search	search	NOUN
aji-163	158	7	strategy	strategy	NOUN
aji-163	158	8	a	a	DET
aji-163	158	9	comprehensive	comprehensive	ADJ
aji-163	158	10	and	and	CCONJ
aji-163	158	11	systematic	systematic	ADJ
aji-163	158	12	literature	literature	NOUN
aji-163	158	13	search	search	NOUN
aji-163	158	14	was	be	AUX
aji-163	158	15	conducted	conduct	VERB
aji-163	158	16	to	to	PART
aji-163	158	17	identify	identify	VERB
aji-163	158	18	relevant	relevant	ADJ
aji-163	158	19	studies	study	NOUN
aji-163	158	20	on	on	ADP
aji-163	158	21	trained	train	VERB
aji-163	158	22	immunity	immunity	NOUN
aji-163	158	23	,	,	PUNCT
aji-163	158	24	epigenetic	epigenetic	ADJ
aji-163	158	25	reprogramming	reprogramming	NOUN
aji-163	158	26	,	,	PUNCT
aji-163	158	27	and	and	CCONJ
aji-163	158	28	long	long	ADJ
aji-163	158	29	-	-	PUNCT
aji-163	158	30	term	term	NOUN
aji-163	158	31	immune	immune	ADJ
aji-163	158	32	responses	response	NOUN
aji-163	158	33	in	in	ADP
aji-163	158	34	the	the	DET
aji-163	158	35	context	context	NOUN
aji-163	158	36	of	of	ADP
aji-163	158	37	infectious	infectious	ADJ
aji-163	158	38	diseases	disease	NOUN
aji-163	158	39	.	.	PUNCT
aji-163	159	1	the	the	DET
aji-163	159	2	search	search	NOUN
aji-163	159	3	was	be	AUX
aji-163	159	4	performed	perform	VERB
aji-163	159	5	across	across	ADP
aji-163	159	6	multiple	multiple	ADJ
aji-163	159	7	databases	database	NOUN
aji-163	159	8	,	,	PUNCT
aji-163	159	9	including	include	VERB
aji-163	159	10	pubmed	pubmed	PROPN
aji-163	159	11	,	,	PUNCT
aji-163	159	12	web	web	NOUN
aji-163	159	13	of	of	ADP
aji-163	159	14	science	science	NOUN
aji-163	159	15	,	,	PUNCT
aji-163	159	16	and	and	CCONJ
aji-163	159	17	google	google	PROPN
aji-163	159	18	scholar	scholar	NOUN
aji-163	159	19	,	,	PUNCT
aji-163	159	20	with	with	ADP
aji-163	159	21	a	a	DET
aji-163	159	22	timeframe	timeframe	NOUN
aji-163	159	23	of	of	ADP
aji-163	159	24	2019	2019	NUM
aji-163	159	25	to	to	ADP
aji-163	159	26	2025	2025	NUM
aji-163	159	27	,	,	PUNCT
aji-163	159	28	ensuring	ensure	VERB
aji-163	159	29	broad	broad	ADJ
aji-163	159	30	coverage	coverage	NOUN
aji-163	159	31	of	of	ADP
aji-163	159	32	biomedical	biomedical	ADJ
aji-163	159	33	and	and	CCONJ
aji-163	159	34	immunological	immunological	ADJ
aji-163	159	35	research	research	NOUN
aji-163	159	36	.	.	PUNCT
aji-163	160	1	the	the	DET
aji-163	160	2	search	search	NOUN
aji-163	160	3	strategy	strategy	NOUN
aji-163	160	4	combined	combine	VERB
aji-163	160	5	medical	medical	ADJ
aji-163	160	6	subject	subject	NOUN
aji-163	160	7	headings	heading	NOUN
aji-163	160	8	(	(	PUNCT
aji-163	160	9	mesh	mesh	NOUN
aji-163	160	10	)	)	PUNCT
aji-163	160	11	terms	term	NOUN
aji-163	160	12	and	and	CCONJ
aji-163	160	13	keywords	keyword	NOUN
aji-163	160	14	related	relate	VERB
aji-163	160	15	to	to	ADP
aji-163	160	16	trained	train	VERB
aji-163	160	17	immunity	immunity	NOUN
aji-163	160	18	,	,	PUNCT
aji-163	160	19	innate	innate	ADJ
aji-163	160	20	immune	immune	ADJ
aji-163	160	21	memory	memory	NOUN
aji-163	160	22	,	,	PUNCT
aji-163	160	23	epigenetics	epigenetic	NOUN
aji-163	160	24	,	,	PUNCT
aji-163	160	25	histone	histone	NOUN
aji-163	160	26	modifications	modification	NOUN
aji-163	160	27	,	,	PUNCT
aji-163	160	28	metabolic	metabolic	NOUN
aji-163	160	29	reprogramming	reprogramming	NOUN
aji-163	160	30	,	,	PUNCT
aji-163	160	31	and	and	CCONJ
aji-163	160	32	infectious	infectious	ADJ
aji-163	160	33	disease	disease	NOUN
aji-163	160	34	protection	protection	NOUN
aji-163	160	35	.	.	PUNCT
aji-163	161	1	boolean	boolean	ADJ
aji-163	161	2	operators	operator	NOUN
aji-163	161	3	(	(	PUNCT
aji-163	161	4	and	and	CCONJ
aji-163	161	5	,	,	PUNCT
aji-163	161	6	or	or	CCONJ
aji-163	161	7	)	)	PUNCT
aji-163	161	8	were	be	AUX
aji-163	161	9	used	use	VERB
aji-163	161	10	to	to	PART
aji-163	161	11	refine	refine	VERB
aji-163	161	12	searches	search	NOUN
aji-163	161	13	(	(	PUNCT
aji-163	161	14	table	table	NOUN
aji-163	161	15	1	1	NUM
aji-163	161	16	)	)	PUNCT
aji-163	161	17	,	,	PUNCT
aji-163	161	18	and	and	CCONJ
aji-163	161	19	databasespecific	databasespecific	ADJ
aji-163	161	20	filters	filter	NOUN
aji-163	161	21	like	like	ADP
aji-163	161	22	full	full	ADJ
aji-163	161	23	-	-	PUNCT
aji-163	161	24	text	text	NOUN
aji-163	161	25	availability	availability	NOUN
aji-163	161	26	,	,	PUNCT
aji-163	161	27	and	and	CCONJ
aji-163	161	28	publication	publication	NOUN
aji-163	161	29	date	date	NOUN
aji-163	161	30	restrictions	restriction	NOUN
aji-163	161	31	.	.	PUNCT
aji-163	162	1	this	this	DET
aji-163	162	2	review	review	NOUN
aji-163	162	3	was	be	AUX
aji-163	162	4	not	not	PART
aji-163	162	5	registered	register	VERB
aji-163	162	6	in	in	ADP
aji-163	162	7	prospero	prospero	NOUN
aji-163	162	8	.	.	PUNCT
aji-163	163	1	janefrancis	janefrancis	PROPN
aji-163	163	2	et	et	PROPN
aji-163	163	3	al	al	PROPN
aji-163	163	4	.	.	PROPN
aji-163	163	5	;	;	PUNCT
aji-163	163	6	asian	asian	PROPN
aji-163	163	7	j.	j.	PROPN
aji-163	163	8	immunol	immunol	PROPN
aji-163	163	9	.	.	PROPN
aji-163	163	10	,	,	PUNCT
aji-163	163	11	vol	vol	NOUN
aji-163	163	12	.	.	PROPN
aji-163	163	13	8	8	NUM
aji-163	163	14	,	,	PUNCT
aji-163	163	15	no	no	INTJ
aji-163	163	16	.	.	NOUN
aji-163	163	17	1	1	NUM
aji-163	163	18	,	,	PUNCT
aji-163	163	19	pp	pp	ADJ
aji-163	163	20	.	.	PUNCT
aji-163	164	1	86	86	NUM
aji-163	164	2	-	-	SYM
aji-163	164	3	96	96	NUM
aji-163	164	4	,	,	PUNCT
aji-163	164	5	2025	2025	NUM
aji-163	164	6	;	;	PUNCT
aji-163	164	7	article	article	NOUN
aji-163	164	8	no.aji.134904	no.aji.134904	VERB
aji-163	164	9	89	89	NUM
aji-163	164	10	table	table	NOUN
aji-163	164	11	1	1	NUM
aji-163	164	12	.	.	PUNCT
aji-163	164	13	search	search	NOUN
aji-163	164	14	string	string	NOUN
aji-163	164	15	combination	combination	NOUN
aji-163	164	16	of	of	ADP
aji-163	164	17	keywords	keyword	NOUN
aji-163	164	18	(	(	PUNCT
aji-163	164	19	“	"	PUNCT
aji-163	164	20	trained	train	VERB
aji-163	164	21	immunity	immunity	NOUN
aji-163	164	22	”	"	PUNCT
aji-163	164	23	or	or	CCONJ
aji-163	164	24	“	"	PUNCT
aji-163	164	25	innate	innate	ADJ
aji-163	164	26	immune	immune	ADJ
aji-163	164	27	memory	memory	NOUN
aji-163	164	28	”	"	PUNCT
aji-163	164	29	)	)	PUNCT
aji-163	164	30	and	and	CCONJ
aji-163	164	31	(	(	PUNCT
aji-163	164	32	“	"	PUNCT
aji-163	164	33	epigenetic	epigenetic	ADJ
aji-163	164	34	reprogramming	reprogramming	NOUN
aji-163	164	35	”	"	PUNCT
aji-163	164	36	or	or	CCONJ
aji-163	164	37	“	"	PUNCT
aji-163	164	38	histone	histone	NOUN
aji-163	164	39	modification	modification	NOUN
aji-163	164	40	”	"	PUNCT
aji-163	164	41	or	or	CCONJ
aji-163	164	42	“	"	PUNCT
aji-163	164	43	dna	dna	PROPN
aji-163	164	44	methylation	methylation	NOUN
aji-163	164	45	”	"	PUNCT
aji-163	164	46	)	)	PUNCT
aji-163	164	47	and	and	CCONJ
aji-163	164	48	(	(	PUNCT
aji-163	164	49	“	"	PUNCT
aji-163	164	50	infectious	infectious	ADJ
aji-163	164	51	disease	disease	NOUN
aji-163	164	52	”	"	PUNCT
aji-163	164	53	or	or	CCONJ
aji-163	164	54	“	"	PUNCT
aji-163	164	55	pathogen	pathogen	NOUN
aji-163	164	56	defense	defense	NOUN
aji-163	164	57	”	"	PUNCT
aji-163	164	58	)	)	PUNCT
aji-163	164	59	and	and	CCONJ
aji-163	164	60	(	(	PUNCT
aji-163	164	61	“	"	PUNCT
aji-163	164	62	metabolic	metabolic	NOUN
aji-163	164	63	shift	shift	NOUN
aji-163	164	64	”	"	PUNCT
aji-163	164	65	or	or	CCONJ
aji-163	164	66	“	"	PUNCT
aji-163	164	67	glycolysis	glycolysis	NOUN
aji-163	164	68	”	"	PUNCT
aji-163	164	69	)	)	PUNCT
aji-163	164	70	table	table	NOUN
aji-163	164	71	2	2	NUM
aji-163	164	72	.	.	PUNCT
aji-163	164	73	methodology	methodology	NOUN
aji-163	164	74	theme	theme	NOUN
aji-163	164	75	method	method	PROPN
aji-163	164	76	literature	literature	PROPN
aji-163	164	77	search	search	PROPN
aji-163	164	78	pubmed	pubmed	PROPN
aji-163	164	79	,	,	PUNCT
aji-163	164	80	web	web	NOUN
aji-163	164	81	of	of	ADP
aji-163	164	82	science	science	NOUN
aji-163	164	83	,	,	PUNCT
aji-163	164	84	google	google	PROPN
aji-163	164	85	scholar	scholar	NOUN
aji-163	164	86	keywords	keyword	NOUN
aji-163	164	87	“	"	PUNCT
aji-163	164	88	trained	train	VERB
aji-163	164	89	immunity	immunity	NOUN
aji-163	164	90	,	,	PUNCT
aji-163	164	91	”	"	PUNCT
aji-163	164	92	“	"	PUNCT
aji-163	164	93	epigenetic	epigenetic	ADJ
aji-163	164	94	reprogramming	reprogramming	NOUN
aji-163	164	95	,	,	PUNCT
aji-163	164	96	”	"	PUNCT
aji-163	164	97	“	"	PUNCT
aji-163	164	98	infectious	infectious	ADJ
aji-163	164	99	disease	disease	NOUN
aji-163	164	100	,	,	PUNCT
aji-163	164	101	”	"	PUNCT
aji-163	164	102	“	"	PUNCT
aji-163	164	103	metabolic	metabolic	ADJ
aji-163	164	104	reprogramming	reprogramming	NOUN
aji-163	164	105	”	"	PUNCT
aji-163	164	106	timeframe	timeframe	NOUN
aji-163	164	107	2019	2019	NUM
aji-163	164	108	to	to	ADP
aji-163	164	109	2025	2025	NUM
aji-163	164	110	selection	selection	NOUN
aji-163	164	111	criteria	criterion	NOUN
aji-163	164	112	peer	peer	NOUN
aji-163	164	113	-	-	PUNCT
aji-163	164	114	reviewed	review	VERB
aji-163	164	115	articles	article	NOUN
aji-163	164	116	of	of	ADP
aji-163	164	117	original	original	ADJ
aji-163	164	118	research	research	NOUN
aji-163	164	119	published	publish	VERB
aji-163	164	120	in	in	ADP
aji-163	164	121	english	english	PROPN
aji-163	164	122	.	.	PUNCT
aji-163	165	1	studies	study	NOUN
aji-163	165	2	that	that	PRON
aji-163	165	3	investigated	investigate	VERB
aji-163	165	4	trained	train	VERB
aji-163	165	5	immunity	immunity	NOUN
aji-163	165	6	and	and	CCONJ
aji-163	165	7	its	its	PRON
aji-163	165	8	mechanisms	mechanism	NOUN
aji-163	165	9	,	,	PUNCT
aji-163	165	10	including	include	VERB
aji-163	165	11	epigenetic	epigenetic	ADJ
aji-163	165	12	and	and	CCONJ
aji-163	165	13	metabolic	metabolic	NOUN
aji-163	165	14	changes	change	NOUN
aji-163	165	15	.	.	PUNCT
aji-163	166	1	research	research	NOUN
aji-163	166	2	focusing	focus	VERB
aji-163	166	3	on	on	ADP
aji-163	166	4	infectious	infectious	ADJ
aji-163	166	5	disease	disease	NOUN
aji-163	166	6	protection	protection	NOUN
aji-163	166	7	through	through	ADP
aji-163	166	8	innate	innate	ADJ
aji-163	166	9	immune	immune	ADJ
aji-163	166	10	memory	memory	NOUN
aji-163	166	11	.	.	PUNCT
aji-163	167	1	experimental	experimental	ADJ
aji-163	167	2	and	and	CCONJ
aji-163	167	3	clinical	clinical	ADJ
aji-163	167	4	studies	study	NOUN
aji-163	167	5	involving	involve	VERB
aji-163	167	6	humans	human	NOUN
aji-163	167	7	and	and	CCONJ
aji-163	167	8	relevant	relevant	ADJ
aji-163	167	9	animal	animal	NOUN
aji-163	167	10	models	model	NOUN
aji-163	167	11	.	.	PUNCT
aji-163	168	1	data	datum	NOUN
aji-163	168	2	extraction	extraction	NOUN
aji-163	168	3	&	&	CCONJ
aji-163	168	4	synthesis	synthesis	NOUN
aji-163	168	5	data	datum	NOUN
aji-163	168	6	were	be	AUX
aji-163	168	7	extracted	extract	VERB
aji-163	168	8	using	use	VERB
aji-163	168	9	a	a	DET
aji-163	168	10	standardized	standardized	ADJ
aji-163	168	11	data	data	NOUN
aji-163	168	12	extraction	extraction	NOUN
aji-163	168	13	form	form	NOUN
aji-163	168	14	.	.	PUNCT
aji-163	169	1	narrative	narrative	ADJ
aji-163	169	2	synthesis	synthesis	NOUN
aji-163	169	3	approach	approach	NOUN
aji-163	169	4	was	be	AUX
aji-163	169	5	used	use	VERB
aji-163	169	6	to	to	PART
aji-163	169	7	summarize	summarize	VERB
aji-163	169	8	key	key	ADJ
aji-163	169	9	findings	finding	NOUN
aji-163	169	10	and	and	CCONJ
aji-163	169	11	highlight	highlight	VERB
aji-163	169	12	common	common	ADJ
aji-163	169	13	themes	theme	NOUN
aji-163	169	14	.	.	PUNCT
aji-163	170	1	2.2	2.2	NUM
aji-163	170	2	selection	selection	NOUN
aji-163	170	3	criteria	criterion	NOUN
aji-163	170	4	this	this	DET
aji-163	170	5	review	review	NOUN
aji-163	170	6	was	be	AUX
aji-163	170	7	conducted	conduct	VERB
aji-163	170	8	following	follow	VERB
aji-163	170	9	the	the	DET
aji-163	170	10	prisma	prisma	NOUN
aji-163	170	11	guidelines	guideline	NOUN
aji-163	170	12	,	,	PUNCT
aji-163	170	13	and	and	CCONJ
aji-163	170	14	a	a	DET
aji-163	170	15	corresponding	correspond	VERB
aji-163	170	16	prisma	prisma	NOUN
aji-163	170	17	flowchart	flowchart	NOUN
aji-163	170	18	is	be	AUX
aji-163	170	19	included	include	VERB
aji-163	170	20	in	in	ADP
aji-163	170	21	the	the	DET
aji-163	170	22	results	result	NOUN
aji-163	170	23	to	to	PART
aji-163	170	24	illustrate	illustrate	VERB
aji-163	170	25	the	the	DET
aji-163	170	26	study	study	NOUN
aji-163	170	27	selection	selection	NOUN
aji-163	170	28	process	process	NOUN
aji-163	170	29	.	.	PUNCT
aji-163	171	1	to	to	PART
aji-163	171	2	ensure	ensure	VERB
aji-163	171	3	relevance	relevance	NOUN
aji-163	171	4	and	and	CCONJ
aji-163	171	5	quality	quality	NOUN
aji-163	171	6	,	,	PUNCT
aji-163	171	7	the	the	DET
aji-163	171	8	following	follow	VERB
aji-163	171	9	selection	selection	NOUN
aji-163	171	10	criteria	criterion	NOUN
aji-163	171	11	were	be	AUX
aji-163	171	12	applied	apply	VERB
aji-163	171	13	:	:	PUNCT
aji-163	171	14	2.2.1	2.2.1	NUM
aji-163	171	15	inclusion	inclusion	NOUN
aji-163	171	16	criteria	criterion	NOUN
aji-163	171	17	•	•	ADP
aji-163	171	18	peer	peer	NOUN
aji-163	171	19	-	-	PUNCT
aji-163	171	20	reviewed	review	VERB
aji-163	171	21	articles	article	NOUN
aji-163	171	22	of	of	ADP
aji-163	171	23	original	original	ADJ
aji-163	171	24	research	research	NOUN
aji-163	171	25	published	publish	VERB
aji-163	171	26	in	in	ADP
aji-163	171	27	english	english	PROPN
aji-163	171	28	.	.	PUNCT
aji-163	172	1	•	•	NUM
aji-163	172	2	studies	study	NOUN
aji-163	172	3	that	that	PRON
aji-163	172	4	investigated	investigate	VERB
aji-163	172	5	trained	train	VERB
aji-163	172	6	immunity	immunity	NOUN
aji-163	172	7	and	and	CCONJ
aji-163	172	8	its	its	PRON
aji-163	172	9	mechanisms	mechanism	NOUN
aji-163	172	10	,	,	PUNCT
aji-163	172	11	including	include	VERB
aji-163	172	12	epigenetic	epigenetic	ADJ
aji-163	172	13	and	and	CCONJ
aji-163	172	14	metabolic	metabolic	NOUN
aji-163	172	15	changes	change	NOUN
aji-163	172	16	.	.	PUNCT
aji-163	173	1	•	•	NOUN
aji-163	173	2	research	research	NOUN
aji-163	173	3	focusing	focus	VERB
aji-163	173	4	on	on	ADP
aji-163	173	5	infectious	infectious	ADJ
aji-163	173	6	disease	disease	NOUN
aji-163	173	7	protection	protection	NOUN
aji-163	173	8	through	through	ADP
aji-163	173	9	innate	innate	ADJ
aji-163	173	10	immune	immune	ADJ
aji-163	173	11	memory	memory	NOUN
aji-163	173	12	.	.	PUNCT
aji-163	174	1	•	•	NOUN
aji-163	174	2	experimental	experimental	ADJ
aji-163	174	3	and	and	CCONJ
aji-163	174	4	clinical	clinical	ADJ
aji-163	174	5	studies	study	NOUN
aji-163	174	6	involving	involve	VERB
aji-163	174	7	humans	human	NOUN
aji-163	174	8	and	and	CCONJ
aji-163	174	9	relevant	relevant	ADJ
aji-163	174	10	animal	animal	NOUN
aji-163	174	11	models	model	NOUN
aji-163	174	12	.	.	PUNCT
aji-163	175	1	2.2.2	2.2.2	NUM
aji-163	175	2	exclusion	exclusion	NOUN
aji-163	175	3	criteria	criterion	NOUN
aji-163	175	4	•	•	ADP
aji-163	175	5	studies	study	NOUN
aji-163	175	6	focusing	focus	VERB
aji-163	175	7	exclusively	exclusively	ADV
aji-163	175	8	on	on	ADP
aji-163	175	9	adaptive	adaptive	ADJ
aji-163	175	10	immunity	immunity	NOUN
aji-163	175	11	without	without	ADP
aji-163	175	12	reference	reference	NOUN
aji-163	175	13	to	to	ADP
aji-163	175	14	trained	train	VERB
aji-163	175	15	immunity	immunity	NOUN
aji-163	175	16	.	.	PUNCT
aji-163	176	1	•	•	NUM
aji-163	176	2	non	non	ADJ
aji-163	176	3	-	-	ADJ
aji-163	176	4	english	english	ADJ
aji-163	176	5	publications	publication	NOUN
aji-163	176	6	.	.	PUNCT
aji-163	177	1	•	•	NUM
aji-163	177	2	opinion	opinion	NOUN
aji-163	177	3	pieces	piece	NOUN
aji-163	177	4	,	,	PUNCT
aji-163	177	5	editorials	editorial	NOUN
aji-163	177	6	,	,	PUNCT
aji-163	177	7	reviews	review	NOUN
aji-163	177	8	,	,	PUNCT
aji-163	177	9	and	and	CCONJ
aji-163	177	10	conference	conference	NOUN
aji-163	177	11	abstracts	abstract	NOUN
aji-163	177	12	without	without	ADP
aji-163	177	13	full	full	ADJ
aji-163	177	14	data	datum	NOUN
aji-163	177	15	.	.	PUNCT
aji-163	178	1	2.3	2.3	NUM
aji-163	178	2	data	data	NOUN
aji-163	178	3	extraction	extraction	NOUN
aji-163	178	4	and	and	CCONJ
aji-163	178	5	synthesis	synthesis	NOUN
aji-163	178	6	search	search	NOUN
aji-163	178	7	results	result	NOUN
aji-163	178	8	were	be	AUX
aji-163	178	9	screened	screen	VERB
aji-163	178	10	based	base	VERB
aji-163	178	11	on	on	ADP
aji-163	178	12	the	the	DET
aji-163	178	13	predefined	predefine	VERB
aji-163	178	14	inclusion	inclusion	NOUN
aji-163	178	15	criteria	criterion	NOUN
aji-163	178	16	and	and	CCONJ
aji-163	178	17	data	datum	NOUN
aji-163	178	18	from	from	ADP
aji-163	178	19	the	the	DET
aji-163	178	20	selected	select	VERB
aji-163	178	21	studies	study	NOUN
aji-163	178	22	were	be	AUX
aji-163	178	23	extracted	extract	VERB
aji-163	178	24	independently	independently	ADV
aji-163	178	25	by	by	ADP
aji-163	178	26	two	two	NUM
aji-163	178	27	reviewers	reviewer	NOUN
aji-163	178	28	using	use	VERB
aji-163	178	29	a	a	DET
aji-163	178	30	standardized	standardized	ADJ
aji-163	178	31	data	data	NOUN
aji-163	178	32	extraction	extraction	NOUN
aji-163	178	33	form	form	NOUN
aji-163	178	34	,	,	PUNCT
aji-163	178	35	capturing	capture	VERB
aji-163	178	36	the	the	DET
aji-163	178	37	study	study	NOUN
aji-163	178	38	design	design	NOUN
aji-163	178	39	,	,	PUNCT
aji-163	179	1	population	population	NOUN
aji-163	179	2	involved	involve	VERB
aji-163	179	3	,	,	PUNCT
aji-163	179	4	interventions	intervention	NOUN
aji-163	179	5	,	,	PUNCT
aji-163	179	6	outcomes	outcome	NOUN
aji-163	179	7	,	,	PUNCT
aji-163	179	8	and	and	CCONJ
aji-163	179	9	key	key	ADJ
aji-163	179	10	findings	finding	NOUN
aji-163	179	11	.	.	PUNCT
aji-163	180	1	when	when	SCONJ
aji-163	180	2	there	there	PRON
aji-163	180	3	were	be	VERB
aji-163	180	4	discrepancies	discrepancy	NOUN
aji-163	180	5	,	,	PUNCT
aji-163	180	6	it	it	PRON
aji-163	180	7	was	be	AUX
aji-163	180	8	resolved	resolve	VERB
aji-163	180	9	through	through	ADP
aji-163	180	10	consensus	consensus	NOUN
aji-163	180	11	.	.	PUNCT
aji-163	181	1	a	a	DET
aji-163	181	2	narrative	narrative	ADJ
aji-163	181	3	synthesis	synthesis	NOUN
aji-163	181	4	was	be	AUX
aji-163	181	5	used	use	VERB
aji-163	181	6	to	to	PART
aji-163	181	7	summarize	summarize	VERB
aji-163	181	8	key	key	ADJ
aji-163	181	9	findings	finding	NOUN
aji-163	181	10	and	and	CCONJ
aji-163	181	11	highlight	highlight	VERB
aji-163	181	12	common	common	ADJ
aji-163	181	13	themes	theme	NOUN
aji-163	181	14	.	.	PUNCT
aji-163	182	1	3	3	X
aji-163	182	2	.	.	NOUN
aji-163	182	3	results	result	NOUN
aji-163	182	4	and	and	CCONJ
aji-163	182	5	discussion	discussion	NOUN
aji-163	182	6	3.1	3.1	NUM
aji-163	182	7	included	include	VERB
aji-163	182	8	studies	study	NOUN
aji-163	182	9	fig	fig	NOUN
aji-163	182	10	.	.	PUNCT
aji-163	183	1	2	2	NUM
aji-163	183	2	illustrates	illustrate	VERB
aji-163	183	3	the	the	DET
aji-163	183	4	included	include	VERB
aji-163	183	5	studies	study	NOUN
aji-163	183	6	selection	selection	NOUN
aji-163	183	7	processes	process	NOUN
aji-163	183	8	.	.	PUNCT
aji-163	184	1	eight	eight	NUM
aji-163	184	2	studies	study	NOUN
aji-163	184	3	were	be	AUX
aji-163	184	4	included	include	VERB
aji-163	184	5	in	in	ADP
aji-163	184	6	this	this	DET
aji-163	184	7	review	review	NOUN
aji-163	184	8	,	,	PUNCT
aji-163	184	9	after	after	ADP
aji-163	184	10	a	a	DET
aji-163	184	11	broad	broad	ADJ
aji-163	184	12	selection	selection	NOUN
aji-163	184	13	and	and	CCONJ
aji-163	184	14	screening	screening	NOUN
aji-163	184	15	of	of	ADP
aji-163	184	16	205	205	NUM
aji-163	184	17	articles	article	NOUN
aji-163	184	18	.	.	PUNCT
aji-163	185	1	the	the	DET
aji-163	185	2	studies	study	NOUN
aji-163	185	3	included	include	VERB
aji-163	185	4	were	be	AUX
aji-163	185	5	conducted	conduct	VERB
aji-163	185	6	between	between	ADP
aji-163	185	7	2019	2019	NUM
aji-163	185	8	and	and	CCONJ
aji-163	185	9	2025	2025	NUM
aji-163	185	10	,	,	PUNCT
aji-163	185	11	with	with	ADP
aji-163	185	12	a	a	DET
aji-163	185	13	majority	majority	NOUN
aji-163	185	14	of	of	ADP
aji-163	185	15	them	they	PRON
aji-163	185	16	employing	employ	VERB
aji-163	185	17	experimental	experimental	ADJ
aji-163	185	18	study	study	NOUN
aji-163	185	19	design	design	NOUN
aji-163	185	20	.	.	PUNCT
aji-163	186	1	three	three	NUM
aji-163	186	2	of	of	ADP
aji-163	186	3	the	the	DET
aji-163	186	4	studies	study	NOUN
aji-163	186	5	had	have	VERB
aji-163	186	6	histone	histone	NOUN
aji-163	186	7	modifications	modification	NOUN
aji-163	186	8	as	as	ADP
aji-163	186	9	their	their	PRON
aji-163	186	10	mechanism	mechanism	NOUN
aji-163	186	11	of	of	ADP
aji-163	186	12	trained	train	VERB
aji-163	186	13	immunity	immunity	NOUN
aji-163	186	14	while	while	SCONJ
aji-163	186	15	two	two	NUM
aji-163	186	16	studies	study	NOUN
aji-163	186	17	identified	identify	VERB
aji-163	186	18	epigenetic	epigenetic	ADJ
aji-163	186	19	modulation	modulation	NOUN
aji-163	186	20	as	as	ADP
aji-163	186	21	their	their	PRON
aji-163	186	22	trained	train	VERB
aji-163	186	23	immunity	immunity	NOUN
aji-163	186	24	mechanism	mechanism	NOUN
aji-163	186	25	.	.	PUNCT
aji-163	187	1	bacterial	bacterial	ADJ
aji-163	187	2	&	&	CCONJ
aji-163	187	3	viral	viral	ADJ
aji-163	187	4	infections	infection	NOUN
aji-163	187	5	were	be	AUX
aji-163	187	6	observed	observe	VERB
aji-163	187	7	to	to	PART
aji-163	187	8	be	be	AUX
aji-163	187	9	the	the	DET
aji-163	187	10	most	most	ADV
aji-163	187	11	common	common	ADJ
aji-163	187	12	pathogen	pathogen	NOUN
aji-163	187	13	context	context	NOUN
aji-163	187	14	across	across	ADP
aji-163	187	15	the	the	DET
aji-163	187	16	studies	study	NOUN
aji-163	187	17	and	and	CCONJ
aji-163	187	18	the	the	DET
aji-163	187	19	duration	duration	NOUN
aji-163	187	20	of	of	ADP
aji-163	187	21	immune	immune	ADJ
aji-163	187	22	training	training	NOUN
aji-163	187	23	was	be	AUX
aji-163	187	24	long	long	ADJ
aji-163	187	25	-	-	PUNCT
aji-163	187	26	term	term	NOUN
aji-163	187	27	.	.	PUNCT
aji-163	188	1	janefrancis	janefrancis	PROPN
aji-163	188	2	et	et	PROPN
aji-163	188	3	al	al	PROPN
aji-163	188	4	.	.	PROPN
aji-163	188	5	;	;	PUNCT
aji-163	188	6	asian	asian	PROPN
aji-163	188	7	j.	j.	PROPN
aji-163	188	8	immunol	immunol	PROPN
aji-163	188	9	.	.	PROPN
aji-163	188	10	,	,	PUNCT
aji-163	188	11	vol	vol	NOUN
aji-163	188	12	.	.	PROPN
aji-163	188	13	8	8	NUM
aji-163	188	14	,	,	PUNCT
aji-163	188	15	no	no	INTJ
aji-163	188	16	.	.	NOUN
aji-163	188	17	1	1	NUM
aji-163	188	18	,	,	PUNCT
aji-163	188	19	pp	pp	ADJ
aji-163	188	20	.	.	PUNCT
aji-163	189	1	86	86	NUM
aji-163	189	2	-	-	SYM
aji-163	189	3	96	96	NUM
aji-163	189	4	,	,	PUNCT
aji-163	189	5	2025	2025	NUM
aji-163	189	6	;	;	PUNCT
aji-163	189	7	article	article	NOUN
aji-163	189	8	no.aji.134904	no.aji.134904	VERB
aji-163	189	9	90	90	NUM
aji-163	189	10	fig	fig	NOUN
aji-163	189	11	.	.	PUNCT
aji-163	190	1	2	2	X
aji-163	190	2	.	.	X
aji-163	190	3	prisma	prisma	PROPN
aji-163	190	4	flow	flow	PROPN
aji-163	190	5	diagram	diagram	NOUN
aji-163	190	6	3.2	3.2	NUM
aji-163	190	7	mechanisms	mechanism	NOUN
aji-163	190	8	underlying	underlie	VERB
aji-163	190	9	trained	train	VERB
aji-163	190	10	immunity	immunity	NOUN
aji-163	190	11	trained	train	VERB
aji-163	190	12	immunity	immunity	NOUN
aji-163	190	13	is	be	AUX
aji-163	190	14	primarily	primarily	ADV
aji-163	190	15	driven	drive	VERB
aji-163	190	16	by	by	ADP
aji-163	190	17	epigenetic	epigenetic	ADJ
aji-163	190	18	and	and	CCONJ
aji-163	190	19	metabolic	metabolic	NOUN
aji-163	190	20	reprogramming	reprogramme	VERB
aji-163	190	21	,	,	PUNCT
aji-163	190	22	enabling	enable	VERB
aji-163	190	23	innate	innate	ADJ
aji-163	190	24	immune	immune	ADJ
aji-163	190	25	cells	cell	NOUN
aji-163	190	26	to	to	PART
aji-163	190	27	mount	mount	VERB
aji-163	190	28	enhanced	enhanced	ADJ
aji-163	190	29	responses	response	NOUN
aji-163	190	30	upon	upon	SCONJ
aji-163	190	31	secondary	secondary	ADJ
aji-163	190	32	stimulation	stimulation	NOUN
aji-163	190	33	.	.	PUNCT
aji-163	191	1	key	key	ADJ
aji-163	191	2	epigenetic	epigenetic	ADJ
aji-163	191	3	mechanisms	mechanism	NOUN
aji-163	191	4	such	such	ADJ
aji-163	191	5	as	as	ADP
aji-163	191	6	histone	histone	NOUN
aji-163	191	7	modifications	modification	NOUN
aji-163	191	8	,	,	PUNCT
aji-163	191	9	dna	dna	PROPN
aji-163	191	10	methylation	methylation	NOUN
aji-163	191	11	and	and	CCONJ
aji-163	191	12	their	their	PRON
aji-163	191	13	regulation	regulation	NOUN
aji-163	191	14	have	have	AUX
aji-163	191	15	all	all	PRON
aji-163	191	16	been	be	AUX
aji-163	191	17	the	the	DET
aji-163	191	18	focus	focus	NOUN
aji-163	191	19	of	of	ADP
aji-163	191	20	several	several	ADJ
aji-163	191	21	studies	study	NOUN
aji-163	191	22	.	.	PUNCT
aji-163	192	1	as	as	ADP
aji-163	192	2	an	an	DET
aji-163	192	3	example	example	NOUN
aji-163	192	4	,	,	PUNCT
aji-163	192	5	jentho	jentho	NOUN
aji-163	192	6	et	et	PROPN
aji-163	192	7	al	al	PROPN
aji-163	192	8	.	.	PROPN
aji-163	193	1	(	(	PUNCT
aji-163	193	2	2021	2021	NUM
aji-163	193	3	)	)	PUNCT
aji-163	193	4	established	establish	VERB
aji-163	193	5	that	that	SCONJ
aji-163	193	6	heme	heme	NOUN
aji-163	193	7	-	-	PUNCT
aji-163	193	8	trained	train	VERB
aji-163	193	9	immunity	immunity	NOUN
aji-163	193	10	results	result	NOUN
aji-163	193	11	in	in	ADP
aji-163	193	12	heme	heme	ADJ
aji-163	193	13	long	long	ADV
aji-163	193	14	-	-	PUNCT
aji-163	193	15	lasting	last	VERB
aji-163	193	16	epigenetic	epigenetic	ADJ
aji-163	193	17	remodelling	remodelling	NOUN
aji-163	193	18	that	that	PRON
aji-163	193	19	alters	alter	VERB
aji-163	193	20	myelopoiesis	myelopoiesis	NOUN
aji-163	193	21	and	and	CCONJ
aji-163	193	22	enhances	enhance	VERB
aji-163	193	23	monocyte	monocyte	NOUN
aji-163	193	24	function	function	NOUN
aji-163	193	25	.	.	PUNCT
aji-163	194	1	in	in	ADP
aji-163	194	2	addition	addition	NOUN
aji-163	194	3	,	,	PUNCT
aji-163	194	4	the	the	DET
aji-163	194	5	set7	set7	PROPN
aji-163	194	6	lysine	lysine	NOUN
aji-163	194	7	methyltransferase	methyltransferase	NOUN
aji-163	194	8	regulates	regulate	VERB
aji-163	194	9	oxidative	oxidative	ADJ
aji-163	194	10	phosphorylation	phosphorylation	NOUN
aji-163	194	11	plasticity	plasticity	NOUN
aji-163	194	12	for	for	ADP
aji-163	194	13	trained	train	VERB
aji-163	194	14	immunity	immunity	NOUN
aji-163	194	15	in	in	ADP
aji-163	194	16	response	response	NOUN
aji-163	194	17	to	to	ADP
aji-163	194	18	β	β	PROPN
aji-163	194	19	glucan	glucan	NOUN
aji-163	194	20	stimulation	stimulation	NOUN
aji-163	194	21	which	which	PRON
aji-163	194	22	was	be	AUX
aji-163	194	23	previously	previously	ADV
aji-163	194	24	shown	show	VERB
aji-163	194	25	by	by	ADP
aji-163	194	26	keating	keate	VERB
aji-163	194	27	et	et	PROPN
aji-163	194	28	al	al	PROPN
aji-163	194	29	.	.	PROPN
aji-163	195	1	(	(	PUNCT
aji-163	195	2	2020	2020	NUM
aji-163	195	3	)	)	PUNCT
aji-163	195	4	.	.	PUNCT
aji-163	196	1	additionally	additionally	ADV
aji-163	196	2	,	,	PUNCT
aji-163	196	3	these	these	DET
aji-163	196	4	findings	finding	NOUN
aji-163	196	5	are	be	AUX
aji-163	196	6	consistent	consistent	ADJ
aji-163	196	7	with	with	ADP
aji-163	196	8	previous	previous	ADJ
aji-163	196	9	work	work	NOUN
aji-163	196	10	that	that	PRON
aji-163	196	11	demonstrated	demonstrate	VERB
aji-163	196	12	the	the	DET
aji-163	196	13	importance	importance	NOUN
aji-163	196	14	of	of	ADP
aji-163	196	15	histone	histone	NOUN
aji-163	196	16	methylation	methylation	NOUN
aji-163	196	17	and	and	CCONJ
aji-163	196	18	acetylation	acetylation	NOUN
aji-163	196	19	of	of	ADP
aji-163	196	20	immune	immune	ADJ
aji-163	196	21	gene	gene	NOUN
aji-163	196	22	promoters	promoter	NOUN
aji-163	196	23	to	to	PART
aji-163	196	24	promote	promote	VERB
aji-163	196	25	hypercytokinemia	hypercytokinemia	NOUN
aji-163	196	26	on	on	ADP
aji-163	196	27	secondary	secondary	ADJ
aji-163	196	28	t	t	PROPN
aji-163	196	29	-	-	PUNCT
aji-163	196	30	cell	cell	NOUN
aji-163	196	31	stimulation	stimulation	NOUN
aji-163	196	32	(	(	PUNCT
aji-163	196	33	fok	fok	NOUN
aji-163	196	34	et	et	PROPN
aji-163	196	35	al	al	PROPN
aji-163	196	36	.	.	PROPN
aji-163	196	37	,	,	PUNCT
aji-163	196	38	2019	2019	NUM
aji-163	196	39	)	)	PUNCT
aji-163	196	40	.	.	PUNCT
aji-163	197	1	other	other	ADJ
aji-163	197	2	important	important	ADJ
aji-163	197	3	drivers	driver	NOUN
aji-163	197	4	of	of	ADP
aji-163	197	5	trained	train	VERB
aji-163	197	6	immunity	immunity	NOUN
aji-163	197	7	are	be	AUX
aji-163	197	8	metabolic	metabolic	NOUN
aji-163	197	9	reprogramming	reprogramming	NOUN
aji-163	197	10	;	;	PUNCT
aji-163	197	11	glycolysis	glycolysis	NOUN
aji-163	197	12	,	,	PUNCT
aji-163	197	13	oxidative	oxidative	ADJ
aji-163	197	14	phosphorylation	phosphorylation	NOUN
aji-163	197	15	,	,	PUNCT
aji-163	197	16	and	and	CCONJ
aji-163	197	17	lipid	lipid	NOUN
aji-163	197	18	metabolism	metabolism	NOUN
aji-163	197	19	are	be	AUX
aji-163	197	20	shifted	shift	VERB
aji-163	197	21	.	.	PUNCT
aji-163	198	1	hao	hao	PROPN
aji-163	198	2	et	et	PROPN
aji-163	198	3	al	al	PROPN
aji-163	198	4	.	.	PROPN
aji-163	199	1	(	(	PUNCT
aji-163	199	2	2025	2025	NUM
aji-163	199	3	)	)	PUNCT
aji-163	199	4	stated	state	VERB
aji-163	199	5	that	that	SCONJ
aji-163	199	6	metabolic	metabolic	NOUN
aji-163	199	7	adaptations	adaptation	NOUN
aji-163	199	8	,	,	PUNCT
aji-163	199	9	such	such	ADJ
aji-163	199	10	as	as	ADP
aji-163	199	11	enhanced	enhanced	ADJ
aji-163	199	12	glycolysis	glycolysis	NOUN
aji-163	199	13	and	and	CCONJ
aji-163	199	14	glutaminolysis	glutaminolysis	NOUN
aji-163	199	15	,	,	PUNCT
aji-163	199	16	have	have	VERB
aji-163	199	17	a	a	DET
aji-163	199	18	crucial	crucial	ADJ
aji-163	199	19	role	role	NOUN
aji-163	199	20	in	in	ADP
aji-163	199	21	innate	innate	ADJ
aji-163	199	22	immune	immune	ADJ
aji-163	199	23	memory	memory	NOUN
aji-163	199	24	.	.	PUNCT
aji-163	200	1	this	this	PRON
aji-163	200	2	is	be	AUX
aji-163	200	3	in	in	ADP
aji-163	200	4	alignment	alignment	NOUN
aji-163	200	5	with	with	ADP
aji-163	200	6	rusek	rusek	PROPN
aji-163	200	7	et	et	PROPN
aji-163	200	8	al	al	PROPN
aji-163	200	9	.	.	PROPN
aji-163	201	1	(	(	PUNCT
aji-163	201	2	2018	2018	NUM
aji-163	201	3	)	)	PUNCT
aji-163	201	4	who	who	PRON
aji-163	201	5	showed	show	VERB
aji-163	201	6	that	that	SCONJ
aji-163	201	7	even	even	ADV
aji-163	201	8	bacterial	bacterial	ADJ
aji-163	201	9	and	and	CCONJ
aji-163	201	10	viral	viral	ADJ
aji-163	201	11	stimuli	stimulus	NOUN
aji-163	201	12	,	,	PUNCT
aji-163	201	13	elicit	elicit	VERB
aji-163	201	14	metabolic	metabolic	NOUN
aji-163	201	15	shifts	shift	NOUN
aji-163	201	16	that	that	PRON
aji-163	201	17	sustain	sustain	VERB
aji-163	201	18	immune	immune	ADJ
aji-163	201	19	memory	memory	NOUN
aji-163	201	20	.	.	PUNCT
aji-163	202	1	in	in	ADP
aji-163	202	2	addition	addition	NOUN
aji-163	202	3	,	,	PUNCT
aji-163	202	4	salauddin	salauddin	NOUN
aji-163	202	5	et	et	PROPN
aji-163	202	6	al	al	PROPN
aji-163	202	7	.	.	PROPN
aji-163	203	1	(	(	PUNCT
aji-163	203	2	2024	2024	NUM
aji-163	203	3	)	)	PUNCT
aji-163	203	4	rethink	rethink	VERB
aji-163	203	5	that	that	SCONJ
aji-163	203	6	both	both	DET
aji-163	203	7	shifts	shift	NOUN
aji-163	203	8	from	from	ADP
aji-163	203	9	oxidative	oxidative	ADJ
aji-163	203	10	phosphorylation	phosphorylation	NOUN
aji-163	203	11	and	and	CCONJ
aji-163	203	12	lipid	lipid	NOUN
aji-163	203	13	metabolism	metabolism	NOUN
aji-163	203	14	are	be	AUX
aji-163	203	15	crucial	crucial	ADJ
aji-163	203	16	for	for	ADP
aji-163	203	17	the	the	DET
aji-163	203	18	immune	immune	ADJ
aji-163	203	19	response	response	NOUN
aji-163	203	20	,	,	PUNCT
aji-163	203	21	so	so	SCONJ
aji-163	203	22	that	that	SCONJ
aji-163	203	23	metabolic	metabolic	NOUN
aji-163	203	24	pathways	pathway	NOUN
aji-163	203	25	may	may	AUX
aji-163	203	26	be	be	AUX
aji-163	203	27	targeted	target	VERB
aji-163	203	28	to	to	PART
aji-163	203	29	amplify	amplify	VERB
aji-163	203	30	the	the	DET
aji-163	203	31	response	response	NOUN
aji-163	203	32	.	.	PUNCT
aji-163	204	1	participation	participation	NOUN
aji-163	204	2	of	of	ADP
aji-163	204	3	non	non	ADJ
aji-163	204	4	-	-	ADJ
aji-163	204	5	coding	coding	ADJ
aji-163	204	6	rnas	rna	NOUN
aji-163	204	7	in	in	ADP
aji-163	204	8	trained	train	VERB
aji-163	204	9	immunity	immunity	NOUN
aji-163	204	10	has	have	AUX
aji-163	204	11	also	also	ADV
aji-163	204	12	been	be	AUX
aji-163	204	13	recently	recently	ADV
aji-163	204	14	highlighted	highlight	VERB
aji-163	204	15	.	.	PUNCT
aji-163	205	1	in	in	ADP
aji-163	205	2	the	the	DET
aji-163	205	3	case	case	NOUN
aji-163	205	4	of	of	ADP
aji-163	205	5	fok	fok	PROPN
aji-163	205	6	et	et	PROPN
aji-163	205	7	al	al	PROPN
aji-163	205	8	.	.	PROPN
aji-163	206	1	(	(	PUNCT
aji-163	206	2	2019	2019	NUM
aji-163	206	3	)	)	PUNCT
aji-163	206	4	,	,	PUNCT
aji-163	206	5	they	they	PRON
aji-163	206	6	observed	observe	VERB
aji-163	206	7	that	that	SCONJ
aji-163	206	8	lncrnas	lncrna	NOUN
aji-163	206	9	mediate	mediate	VERB
aji-163	206	10	the	the	DET
aji-163	206	11	crosstalk	crosstalk	NOUN
aji-163	206	12	between	between	ADP
aji-163	206	13	cellular	cellular	ADJ
aji-163	206	14	metabolism	metabolism	NOUN
aji-163	206	15	and	and	CCONJ
aji-163	206	16	epigenetic	epigenetic	ADJ
aji-163	206	17	modifications	modification	NOUN
aji-163	206	18	to	to	PART
aji-163	206	19	modulate	modulate	VERB
aji-163	206	20	innate	innate	ADJ
aji-163	206	21	immune	immune	ADJ
aji-163	206	22	reprogramming	reprogramming	NOUN
aji-163	206	23	.	.	PUNCT
aji-163	207	1	this	this	PRON
aji-163	207	2	coincides	coincide	VERB
aji-163	207	3	with	with	ADP
aji-163	207	4	abhimanyu	abhimanyu	PROPN
aji-163	207	5	et	et	PROPN
aji-163	207	6	al	al	PROPN
aji-163	207	7	.	.	PROPN
aji-163	208	1	(	(	PUNCT
aji-163	208	2	2021	2021	NUM
aji-163	208	3	)	)	PUNCT
aji-163	208	4	,	,	PUNCT
aji-163	208	5	who	who	PRON
aji-163	208	6	showed	show	VERB
aji-163	208	7	that	that	SCONJ
aji-163	208	8	targeting	target	VERB
aji-163	208	9	rnabased	rnabase	VERB
aji-163	208	10	regulatory	regulatory	ADJ
aji-163	208	11	pathways	pathway	NOUN
aji-163	208	12	can	can	AUX
aji-163	208	13	reverse	reverse	VERB
aji-163	208	14	the	the	DET
aji-163	208	15	postinfectious	postinfectious	ADJ
aji-163	208	16	epigenetic	epigenetic	ADJ
aji-163	208	17	-	-	PUNCT
aji-163	208	18	mediated	mediate	VERB
aji-163	208	19	immune	immune	ADJ
aji-163	208	20	suppression	suppression	NOUN
aji-163	208	21	.	.	PUNCT
aji-163	209	1	overall	overall	ADV
aji-163	209	2	,	,	PUNCT
aji-163	209	3	the	the	DET
aji-163	209	4	convergence	convergence	NOUN
aji-163	209	5	of	of	ADP
aji-163	209	6	epigenetic	epigenetic	ADJ
aji-163	209	7	and	and	CCONJ
aji-163	209	8	metabolic	metabolic	NOUN
aji-163	209	9	reprogramming	reprogramme	VERB
aji-163	209	10	in	in	ADP
aji-163	209	11	the	the	DET
aji-163	209	12	form	form	NOUN
aji-163	209	13	of	of	ADP
aji-163	209	14	trained	train	VERB
aji-163	209	15	immunity	immunity	NOUN
aji-163	209	16	indicates	indicate	VERB
aji-163	209	17	the	the	DET
aji-163	209	18	possibility	possibility	NOUN
aji-163	209	19	of	of	ADP
aji-163	209	20	its	its	PRON
aji-163	209	21	therapeutic	therapeutic	ADJ
aji-163	209	22	manipulation	manipulation	NOUN
aji-163	209	23	.	.	PUNCT
aji-163	210	1	while	while	SCONJ
aji-163	210	2	the	the	DET
aji-163	210	3	reliance	reliance	NOUN
aji-163	210	4	on	on	ADP
aji-163	210	5	antigen	antigen	NOUN
aji-163	210	6	-	-	PUNCT
aji-163	210	7	specific	specific	ADJ
aji-163	210	8	lymphocytes	lymphocyte	NOUN
aji-163	210	9	for	for	ADP
aji-163	210	10	classical	classical	ADJ
aji-163	210	11	immunological	immunological	ADJ
aji-163	210	12	memory	memory	NOUN
aji-163	210	13	,	,	PUNCT
aji-163	210	14	trained	train	VERB
aji-163	210	15	immunity	immunity	NOUN
aji-163	210	16	might	might	AUX
aji-163	210	17	be	be	AUX
aji-163	210	18	a	a	DET
aji-163	210	19	broader	broad	ADJ
aji-163	210	20	,	,	PUNCT
aji-163	210	21	non	non	ADJ
aji-163	210	22	-	-	ADJ
aji-163	210	23	specific	specific	ADJ
aji-163	210	24	protective	protective	ADJ
aji-163	210	25	mechanism	mechanism	NOUN
aji-163	210	26	that	that	PRON
aji-163	210	27	can	can	AUX
aji-163	210	28	be	be	AUX
aji-163	210	29	used	use	VERB
aji-163	210	30	for	for	ADP
aji-163	210	31	vaccine	vaccine	NOUN
aji-163	210	32	development	development	NOUN
aji-163	210	33	and	and	CCONJ
aji-163	210	34	immunotherapy	immunotherapy	NOUN
aji-163	210	35	(	(	PUNCT
aji-163	210	36	hajishengallis	hajishengallis	INTJ
aji-163	210	37	et	et	PROPN
aji-163	210	38	al	al	PROPN
aji-163	210	39	.	.	PROPN
aji-163	210	40	,	,	PUNCT
aji-163	210	41	2025	2025	NUM
aji-163	210	42	)	)	PUNCT
aji-163	210	43	.	.	PUNCT
aji-163	211	1	3.3	3.3	NUM
aji-163	211	2	duration	duration	NOUN
aji-163	211	3	and	and	CCONJ
aji-163	211	4	sustainability	sustainability	NOUN
aji-163	211	5	of	of	ADP
aji-163	211	6	trained	train	VERB
aji-163	211	7	immunity	immunity	NOUN
aji-163	211	8	trained	train	VERB
aji-163	211	9	immunity	immunity	NOUN
aji-163	211	10	varies	vary	VERB
aji-163	211	11	with	with	ADP
aji-163	211	12	different	different	ADJ
aji-163	211	13	persistence	persistence	NOUN
aji-163	211	14	depending	depend	VERB
aji-163	211	15	on	on	ADP
aji-163	211	16	the	the	DET
aji-163	211	17	stimulus	stimulus	NOUN
aji-163	211	18	,	,	PUNCT
aji-163	211	19	the	the	DET
aji-163	211	20	immune	immune	ADJ
aji-163	211	21	cell	cell	NOUN
aji-163	211	22	type	type	NOUN
aji-163	211	23	,	,	PUNCT
aji-163	211	24	as	as	ADV
aji-163	211	25	well	well	ADV
aji-163	211	26	as	as	ADP
aji-163	211	27	metabolic	metabolic	NOUN
aji-163	211	28	and	and	CCONJ
aji-163	211	29	janefrancis	janefrancis	PROPN
aji-163	211	30	et	et	PROPN
aji-163	211	31	al	al	PROPN
aji-163	211	32	.	.	PROPN
aji-163	211	33	;	;	PUNCT
aji-163	211	34	asian	asian	PROPN
aji-163	211	35	j.	j.	PROPN
aji-163	211	36	immunol	immunol	PROPN
aji-163	211	37	.	.	PROPN
aji-163	211	38	,	,	PUNCT
aji-163	211	39	vol	vol	NOUN
aji-163	211	40	.	.	PROPN
aji-163	211	41	8	8	NUM
aji-163	211	42	,	,	PUNCT
aji-163	211	43	no	no	INTJ
aji-163	211	44	.	.	NOUN
aji-163	211	45	1	1	NUM
aji-163	211	46	,	,	PUNCT
aji-163	211	47	pp	pp	ADJ
aji-163	211	48	.	.	PUNCT
aji-163	212	1	86	86	NUM
aji-163	212	2	-	-	SYM
aji-163	212	3	96	96	NUM
aji-163	212	4	,	,	PUNCT
aji-163	212	5	2025	2025	NUM
aji-163	212	6	;	;	PUNCT
aji-163	212	7	article	article	NOUN
aji-163	212	8	no.aji.134904	no.aji.134904	VERB
aji-163	212	9	91	91	NUM
aji-163	212	10	table	table	NOUN
aji-163	212	11	3	3	NUM
aji-163	212	12	.	.	PUNCT
aji-163	212	13	findings	finding	NOUN
aji-163	212	14	from	from	ADP
aji-163	212	15	included	include	VERB
aji-163	212	16	studies	study	NOUN
aji-163	212	17	author	author	NOUN
aji-163	212	18	&	&	CCONJ
aji-163	212	19	year	year	PROPN
aji-163	212	20	study	study	NOUN
aji-163	212	21	objective	objective	ADJ
aji-163	212	22	study	study	NOUN
aji-163	212	23	design	design	NOUN
aji-163	212	24	mechanisms	mechanism	NOUN
aji-163	212	25	of	of	ADP
aji-163	212	26	trained	train	VERB
aji-163	212	27	immunity	immunity	NOUN
aji-163	212	28	disease	disease	NOUN
aji-163	212	29	/	/	SYM
aji-163	212	30	pathogen	pathogen	NOUN
aji-163	212	31	context	context	NOUN
aji-163	212	32	duration	duration	NOUN
aji-163	212	33	of	of	ADP
aji-163	212	34	immune	immune	ADJ
aji-163	212	35	training	training	NOUN
aji-163	212	36	clinical	clinical	ADJ
aji-163	212	37	/	/	SYM
aji-163	212	38	translational	translational	ADJ
aji-163	212	39	relevance	relevance	NOUN
aji-163	212	40	key	key	NOUN
aji-163	212	41	findings	finding	NOUN
aji-163	212	42	abhimanyu	abhimanyu	PROPN
aji-163	212	43	et	et	PROPN
aji-163	212	44	al	al	PROPN
aji-163	212	45	.	.	PROPN
aji-163	212	46	,	,	PUNCT
aji-163	212	47	2021	2021	NUM
aji-163	212	48	investigate	investigate	VERB
aji-163	212	49	the	the	DET
aji-163	212	50	reversal	reversal	NOUN
aji-163	212	51	of	of	ADP
aji-163	212	52	postinfectious	postinfectious	ADJ
aji-163	212	53	immune	immune	ADJ
aji-163	212	54	suppression	suppression	NOUN
aji-163	212	55	via	via	ADP
aji-163	212	56	epigenetic	epigenetic	ADJ
aji-163	212	57	modifications	modification	NOUN
aji-163	212	58	experimental	experimental	ADJ
aji-163	212	59	study	study	NOUN
aji-163	212	60	(	(	PUNCT
aji-163	212	61	in	in	ADP
aji-163	212	62	vitro	vitro	X
aji-163	212	63	&	&	CCONJ
aji-163	212	64	in	in	ADP
aji-163	212	65	vivo	vivo	NOUN
aji-163	212	66	)	)	PUNCT
aji-163	212	67	epigenetic	epigenetic	ADJ
aji-163	212	68	modulation	modulation	NOUN
aji-163	212	69	through	through	ADP
aji-163	212	70	histone	histone	NOUN
aji-163	212	71	acetylation	acetylation	NOUN
aji-163	212	72	bacterial	bacterial	ADJ
aji-163	212	73	&	&	CCONJ
aji-163	212	74	viral	viral	ADJ
aji-163	212	75	infections	infection	NOUN
aji-163	212	76	long	long	ADJ
aji-163	212	77	-	-	PUNCT
aji-163	212	78	term	term	NOUN
aji-163	212	79	effects	effect	NOUN
aji-163	212	80	assessed	assess	VERB
aji-163	212	81	potential	potential	NOUN
aji-163	212	82	for	for	ADP
aji-163	212	83	therapeutic	therapeutic	ADJ
aji-163	212	84	reprogramming	reprogramming	NOUN
aji-163	212	85	of	of	ADP
aji-163	212	86	immune	immune	ADJ
aji-163	212	87	responses	response	NOUN
aji-163	212	88	identified	identify	VERB
aji-163	212	89	key	key	ADJ
aji-163	212	90	epigenetic	epigenetic	ADJ
aji-163	212	91	markers	marker	NOUN
aji-163	212	92	that	that	PRON
aji-163	212	93	can	can	AUX
aji-163	212	94	reverse	reverse	VERB
aji-163	212	95	immune	immune	ADJ
aji-163	212	96	suppression	suppression	NOUN
aji-163	212	97	post	post	NOUN
aji-163	212	98	-	-	NOUN
aji-163	212	99	infection	infection	ADJ
aji-163	212	100	hao	hao	PROPN
aji-163	212	101	et	et	PROPN
aji-163	212	102	al	al	PROPN
aji-163	212	103	.	.	PROPN
aji-163	212	104	,	,	PUNCT
aji-163	212	105	2025	2025	NUM
aji-163	212	106	explore	explore	VERB
aji-163	212	107	metabolic	metabolic	NOUN
aji-163	212	108	adaptations	adaptation	NOUN
aji-163	212	109	driving	drive	VERB
aji-163	212	110	innate	innate	ADJ
aji-163	212	111	immune	immune	ADJ
aji-163	212	112	memory	memory	NOUN
aji-163	212	113	review	review	NOUN
aji-163	212	114	of	of	ADP
aji-163	212	115	metabolic	metabolic	NOUN
aji-163	212	116	pathways	pathway	NOUN
aji-163	212	117	glycolysis	glycolysis	NOUN
aji-163	212	118	and	and	CCONJ
aji-163	212	119	oxidative	oxidative	ADJ
aji-163	212	120	phosphorylation	phosphorylation	NOUN
aji-163	212	121	shifts	shift	NOUN
aji-163	212	122	broad	broad	ADJ
aji-163	212	123	infectious	infectious	ADJ
aji-163	212	124	diseases	disease	NOUN
aji-163	212	125	variable	variable	ADJ
aji-163	212	126	depending	depend	VERB
aji-163	212	127	on	on	ADP
aji-163	212	128	stimulus	stimulus	NOUN
aji-163	212	129	identifying	identify	VERB
aji-163	212	130	metabolic	metabolic	NOUN
aji-163	212	131	targets	target	NOUN
aji-163	212	132	for	for	ADP
aji-163	212	133	immunotherapies	immunotherapy	NOUN
aji-163	212	134	highlighted	highlight	VERB
aji-163	212	135	the	the	DET
aji-163	212	136	role	role	NOUN
aji-163	212	137	of	of	ADP
aji-163	212	138	metabolic	metabolic	NOUN
aji-163	212	139	rewiring	rewire	VERB
aji-163	212	140	in	in	ADP
aji-163	212	141	sustaining	sustain	VERB
aji-163	212	142	trained	train	VERB
aji-163	212	143	immunity	immunity	NOUN
aji-163	212	144	jentho	jentho	NOUN
aji-163	212	145	et	et	PROPN
aji-163	212	146	al	al	PROPN
aji-163	212	147	.	.	PROPN
aji-163	212	148	,	,	PUNCT
aji-163	212	149	2021	2021	NUM
aji-163	212	150	study	study	NOUN
aji-163	212	151	epigenetic	epigenetic	ADJ
aji-163	212	152	modulation	modulation	NOUN
aji-163	212	153	in	in	ADP
aji-163	212	154	trained	train	VERB
aji-163	212	155	immunity	immunity	NOUN
aji-163	212	156	induced	induce	VERB
aji-163	212	157	by	by	ADP
aji-163	212	158	heme	heme	NOUN
aji-163	212	159	experimental	experimental	ADJ
aji-163	212	160	study	study	NOUN
aji-163	212	161	(	(	PUNCT
aji-163	212	162	animal	animal	NOUN
aji-163	212	163	models	model	NOUN
aji-163	212	164	)	)	PUNCT
aji-163	212	165	histone	histone	NOUN
aji-163	212	166	methylation	methylation	NOUN
aji-163	212	167	and	and	CCONJ
aji-163	212	168	dna	dna	PROPN
aji-163	212	169	modifications	modification	VERB
aji-163	212	170	heme	heme	NOUN
aji-163	212	171	-	-	PUNCT
aji-163	212	172	related	relate	VERB
aji-163	212	173	immune	immune	ADJ
aji-163	212	174	disorders	disorder	NOUN
aji-163	212	175	longlasting	longlaste	VERB
aji-163	212	176	(	(	PUNCT
aji-163	212	177	several	several	ADJ
aji-163	212	178	months	month	NOUN
aji-163	212	179	)	)	PUNCT
aji-163	212	180	potential	potential	NOUN
aji-163	212	181	for	for	ADP
aji-163	212	182	improving	improve	VERB
aji-163	212	183	anemia	anemia	NOUN
aji-163	212	184	and	and	CCONJ
aji-163	212	185	inflammatory	inflammatory	ADJ
aji-163	212	186	conditions	condition	NOUN
aji-163	212	187	demonstrated	demonstrate	VERB
aji-163	212	188	sustained	sustained	ADJ
aji-163	212	189	myelopoiesis	myelopoiesis	NOUN
aji-163	212	190	and	and	CCONJ
aji-163	212	191	immune	immune	ADJ
aji-163	212	192	adaptation	adaptation	NOUN
aji-163	212	193	via	via	ADP
aji-163	212	194	heme	heme	NOUN
aji-163	212	195	exposure	exposure	NOUN
aji-163	212	196	xing	xing	PROPN
aji-163	212	197	et	et	PROPN
aji-163	212	198	al	al	PROPN
aji-163	212	199	.	.	PROPN
aji-163	212	200	,	,	PUNCT
aji-163	212	201	2020	2020	NUM
aji-163	212	202	examine	examine	VERB
aji-163	212	203	trained	train	VERB
aji-163	212	204	immunity	immunity	NOUN
aji-163	212	205	in	in	ADP
aji-163	212	206	tissueresident	tissueresident	NOUN
aji-163	212	207	macrophages	macrophage	NOUN
aji-163	212	208	experimental	experimental	ADJ
aji-163	212	209	&	&	CCONJ
aji-163	212	210	review	review	VERB
aji-163	212	211	epigenetic	epigenetic	ADJ
aji-163	212	212	and	and	CCONJ
aji-163	212	213	metabolic	metabolic	NOUN
aji-163	212	214	modifications	modification	NOUN
aji-163	212	215	in	in	ADP
aji-163	212	216	macrophages	macrophage	NOUN
aji-163	212	217	respiratory	respiratory	ADJ
aji-163	212	218	infections	infection	NOUN
aji-163	212	219	months	month	NOUN
aji-163	212	220	to	to	ADP
aji-163	212	221	years	year	NOUN
aji-163	212	222	implications	implication	NOUN
aji-163	212	223	for	for	ADP
aji-163	212	224	vaccine	vaccine	NOUN
aji-163	212	225	strategies	strategy	NOUN
aji-163	212	226	proposed	propose	VERB
aji-163	212	227	a	a	DET
aji-163	212	228	new	new	ADJ
aji-163	212	229	vaccination	vaccination	NOUN
aji-163	212	230	model	model	NOUN
aji-163	212	231	leveraging	leverage	VERB
aji-163	212	232	trained	train	VERB
aji-163	212	233	macrophage	macrophage	ADJ
aji-163	212	234	responses	response	NOUN
aji-163	212	235	fok	fok	NOUN
aji-163	212	236	et	et	PROPN
aji-163	212	237	al	al	PROPN
aji-163	212	238	.	.	PROPN
aji-163	212	239	,	,	PUNCT
aji-163	212	240	2019	2019	NUM
aji-163	212	241	investigate	investigate	VERB
aji-163	212	242	lncrna	lncrna	NOUN
aji-163	212	243	involvement	involvement	NOUN
aji-163	212	244	in	in	ADP
aji-163	212	245	metabolic	metabolic	NOUN
aji-163	212	246	-	-	PUNCT
aji-163	212	247	epigenetic	epigenetic	NOUN
aji-163	212	248	immunity	immunity	NOUN
aji-163	212	249	links	link	NOUN
aji-163	212	250	experimental	experimental	ADJ
aji-163	212	251	study	study	NOUN
aji-163	212	252	long	long	ADJ
aji-163	212	253	non	non	ADJ
aji-163	212	254	-	-	ADJ
aji-163	212	255	coding	coding	ADJ
aji-163	212	256	rnas	rna	NOUN
aji-163	212	257	(	(	PUNCT
aji-163	212	258	lncrnas	lncrna	NOUN
aji-163	212	259	)	)	PUNCT
aji-163	212	260	in	in	ADP
aji-163	212	261	immune	immune	ADJ
aji-163	212	262	reprogramming	reprogramme	VERB
aji-163	212	263	bacterial	bacterial	ADJ
aji-163	212	264	&	&	CCONJ
aji-163	212	265	viral	viral	ADJ
aji-163	212	266	infections	infection	NOUN
aji-163	212	267	persistent	persistent	ADJ
aji-163	212	268	effects	effect	NOUN
aji-163	212	269	possible	possible	ADJ
aji-163	212	270	rna	rna	NOUN
aji-163	212	271	-	-	PUNCT
aji-163	212	272	based	base	VERB
aji-163	212	273	immunotherapies	immunotherapy	NOUN
aji-163	212	274	found	find	VERB
aji-163	212	275	lncrnamediated	lncrnamediate	VERB
aji-163	212	276	regulatory	regulatory	ADJ
aji-163	212	277	pathways	pathway	NOUN
aji-163	212	278	crucial	crucial	ADJ
aji-163	212	279	for	for	ADP
aji-163	212	280	trained	train	VERB
aji-163	212	281	immunity	immunity	NOUN
aji-163	212	282	table	table	NOUN
aji-163	212	283	3	3	NUM
aji-163	212	284	cont’d	cont’d	NOUN
aji-163	212	285	author	author	NOUN
aji-163	212	286	&	&	CCONJ
aji-163	212	287	year	year	PROPN
aji-163	212	288	study	study	NOUN
aji-163	212	289	objective	objective	ADJ
aji-163	212	290	study	study	NOUN
aji-163	212	291	design	design	NOUN
aji-163	212	292	mechanisms	mechanism	NOUN
aji-163	212	293	of	of	ADP
aji-163	212	294	trained	train	VERB
aji-163	212	295	immunity	immunity	NOUN
aji-163	212	296	disease	disease	NOUN
aji-163	212	297	/	/	SYM
aji-163	212	298	pathogen	pathogen	NOUN
aji-163	212	299	context	context	NOUN
aji-163	212	300	duration	duration	NOUN
aji-163	212	301	of	of	ADP
aji-163	212	302	immune	immune	ADJ
aji-163	212	303	training	training	NOUN
aji-163	212	304	clinical	clinical	ADJ
aji-163	212	305	/	/	SYM
aji-163	212	306	translational	translational	ADJ
aji-163	212	307	relevance	relevance	NOUN
aji-163	212	308	key	key	NOUN
aji-163	212	309	findings	finding	NOUN
aji-163	212	310	wang	wang	PROPN
aji-163	212	311	et	et	PROPN
aji-163	212	312	al	al	PROPN
aji-163	212	313	.	.	PROPN
aji-163	212	314	,	,	PUNCT
aji-163	212	315	2024	2024	NUM
aji-163	212	316	explore	explore	VERB
aji-163	212	317	trained	train	VERB
aji-163	212	318	immunity	immunity	NOUN
aji-163	212	319	’s	’s	PART
aji-163	212	320	impact	impact	NOUN
aji-163	212	321	on	on	ADP
aji-163	212	322	sepsis	sepsis	NOUN
aji-163	212	323	experimental	experimental	ADJ
aji-163	212	324	study	study	NOUN
aji-163	212	325	(	(	PUNCT
aji-163	212	326	animal	animal	NOUN
aji-163	212	327	models	model	NOUN
aji-163	212	328	)	)	PUNCT
aji-163	212	329	histone	histone	NOUN
aji-163	212	330	modifications	modification	NOUN
aji-163	212	331	,	,	PUNCT
aji-163	212	332	cytokine	cytokine	ADJ
aji-163	212	333	reprogramming	reprogramme	VERB
aji-163	212	334	sepsis	sepsis	NOUN
aji-163	212	335	weeks	week	NOUN
aji-163	212	336	to	to	ADP
aji-163	212	337	months	month	NOUN
aji-163	212	338	new	new	ADJ
aji-163	212	339	therapeutic	therapeutic	ADJ
aji-163	212	340	avenues	avenue	NOUN
aji-163	212	341	for	for	ADP
aji-163	212	342	sepsis	sepsis	NOUN
aji-163	212	343	management	management	NOUN
aji-163	212	344	found	find	VERB
aji-163	212	345	that	that	SCONJ
aji-163	212	346	trained	train	VERB
aji-163	212	347	immunity	immunity	NOUN
aji-163	212	348	can	can	AUX
aji-163	212	349	enhance	enhance	VERB
aji-163	212	350	sepsis	sepsis	NOUN
aji-163	212	351	resistance	resistance	NOUN
aji-163	212	352	but	but	CCONJ
aji-163	212	353	also	also	ADV
aji-163	212	354	janefrancis	janefrancis	PROPN
aji-163	212	355	et	et	PROPN
aji-163	212	356	al	al	PROPN
aji-163	212	357	.	.	PROPN
aji-163	212	358	;	;	PUNCT
aji-163	213	1	asian	asian	PROPN
aji-163	213	2	j.	j.	PROPN
aji-163	213	3	immunol	immunol	PROPN
aji-163	213	4	.	.	PROPN
aji-163	213	5	,	,	PUNCT
aji-163	213	6	vol	vol	NOUN
aji-163	213	7	.	.	PROPN
aji-163	213	8	8	8	NUM
aji-163	213	9	,	,	PUNCT
aji-163	213	10	no	no	INTJ
aji-163	213	11	.	.	NOUN
aji-163	213	12	1	1	NUM
aji-163	213	13	,	,	PUNCT
aji-163	213	14	pp	pp	ADJ
aji-163	213	15	.	.	PUNCT
aji-163	214	1	86	86	NUM
aji-163	214	2	-	-	SYM
aji-163	214	3	96	96	NUM
aji-163	214	4	,	,	PUNCT
aji-163	214	5	2025	2025	NUM
aji-163	214	6	;	;	PUNCT
aji-163	214	7	article	article	NOUN
aji-163	214	8	no.aji.134904	no.aji.134904	VERB
aji-163	214	9	92	92	NUM
aji-163	214	10	author	author	NOUN
aji-163	214	11	&	&	CCONJ
aji-163	214	12	year	year	PROPN
aji-163	214	13	study	study	NOUN
aji-163	214	14	objective	objective	ADJ
aji-163	214	15	study	study	NOUN
aji-163	214	16	design	design	NOUN
aji-163	214	17	mechanisms	mechanism	NOUN
aji-163	214	18	of	of	ADP
aji-163	214	19	trained	train	VERB
aji-163	214	20	immunity	immunity	NOUN
aji-163	214	21	disease	disease	NOUN
aji-163	214	22	/	/	SYM
aji-163	214	23	pathogen	pathogen	NOUN
aji-163	214	24	context	context	NOUN
aji-163	214	25	duration	duration	NOUN
aji-163	214	26	of	of	ADP
aji-163	214	27	immune	immune	ADJ
aji-163	214	28	training	training	NOUN
aji-163	214	29	clinical	clinical	ADJ
aji-163	214	30	/	/	SYM
aji-163	214	31	translational	translational	ADJ
aji-163	214	32	relevance	relevance	NOUN
aji-163	214	33	key	key	ADJ
aji-163	214	34	findings	finding	NOUN
aji-163	214	35	risk	risk	NOUN
aji-163	214	36	hyperinflammation	hyperinflammation	NOUN
aji-163	214	37	lajqi	lajqi	NOUN
aji-163	214	38	et	et	PROPN
aji-163	214	39	al	al	PROPN
aji-163	214	40	.	.	PROPN
aji-163	214	41	,	,	PUNCT
aji-163	214	42	2024	2024	NUM
aji-163	214	43	investigate	investigate	VERB
aji-163	214	44	trained	train	VERB
aji-163	214	45	immunity	immunity	NOUN
aji-163	214	46	in	in	ADP
aji-163	214	47	pediatric	pediatric	ADJ
aji-163	214	48	infections	infection	NOUN
aji-163	214	49	experimental	experimental	ADJ
aji-163	214	50	study	study	NOUN
aji-163	214	51	(	(	PUNCT
aji-163	214	52	pediatric	pediatric	ADJ
aji-163	214	53	models	model	NOUN
aji-163	214	54	)	)	PUNCT
aji-163	214	55	histone	histone	NOUN
aji-163	214	56	modifications	modification	NOUN
aji-163	214	57	,	,	PUNCT
aji-163	214	58	cytokine	cytokine	ADJ
aji-163	214	59	memory	memory	NOUN
aji-163	214	60	pediatric	pediatric	ADJ
aji-163	214	61	bacterial	bacterial	ADJ
aji-163	214	62	&	&	CCONJ
aji-163	214	63	viral	viral	ADJ
aji-163	214	64	infections	infection	NOUN
aji-163	214	65	months	month	NOUN
aji-163	214	66	to	to	ADP
aji-163	214	67	years	year	NOUN
aji-163	214	68	potential	potential	ADJ
aji-163	214	69	for	for	ADP
aji-163	214	70	improving	improve	VERB
aji-163	214	71	pediatric	pediatric	ADJ
aji-163	214	72	vaccine	vaccine	NOUN
aji-163	214	73	efficacy	efficacy	NOUN
aji-163	214	74	found	find	VERB
aji-163	214	75	that	that	SCONJ
aji-163	214	76	early	early	ADJ
aji-163	214	77	-	-	PUNCT
aji-163	214	78	life	life	NOUN
aji-163	214	79	infections	infection	NOUN
aji-163	214	80	induce	induce	VERB
aji-163	214	81	long	long	ADV
aji-163	214	82	-	-	PUNCT
aji-163	214	83	lasting	last	VERB
aji-163	214	84	immune	immune	ADJ
aji-163	214	85	adaptations	adaptation	NOUN
aji-163	214	86	keating	keate	VERB
aji-163	214	87	et	et	PROPN
aji-163	214	88	al	al	PROPN
aji-163	214	89	.	.	PROPN
aji-163	214	90	,	,	PUNCT
aji-163	214	91	2020	2020	NUM
aji-163	214	92	examine	examine	VERB
aji-163	214	93	set7	set7	NOUN
aji-163	214	94	methyltransferase	methyltransferase	NOUN
aji-163	214	95	’s	’s	PART
aji-163	214	96	role	role	NOUN
aji-163	214	97	in	in	ADP
aji-163	214	98	trained	train	VERB
aji-163	214	99	immunity	immunity	NOUN
aji-163	214	100	experimental	experimental	ADJ
aji-163	214	101	study	study	NOUN
aji-163	214	102	set7	set7	NOUN
aji-163	214	103	-	-	PUNCT
aji-163	214	104	driven	drive	VERB
aji-163	214	105	oxidative	oxidative	ADJ
aji-163	214	106	phosphorylation	phosphorylation	NOUN
aji-163	214	107	plasticity	plasticity	NOUN
aji-163	214	108	fungal	fungal	ADJ
aji-163	214	109	infections	infection	NOUN
aji-163	214	110	(	(	PUNCT
aji-163	214	111	βglucan	βglucan	ADJ
aji-163	214	112	exposure	exposure	NOUN
aji-163	214	113	)	)	PUNCT
aji-163	214	114	long	long	ADJ
aji-163	214	115	-	-	PUNCT
aji-163	214	116	term	term	NOUN
aji-163	214	117	metabolic	metabolic	NOUN
aji-163	214	118	imprinting	imprint	VERB
aji-163	214	119	targeting	targeting	NOUN
aji-163	214	120	set7	set7	NOUN
aji-163	214	121	for	for	ADP
aji-163	214	122	trained	train	VERB
aji-163	214	123	immunity	immunity	NOUN
aji-163	214	124	-	-	PUNCT
aji-163	214	125	based	base	VERB
aji-163	214	126	therapies	therapy	NOUN
aji-163	214	127	identified	identify	VERB
aji-163	214	128	set7	set7	NOUN
aji-163	214	129	as	as	ADP
aji-163	214	130	a	a	DET
aji-163	214	131	key	key	ADJ
aji-163	214	132	regulator	regulator	NOUN
aji-163	214	133	of	of	ADP
aji-163	214	134	trained	train	VERB
aji-163	214	135	immunity	immunity	NOUN
aji-163	214	136	in	in	ADP
aji-163	214	137	response	response	NOUN
aji-163	214	138	to	to	ADP
aji-163	214	139	β	β	NOUN
aji-163	214	140	-	-	PUNCT
aji-163	214	141	glucan	glucan	NOUN
aji-163	214	142	janefrancis	janefrancis	PROPN
aji-163	214	143	et	et	PROPN
aji-163	214	144	al	al	PROPN
aji-163	214	145	.	.	PROPN
aji-163	214	146	;	;	PUNCT
aji-163	215	1	asian	asian	PROPN
aji-163	215	2	j.	j.	PROPN
aji-163	215	3	immunol	immunol	PROPN
aji-163	215	4	.	.	PROPN
aji-163	215	5	,	,	PUNCT
aji-163	215	6	vol	vol	NOUN
aji-163	215	7	.	.	PROPN
aji-163	215	8	8	8	NUM
aji-163	215	9	,	,	PUNCT
aji-163	215	10	no	no	INTJ
aji-163	215	11	.	.	NOUN
aji-163	215	12	1	1	NUM
aji-163	215	13	,	,	PUNCT
aji-163	215	14	pp	pp	ADJ
aji-163	215	15	.	.	PUNCT
aji-163	216	1	86	86	NUM
aji-163	216	2	-	-	SYM
aji-163	216	3	96	96	NUM
aji-163	216	4	,	,	PUNCT
aji-163	216	5	2025	2025	NUM
aji-163	216	6	;	;	PUNCT
aji-163	216	7	article	article	NOUN
aji-163	216	8	no.aji.134904	no.aji.134904	VERB
aji-163	216	9	93	93	NUM
aji-163	216	10	epigenetic	epigenetic	ADJ
aji-163	216	11	adaptations	adaptation	NOUN
aji-163	216	12	.	.	PUNCT
aji-163	217	1	several	several	ADJ
aji-163	217	2	studies	study	NOUN
aji-163	217	3	show	show	VERB
aji-163	217	4	that	that	SCONJ
aji-163	217	5	trained	train	VERB
aji-163	217	6	immunity	immunity	NOUN
aji-163	217	7	can	can	AUX
aji-163	217	8	persist	persist	VERB
aji-163	217	9	from	from	ADP
aji-163	217	10	weeks	week	NOUN
aji-163	217	11	to	to	ADP
aji-163	217	12	months	month	NOUN
aji-163	217	13	and	and	CCONJ
aji-163	217	14	for	for	ADP
aji-163	217	15	years	year	NOUN
aji-163	217	16	in	in	ADP
aji-163	217	17	some	some	DET
aji-163	217	18	cases	case	NOUN
aji-163	217	19	.	.	PUNCT
aji-163	218	1	according	accord	VERB
aji-163	218	2	to	to	ADP
aji-163	218	3	jentho	jentho	PROPN
aji-163	218	4	et	et	PROPN
aji-163	218	5	al	al	PROPN
aji-163	218	6	.	.	PROPN
aji-163	218	7	(	(	PUNCT
aji-163	218	8	2021	2021	NUM
aji-163	218	9	)	)	PUNCT
aji-163	218	10	,	,	PUNCT
aji-163	218	11	when	when	SCONJ
aji-163	218	12	myeloid	myeloid	ADJ
aji-163	218	13	progenitors	progenitor	NOUN
aji-163	218	14	are	be	AUX
aji-163	218	15	exposed	expose	VERB
aji-163	218	16	to	to	ADP
aji-163	218	17	heme	heme	NOUN
aji-163	218	18	,	,	PUNCT
aji-163	218	19	these	these	DET
aji-163	218	20	epigenetic	epigenetic	ADJ
aji-163	218	21	modifications	modification	NOUN
aji-163	218	22	lead	lead	VERB
aji-163	218	23	to	to	ADP
aji-163	218	24	long	long	ADJ
aji-163	218	25	-	-	PUNCT
aji-163	218	26	term	term	NOUN
aji-163	218	27	immune	immune	ADJ
aji-163	218	28	reprogramming	reprogramme	VERB
aji-163	218	29	beyond	beyond	ADP
aji-163	218	30	the	the	DET
aji-163	218	31	life	life	NOUN
aji-163	218	32	span	span	NOUN
aji-163	218	33	of	of	ADP
aji-163	218	34	a	a	DET
aji-163	218	35	single	single	ADJ
aji-163	218	36	immune	immune	ADJ
aji-163	218	37	cell	cell	NOUN
aji-163	218	38	through	through	ADP
aji-163	218	39	altered	altered	ADJ
aji-163	218	40	hematopoiesis	hematopoiesis	NOUN
aji-163	218	41	.	.	PUNCT
aji-163	219	1	as	as	ADP
aji-163	219	2	in	in	ADP
aji-163	219	3	keating	keating	NOUN
aji-163	219	4	et	et	PROPN
aji-163	219	5	al	al	PROPN
aji-163	219	6	(	(	PUNCT
aji-163	219	7	2020	2020	NUM
aji-163	219	8	)	)	PUNCT
aji-163	219	9	,	,	PUNCT
aji-163	219	10	β	β	X
aji-163	219	11	glucan	glucan	VERB
aji-163	219	12	-	-	PUNCT
aji-163	219	13	induced	induce	VERB
aji-163	219	14	trained	train	VERB
aji-163	219	15	immunity	immunity	NOUN
aji-163	219	16	can	can	AUX
aji-163	219	17	persist	persist	VERB
aji-163	219	18	for	for	ADP
aji-163	219	19	up	up	ADP
aji-163	219	20	to	to	ADP
aji-163	219	21	several	several	ADJ
aji-163	219	22	months	month	NOUN
aji-163	219	23	through	through	ADP
aji-163	219	24	the	the	DET
aji-163	219	25	sustained	sustained	ADJ
aji-163	219	26	effect	effect	NOUN
aji-163	219	27	of	of	ADP
aji-163	219	28	changes	change	NOUN
aji-163	219	29	in	in	ADP
aji-163	219	30	oxidative	oxidative	ADJ
aji-163	219	31	phosphorylation	phosphorylation	NOUN
aji-163	219	32	and	and	CCONJ
aji-163	219	33	mitochondrial	mitochondrial	ADJ
aji-163	219	34	function	function	NOUN
aji-163	219	35	.	.	PUNCT
aji-163	220	1	recovery	recovery	NOUN
aji-163	220	2	of	of	ADP
aji-163	220	3	trained	train	VERB
aji-163	220	4	immunity	immunity	NOUN
aji-163	220	5	also	also	ADV
aji-163	220	6	depends	depend	VERB
aji-163	220	7	on	on	ADP
aji-163	220	8	repeated	repeat	VERB
aji-163	220	9	exposure	exposure	NOUN
aji-163	220	10	to	to	AUX
aji-163	220	11	stimuli	stimulus	NOUN
aji-163	220	12	.	.	PUNCT
aji-163	221	1	by	by	ADP
aji-163	221	2	repeatedly	repeatedly	ADV
aji-163	221	3	encountering	encounter	VERB
aji-163	221	4	the	the	DET
aji-163	221	5	same	same	ADJ
aji-163	221	6	microbes	microbe	NOUN
aji-163	221	7	,	,	PUNCT
aji-163	221	8	recurrent	recurrent	ADJ
aji-163	221	9	encounters	encounter	NOUN
aji-163	221	10	furthered	further	VERB
aji-163	221	11	the	the	DET
aji-163	221	12	training	training	NOUN
aji-163	221	13	of	of	ADP
aji-163	221	14	the	the	DET
aji-163	221	15	immune	immune	ADJ
aji-163	221	16	system	system	NOUN
aji-163	221	17	,	,	PUNCT
aji-163	221	18	keeping	keep	VERB
aji-163	221	19	it	it	PRON
aji-163	221	20	lasting	last	VERB
aji-163	221	21	much	much	ADV
aji-163	221	22	further	far	ADV
aji-163	221	23	by	by	ADP
aji-163	221	24	continuously	continuously	ADV
aji-163	221	25	reprogramming	reprogramme	VERB
aji-163	221	26	metabolic	metabolic	NOUN
aji-163	221	27	and	and	CCONJ
aji-163	221	28	epigenetic	epigenetic	ADJ
aji-163	221	29	pathways	pathway	NOUN
aji-163	221	30	(	(	PUNCT
aji-163	221	31	rusek	rusek	VERB
aji-163	221	32	et	et	PROPN
aji-163	221	33	al	al	PROPN
aji-163	221	34	.	.	PROPN
aji-163	221	35	,	,	PUNCT
aji-163	221	36	2018	2018	NUM
aji-163	221	37	)	)	PUNCT
aji-163	221	38	.	.	PUNCT
aji-163	222	1	on	on	ADP
aji-163	222	2	the	the	DET
aji-163	222	3	other	other	ADJ
aji-163	222	4	hand	hand	NOUN
aji-163	222	5	,	,	PUNCT
aji-163	222	6	abhimanyu	abhimanyu	PROPN
aji-163	222	7	et	et	PROPN
aji-163	222	8	al	al	PROPN
aji-163	222	9	.	.	PROPN
aji-163	222	10	(	(	PUNCT
aji-163	222	11	2021	2021	NUM
aji-163	222	12	)	)	PUNCT
aji-163	222	13	reported	report	VERB
aji-163	222	14	that	that	SCONJ
aji-163	222	15	the	the	DET
aji-163	222	16	longevity	longevity	NOUN
aji-163	222	17	of	of	ADP
aji-163	222	18	trained	train	VERB
aji-163	222	19	immunity	immunity	NOUN
aji-163	222	20	is	be	AUX
aji-163	222	21	contextdependent	contextdependent	ADJ
aji-163	222	22	and	and	CCONJ
aji-163	222	23	reversible	reversible	ADJ
aji-163	222	24	under	under	ADP
aji-163	222	25	immunosuppressive	immunosuppressive	ADJ
aji-163	222	26	conditions	condition	NOUN
aji-163	222	27	.	.	PUNCT
aji-163	223	1	this	this	PRON
aji-163	223	2	is	be	AUX
aji-163	223	3	further	far	ADV
aji-163	223	4	corroborated	corroborate	VERB
aji-163	223	5	by	by	ADP
aji-163	223	6	capriotti	capriotti	NOUN
aji-163	223	7	and	and	CCONJ
aji-163	223	8	klase	klase	PROPN
aji-163	223	9	(	(	PUNCT
aji-163	223	10	2024	2024	NUM
aji-163	223	11	)	)	PUNCT
aji-163	223	12	,	,	PUNCT
aji-163	223	13	who	who	PRON
aji-163	223	14	demonstrate	demonstrate	VERB
aji-163	223	15	that	that	SCONJ
aji-163	223	16	trained	train	VERB
aji-163	223	17	immunity	immunity	NOUN
aji-163	223	18	mechanisms	mechanism	NOUN
aji-163	223	19	break	break	VERB
aji-163	223	20	down	down	ADP
aji-163	223	21	in	in	ADP
aji-163	223	22	chronic	chronic	ADJ
aji-163	223	23	hiv	hiv	PROPN
aji-163	223	24	infection	infection	NOUN
aji-163	223	25	and	and	CCONJ
aji-163	223	26	are	be	AUX
aji-163	223	27	lost	lose	VERB
aji-163	223	28	more	more	ADV
aji-163	223	29	quickly	quickly	ADV
aji-163	223	30	than	than	SCONJ
aji-163	223	31	would	would	AUX
aji-163	223	32	have	have	AUX
aji-163	223	33	been	be	AUX
aji-163	223	34	otherwise	otherwise	ADV
aji-163	223	35	the	the	DET
aji-163	223	36	case	case	NOUN
aji-163	223	37	.	.	PUNCT
aji-163	224	1	in	in	ADP
aji-163	224	2	addition	addition	NOUN
aji-163	224	3	,	,	PUNCT
aji-163	224	4	it	it	PRON
aji-163	224	5	has	have	AUX
aji-163	224	6	been	be	AUX
aji-163	224	7	noted	note	VERB
aji-163	224	8	in	in	ADP
aji-163	224	9	studies	study	NOUN
aji-163	224	10	that	that	PRON
aji-163	224	11	trained	train	VERB
aji-163	224	12	immunity	immunity	NOUN
aji-163	224	13	persistence	persistence	NOUN
aji-163	224	14	is	be	AUX
aji-163	224	15	disease	disease	NOUN
aji-163	224	16	model	model	NOUN
aji-163	224	17	-	-	PUNCT
aji-163	224	18	dependent	dependent	ADJ
aji-163	224	19	.	.	PUNCT
aji-163	225	1	in	in	ADP
aji-163	225	2	sepsis	sepsis	NOUN
aji-163	225	3	-	-	PUNCT
aji-163	225	4	induced	induce	VERB
aji-163	225	5	trained	train	VERB
aji-163	225	6	immunity	immunity	NOUN
aji-163	225	7	,	,	PUNCT
aji-163	225	8	metabolic	metabolic	NOUN
aji-163	225	9	adaptations	adaptation	NOUN
aji-163	225	10	shown	show	VERB
aji-163	225	11	by	by	ADP
aji-163	225	12	hao	hao	PROPN
aji-163	225	13	et	et	PROPN
aji-163	225	14	al	al	PROPN
aji-163	225	15	.	.	PROPN
aji-163	226	1	(	(	PUNCT
aji-163	226	2	2025	2025	NUM
aji-163	226	3	)	)	PUNCT
aji-163	226	4	are	be	AUX
aji-163	226	5	transient	transient	ADJ
aji-163	226	6	and	and	CCONJ
aji-163	226	7	come	come	VERB
aji-163	226	8	back	back	ADV
aji-163	226	9	to	to	PART
aji-163	226	10	baseline	baseline	VERB
aji-163	226	11	in	in	ADP
aji-163	226	12	a	a	DET
aji-163	226	13	couple	couple	NOUN
aji-163	226	14	of	of	ADP
aji-163	226	15	weeks	week	NOUN
aji-163	226	16	.	.	PUNCT
aji-163	227	1	hajishengallis	hajishengallis	INTJ
aji-163	227	2	et	et	PROPN
aji-163	227	3	al	al	PROPN
aji-163	227	4	.	.	PROPN
aji-163	228	1	(	(	PUNCT
aji-163	228	2	2025	2025	NUM
aji-163	228	3	)	)	PUNCT
aji-163	228	4	demonstrated	demonstrate	VERB
aji-163	228	5	that	that	SCONJ
aji-163	228	6	chronic	chronic	ADJ
aji-163	228	7	inflammatory	inflammatory	ADJ
aji-163	228	8	disease	disease	NOUN
aji-163	228	9	would	would	AUX
aji-163	228	10	maintain	maintain	VERB
aji-163	228	11	trained	trained	ADJ
aji-163	228	12	immunity	immunity	NOUN
aji-163	228	13	for	for	ADP
aji-163	228	14	extended	extended	ADJ
aji-163	228	15	periods	period	NOUN
aji-163	228	16	,	,	PUNCT
aji-163	228	17	and	and	CCONJ
aji-163	228	18	they	they	PRON
aji-163	228	19	suggest	suggest	VERB
aji-163	228	20	a	a	DET
aji-163	228	21	possible	possible	ADJ
aji-163	228	22	role	role	NOUN
aji-163	228	23	in	in	ADP
aji-163	228	24	disease	disease	NOUN
aji-163	228	25	progression	progression	NOUN
aji-163	228	26	.	.	PUNCT
aji-163	229	1	taken	take	VERB
aji-163	229	2	as	as	ADP
aji-163	229	3	a	a	DET
aji-163	229	4	whole	whole	NOUN
aji-163	229	5	these	these	DET
aji-163	229	6	findings	finding	NOUN
aji-163	229	7	suggest	suggest	VERB
aji-163	229	8	that	that	SCONJ
aji-163	229	9	trained	train	VERB
aji-163	229	10	immunity	immunity	NOUN
aji-163	229	11	can	can	AUX
aji-163	229	12	be	be	AUX
aji-163	229	13	maintained	maintain	VERB
aji-163	229	14	on	on	ADP
aji-163	229	15	a	a	DET
aji-163	229	16	sustained	sustained	ADJ
aji-163	229	17	basis	basis	NOUN
aji-163	229	18	but	but	CCONJ
aji-163	229	19	its	its	PRON
aji-163	229	20	persistence	persistence	NOUN
aji-163	229	21	depends	depend	VERB
aji-163	229	22	on	on	ADP
aji-163	229	23	external	external	ADJ
aji-163	229	24	stimuli	stimulus	NOUN
aji-163	229	25	disease	disease	NOUN
aji-163	229	26	states	state	NOUN
aji-163	229	27	and	and	CCONJ
aji-163	229	28	the	the	DET
aji-163	229	29	cellular	cellular	ADJ
aji-163	229	30	environment	environment	NOUN
aji-163	229	31	.	.	PUNCT
aji-163	230	1	consequently	consequently	ADV
aji-163	230	2	,	,	PUNCT
aji-163	230	3	this	this	PRON
aji-163	230	4	opens	open	VERB
aji-163	230	5	up	up	ADP
aji-163	230	6	the	the	DET
aji-163	230	7	potential	potential	NOUN
aji-163	230	8	for	for	ADP
aji-163	230	9	vaccine	vaccine	NOUN
aji-163	230	10	development	development	NOUN
aji-163	230	11	,	,	PUNCT
aji-163	230	12	as	as	ADP
aji-163	230	13	prolonging	prolong	VERB
aji-163	230	14	trained	train	VERB
aji-163	230	15	immunity	immunity	NOUN
aji-163	230	16	from	from	ADP
aji-163	230	17	a	a	DET
aji-163	230	18	trained	train	VERB
aji-163	230	19	immunity	immunity	NOUN
aji-163	230	20	-	-	PUNCT
aji-163	230	21	inducing	induce	VERB
aji-163	230	22	vaccine	vaccine	NOUN
aji-163	230	23	,	,	PUNCT
aji-163	230	24	could	could	AUX
aji-163	230	25	provide	provide	VERB
aji-163	230	26	wide	wide	ADJ
aji-163	230	27	-	-	PUNCT
aji-163	230	28	spectrum	spectrum	NOUN
aji-163	230	29	protection	protection	NOUN
aji-163	230	30	against	against	ADP
aji-163	230	31	infectious	infectious	ADJ
aji-163	230	32	diseases	disease	NOUN
aji-163	230	33	(	(	PUNCT
aji-163	230	34	salauddin	salauddin	NOUN
aji-163	230	35	et	et	PROPN
aji-163	230	36	al	al	PROPN
aji-163	230	37	.	.	PROPN
aji-163	230	38	,	,	PUNCT
aji-163	230	39	2024	2024	NUM
aji-163	230	40	)	)	PUNCT
aji-163	230	41	.	.	PUNCT
aji-163	231	1	3.4	3.4	NUM
aji-163	231	2	emerging	emerge	VERB
aji-163	231	3	therapeutic	therapeutic	ADJ
aji-163	231	4	strategies	strategy	NOUN
aji-163	231	5	leveraging	leverage	VERB
aji-163	231	6	recent	recent	ADJ
aji-163	231	7	advancement	advancement	NOUN
aji-163	231	8	has	have	AUX
aji-163	231	9	highlighted	highlight	VERB
aji-163	231	10	trained	train	VERB
aji-163	231	11	immunity	immunity	NOUN
aji-163	231	12	as	as	ADP
aji-163	231	13	a	a	DET
aji-163	231	14	promising	promising	ADJ
aji-163	231	15	avenue	avenue	NOUN
aji-163	231	16	for	for	ADP
aji-163	231	17	the	the	DET
aji-163	231	18	development	development	NOUN
aji-163	231	19	of	of	ADP
aji-163	231	20	new	new	ADJ
aji-163	231	21	therapeutic	therapeutic	ADJ
aji-163	231	22	strategies	strategy	NOUN
aji-163	231	23	for	for	ADP
aji-163	231	24	the	the	DET
aji-163	231	25	promotion	promotion	NOUN
aji-163	231	26	of	of	ADP
aji-163	231	27	host	host	NOUN
aji-163	231	28	defense	defense	NOUN
aji-163	231	29	,	,	PUNCT
aji-163	231	30	modulation	modulation	NOUN
aji-163	231	31	of	of	ADP
aji-163	231	32	chronic	chronic	ADJ
aji-163	231	33	inflammatory	inflammatory	ADJ
aji-163	231	34	conditions	condition	NOUN
aji-163	231	35	,	,	PUNCT
aji-163	231	36	and	and	CCONJ
aji-163	231	37	other	other	ADJ
aji-163	231	38	desirable	desirable	ADJ
aji-163	231	39	effects	effect	NOUN
aji-163	231	40	by	by	ADP
aji-163	231	41	vaccine	vaccine	NOUN
aji-163	231	42	.	.	PUNCT
aji-163	232	1	using	use	VERB
aji-163	232	2	trained	train	VERB
aji-163	232	3	immunity	immunity	NOUN
aji-163	232	4	inducing	induce	VERB
aji-163	232	5	agents	agent	NOUN
aji-163	232	6	(	(	PUNCT
aji-163	232	7	tiis	tiis	NOUN
aji-163	232	8	)	)	PUNCT
aji-163	232	9	,	,	PUNCT
aji-163	232	10	a	a	DET
aji-163	232	11	class	class	NOUN
aji-163	232	12	of	of	ADP
aji-163	232	13	agents	agent	NOUN
aji-163	232	14	including	include	VERB
aji-163	232	15	the	the	DET
aji-163	232	16	β	β	NOUN
aji-163	232	17	-	-	PUNCT
aji-163	232	18	glucan	glucan	NOUN
aji-163	232	19	and	and	CCONJ
aji-163	232	20	the	the	DET
aji-163	232	21	cell	cell	NOUN
aji-163	232	22	wall	wall	PROPN
aji-163	232	23	component	component	NOUN
aji-163	232	24	vaccine	vaccine	NOUN
aji-163	232	25	bacillus	bacillus	NOUN
aji-163	232	26	calmette	calmette	NOUN
aji-163	232	27	guérin	guérin	PROPN
aji-163	232	28	(	(	PUNCT
aji-163	232	29	bcg	bcg	PROPN
aji-163	232	30	)	)	PUNCT
aji-163	232	31	is	be	AUX
aji-163	232	32	one	one	NUM
aji-163	232	33	of	of	ADP
aji-163	232	34	the	the	DET
aji-163	232	35	most	most	ADV
aji-163	232	36	actively	actively	ADV
aji-163	232	37	explored	explore	VERB
aji-163	232	38	approaches	approach	NOUN
aji-163	232	39	to	to	ADP
aji-163	232	40	providing	provide	VERB
aji-163	232	41	general	general	ADJ
aji-163	232	42	protection	protection	NOUN
aji-163	232	43	against	against	ADP
aji-163	232	44	infections	infection	NOUN
aji-163	232	45	.	.	PUNCT
aji-163	233	1	bcg	bcg	NOUN
aji-163	233	2	vaccination	vaccination	NOUN
aji-163	233	3	induces	induce	VERB
aji-163	233	4	long	long	ADJ
aji-163	233	5	-	-	PUNCT
aji-163	233	6	term	term	NOUN
aji-163	233	7	metabolic	metabolic	NOUN
aji-163	233	8	and	and	CCONJ
aji-163	233	9	epigenetic	epigenetic	ADJ
aji-163	233	10	reprogramming	reprogramming	NOUN
aji-163	233	11	in	in	ADP
aji-163	233	12	monocytes	monocyte	NOUN
aji-163	233	13	and	and	CCONJ
aji-163	233	14	enhanced	enhance	VERB
aji-163	233	15	resistance	resistance	NOUN
aji-163	233	16	to	to	ADP
aji-163	233	17	viral	viral	ADJ
aji-163	233	18	and	and	CCONJ
aji-163	233	19	bacterial	bacterial	ADJ
aji-163	233	20	pathogens	pathogen	NOUN
aji-163	233	21	beyond	beyond	ADP
aji-163	233	22	tuberculosis	tuberculosis	NOUN
aji-163	233	23	(	(	PUNCT
aji-163	233	24	xing	xing	PROPN
aji-163	233	25	et	et	PROPN
aji-163	233	26	al	al	PROPN
aji-163	233	27	.	.	PROPN
aji-163	233	28	,	,	PUNCT
aji-163	233	29	2020	2020	NUM
aji-163	233	30	)	)	PUNCT
aji-163	233	31	.	.	PUNCT
aji-163	234	1	wang	wang	PROPN
aji-163	234	2	et	et	PROPN
aji-163	234	3	al	al	PROPN
aji-163	234	4	.	.	PROPN
aji-163	234	5	(	(	PUNCT
aji-163	234	6	2024	2024	NUM
aji-163	234	7	)	)	PUNCT
aji-163	234	8	also	also	ADV
aji-163	234	9	suggested	suggest	VERB
aji-163	234	10	that	that	SCONJ
aji-163	234	11	trained	train	VERB
aji-163	234	12	immunityinducing	immunityinducing	NOUN
aji-163	234	13	compounds	compound	NOUN
aji-163	234	14	could	could	AUX
aji-163	234	15	be	be	AUX
aji-163	234	16	used	use	VERB
aji-163	234	17	to	to	PART
aji-163	234	18	strengthen	strengthen	VERB
aji-163	234	19	innate	innate	ADJ
aji-163	234	20	immune	immune	ADJ
aji-163	234	21	responses	response	NOUN
aji-163	234	22	and	and	CCONJ
aji-163	234	23	thus	thus	ADV
aji-163	234	24	help	help	VERB
aji-163	234	25	host	host	NOUN
aji-163	234	26	resilience	resilience	NOUN
aji-163	234	27	to	to	ADP
aji-163	234	28	sepsis	sepsis	NOUN
aji-163	234	29	.	.	PUNCT
aji-163	235	1	trained	train	VERB
aji-163	235	2	immunity	immunity	NOUN
aji-163	235	3	is	be	AUX
aji-163	235	4	also	also	ADV
aji-163	235	5	a	a	DET
aji-163	235	6	target	target	NOUN
aji-163	235	7	beyond	beyond	ADP
aji-163	235	8	infectious	infectious	ADJ
aji-163	235	9	diseases	disease	NOUN
aji-163	235	10	towards	towards	ADP
aji-163	235	11	autoimmune	autoimmune	ADJ
aji-163	235	12	and	and	CCONJ
aji-163	235	13	chronic	chronic	ADJ
aji-163	235	14	inflammatory	inflammatory	ADJ
aji-163	235	15	disorders	disorder	NOUN
aji-163	235	16	.	.	PUNCT
aji-163	236	1	based	base	VERB
aji-163	236	2	on	on	ADP
aji-163	236	3	their	their	PRON
aji-163	236	4	results	result	NOUN
aji-163	236	5	,	,	PUNCT
aji-163	236	6	hajishengallis	hajishengallis	X
aji-163	236	7	et	et	PROPN
aji-163	236	8	al	al	PROPN
aji-163	236	9	.	.	PROPN
aji-163	237	1	(	(	PUNCT
aji-163	237	2	2025	2025	NUM
aji-163	237	3	)	)	PUNCT
aji-163	237	4	proposed	propose	VERB
aji-163	237	5	that	that	SCONJ
aji-163	237	6	the	the	DET
aji-163	237	7	trained	train	VERB
aji-163	237	8	monocytes	monocyte	NOUN
aji-163	237	9	and	and	CCONJ
aji-163	237	10	macrophages	macrophage	NOUN
aji-163	237	11	seem	seem	VERB
aji-163	237	12	to	to	PART
aji-163	237	13	participate	participate	VERB
aji-163	237	14	in	in	ADP
aji-163	237	15	the	the	DET
aji-163	237	16	continuous	continuous	ADJ
aji-163	237	17	inflammatory	inflammatory	ADJ
aji-163	237	18	cascade	cascade	NOUN
aji-163	237	19	in	in	ADP
aji-163	237	20	chronic	chronic	ADJ
aji-163	237	21	diseases	disease	NOUN
aji-163	237	22	,	,	PUNCT
aji-163	237	23	which	which	PRON
aji-163	237	24	makes	make	VERB
aji-163	237	25	them	they	PRON
aji-163	237	26	potential	potential	ADJ
aji-163	237	27	target	target	NOUN
aji-163	237	28	of	of	ADP
aji-163	237	29	immunomodulatory	immunomodulatory	ADJ
aji-163	237	30	therapies	therapy	NOUN
aji-163	237	31	.	.	PUNCT
aji-163	238	1	lajqi	lajqi	ADV
aji-163	238	2	et	et	PROPN
aji-163	238	3	al	al	PROPN
aji-163	238	4	.	.	PROPN
aji-163	239	1	(	(	PUNCT
aji-163	239	2	2024	2024	NUM
aji-163	239	3	)	)	PUNCT
aji-163	239	4	explored	explore	VERB
aji-163	239	5	pediatric	pediatric	ADJ
aji-163	239	6	infectious	infectious	ADJ
aji-163	239	7	diseases	disease	NOUN
aji-163	239	8	and	and	CCONJ
aji-163	239	9	showed	show	VERB
aji-163	239	10	that	that	SCONJ
aji-163	239	11	manipulating	manipulate	VERB
aji-163	239	12	trained	train	VERB
aji-163	239	13	immunity	immunity	NOUN
aji-163	239	14	could	could	AUX
aji-163	239	15	improve	improve	VERB
aji-163	239	16	immune	immune	ADJ
aji-163	239	17	response	response	NOUN
aji-163	239	18	in	in	ADP
aji-163	239	19	immunocompromised	immunocompromise	VERB
aji-163	239	20	children	child	NOUN
aji-163	239	21	.	.	PUNCT
aji-163	240	1	an	an	DET
aji-163	240	2	additional	additional	ADJ
aji-163	240	3	creative	creative	ADJ
aji-163	240	4	aspect	aspect	NOUN
aji-163	240	5	is	be	AUX
aji-163	240	6	using	use	VERB
aji-163	240	7	epigenetic	epigenetic	ADJ
aji-163	240	8	and	and	CCONJ
aji-163	240	9	metabolic	metabolic	NOUN
aji-163	240	10	modulators	modulator	NOUN
aji-163	240	11	to	to	PART
aji-163	240	12	control	control	VERB
aji-163	240	13	trained	train	VERB
aji-163	240	14	immunity	immunity	NOUN
aji-163	240	15	in	in	ADP
aji-163	240	16	therapeutic	therapeutic	ADJ
aji-163	240	17	areas	area	NOUN
aji-163	240	18	.	.	PUNCT
aji-163	241	1	this	this	PRON
aji-163	241	2	led	lead	VERB
aji-163	241	3	fok	fok	PROPN
aji-163	241	4	et	et	PROPN
aji-163	241	5	al	al	PROPN
aji-163	241	6	.	.	PROPN
aji-163	242	1	(	(	PUNCT
aji-163	242	2	2019	2019	NUM
aji-163	242	3	)	)	PUNCT
aji-163	243	1	to	to	PART
aji-163	243	2	find	find	VERB
aji-163	243	3	that	that	PRON
aji-163	243	4	immune	immune	ADJ
aji-163	243	5	training	training	NOUN
aji-163	243	6	is	be	AUX
aji-163	243	7	driven	drive	VERB
aji-163	243	8	by	by	ADP
aji-163	243	9	long	long	ADJ
aji-163	243	10	noncoding	noncoding	ADJ
aji-163	243	11	rnas	rna	NOUN
aji-163	243	12	(	(	PUNCT
aji-163	243	13	lncrnas	lncrna	NOUN
aji-163	243	14	)	)	PUNCT
aji-163	243	15	as	as	ADP
aji-163	243	16	critical	critical	ADJ
aji-163	243	17	regulators	regulator	NOUN
aji-163	243	18	,	,	PUNCT
aji-163	243	19	that	that	PRON
aji-163	243	20	provide	provide	VERB
aji-163	243	21	new	new	ADJ
aji-163	243	22	targets	target	NOUN
aji-163	243	23	of	of	ADP
aji-163	243	24	epigenetic	epigenetic	NOUN
aji-163	243	25	-	-	PUNCT
aji-163	243	26	based	base	VERB
aji-163	243	27	therapies	therapy	NOUN
aji-163	244	1	.	.	PUNCT
aji-163	245	1	metabolic	metabolic	NOUN
aji-163	245	2	intervention	intervention	NOUN
aji-163	245	3	strategy	strategy	NOUN
aji-163	245	4	targeting	target	VERB
aji-163	245	5	lysine	lysine	NOUN
aji-163	245	6	methyltransferase	methyltransferase	NOUN
aji-163	245	7	set7	set7	PROPN
aji-163	245	8	was	be	AUX
aji-163	245	9	also	also	ADV
aji-163	245	10	found	find	VERB
aji-163	245	11	by	by	ADP
aji-163	245	12	keating	keating	PROPN
aji-163	245	13	et	et	PROPN
aji-163	245	14	al	al	PROPN
aji-163	245	15	.	.	PROPN
aji-163	246	1	(	(	PUNCT
aji-163	246	2	2020	2020	NUM
aji-163	246	3	)	)	PUNCT
aji-163	246	4	to	to	PART
aji-163	246	5	boost	boost	VERB
aji-163	246	6	trained	train	VERB
aji-163	246	7	immunity	immunity	NOUN
aji-163	246	8	via	via	ADP
aji-163	246	9	optimization	optimization	NOUN
aji-163	246	10	of	of	ADP
aji-163	246	11	mitochondrial	mitochondrial	ADJ
aji-163	246	12	function	function	NOUN
aji-163	246	13	.	.	PUNCT
aji-163	247	1	trained	train	VERB
aji-163	247	2	immunity	immunity	NOUN
aji-163	247	3	is	be	AUX
aji-163	247	4	currently	currently	ADV
aji-163	247	5	being	be	AUX
aji-163	247	6	studied	study	VERB
aji-163	247	7	as	as	ADP
aji-163	247	8	a	a	DET
aji-163	247	9	potential	potential	ADJ
aji-163	247	10	tool	tool	NOUN
aji-163	247	11	for	for	ADP
aji-163	247	12	the	the	DET
aji-163	247	13	treatment	treatment	NOUN
aji-163	247	14	of	of	ADP
aji-163	247	15	neuro	neuro	NOUN
aji-163	247	16	-	-	PUNCT
aji-163	247	17	inflammatory	inflammatory	ADJ
aji-163	247	18	and	and	CCONJ
aji-163	247	19	chronic	chronic	ADJ
aji-163	247	20	infection	infection	NOUN
aji-163	247	21	conditions	condition	NOUN
aji-163	247	22	,	,	PUNCT
aji-163	247	23	including	include	VERB
aji-163	247	24	hiv	hiv	PROPN
aji-163	247	25	-	-	PUNCT
aji-163	247	26	associated	associate	VERB
aji-163	247	27	neurocognitive	neurocognitive	ADJ
aji-163	247	28	disorders	disorder	NOUN
aji-163	247	29	(	(	PUNCT
aji-163	247	30	hand	hand	NOUN
aji-163	247	31	)	)	PUNCT
aji-163	247	32	.	.	PUNCT
aji-163	248	1	according	accord	VERB
aji-163	248	2	to	to	ADP
aji-163	248	3	capriotti	capriotti	NOUN
aji-163	248	4	and	and	CCONJ
aji-163	248	5	klase	klase	PROPN
aji-163	248	6	(	(	PUNCT
aji-163	248	7	2024	2024	NUM
aji-163	248	8	)	)	PUNCT
aji-163	248	9	,	,	PUNCT
aji-163	248	10	trained	train	VERB
aji-163	248	11	immunitymodulating	immunitymodulating	NOUN
aji-163	248	12	agents	agent	NOUN
aji-163	248	13	might	might	AUX
aji-163	248	14	reverse	reverse	VERB
aji-163	248	15	innate	innate	ADJ
aji-163	248	16	immune	immune	ADJ
aji-163	248	17	dysfunction	dysfunction	NOUN
aji-163	248	18	in	in	ADP
aji-163	248	19	hiv	hiv	NOUN
aji-163	248	20	resulting	result	VERB
aji-163	248	21	in	in	ADP
aji-163	248	22	the	the	DET
aji-163	248	23	restoration	restoration	NOUN
aji-163	248	24	of	of	ADP
aji-163	248	25	immune	immune	ADJ
aji-163	248	26	function	function	NOUN
aji-163	248	27	.	.	PUNCT
aji-163	249	1	4	4	X
aji-163	249	2	.	.	X
aji-163	249	3	challenges	challenge	NOUN
aji-163	249	4	and	and	CCONJ
aji-163	249	5	future	future	ADJ
aji-163	249	6	perspectives	perspective	NOUN
aji-163	249	7	despite	despite	SCONJ
aji-163	249	8	all	all	PRON
aji-163	249	9	of	of	ADP
aji-163	249	10	this	this	DET
aji-163	249	11	interest	interest	NOUN
aji-163	249	12	in	in	ADP
aji-163	249	13	trained	train	VERB
aji-163	249	14	immunity	immunity	NOUN
aji-163	249	15	as	as	ADP
aji-163	249	16	a	a	DET
aji-163	249	17	therapeutic	therapeutic	ADJ
aji-163	249	18	target	target	NOUN
aji-163	249	19	,	,	PUNCT
aji-163	249	20	many	many	ADJ
aji-163	249	21	challenges	challenge	NOUN
aji-163	249	22	and	and	CCONJ
aji-163	249	23	knowledge	knowledge	NOUN
aji-163	249	24	gaps	gap	NOUN
aji-163	249	25	remain	remain	VERB
aji-163	249	26	.	.	PUNCT
aji-163	250	1	the	the	DET
aji-163	250	2	lack	lack	NOUN
aji-163	250	3	of	of	ADP
aji-163	250	4	an	an	DET
aji-163	250	5	understanding	understanding	NOUN
aji-163	250	6	of	of	ADP
aji-163	250	7	the	the	DET
aji-163	250	8	long	long	ADJ
aji-163	250	9	-	-	PUNCT
aji-163	250	10	term	term	NOUN
aji-163	250	11	consequences	consequence	NOUN
aji-163	250	12	of	of	ADP
aji-163	250	13	trained	train	VERB
aji-163	250	14	immunity	immunity	NOUN
aji-163	250	15	induction	induction	NOUN
aji-163	250	16	is	be	AUX
aji-163	250	17	a	a	DET
aji-163	250	18	major	major	ADJ
aji-163	250	19	limitation	limitation	NOUN
aji-163	250	20	.	.	PUNCT
aji-163	251	1	although	although	SCONJ
aji-163	251	2	many	many	ADJ
aji-163	251	3	studies	study	NOUN
aji-163	251	4	have	have	AUX
aji-163	251	5	uncovered	uncover	VERB
aji-163	251	6	the	the	DET
aji-163	251	7	links	link	NOUN
aji-163	251	8	between	between	ADP
aji-163	251	9	epigenetic	epigenetic	ADJ
aji-163	251	10	and	and	CCONJ
aji-163	251	11	metabolic	metabolic	NOUN
aji-163	251	12	hallmarks	hallmark	NOUN
aji-163	251	13	of	of	ADP
aji-163	251	14	innate	innate	ADJ
aji-163	251	15	immune	immune	ADJ
aji-163	251	16	memory	memory	NOUN
aji-163	251	17	(	(	PUNCT
aji-163	251	18	keating	keating	NOUN
aji-163	251	19	et	et	PROPN
aji-163	251	20	al	al	PROPN
aji-163	251	21	.	.	PROPN
aji-163	251	22	,	,	PUNCT
aji-163	251	23	2020	2020	NUM
aji-163	251	24	;	;	PUNCT
aji-163	251	25	janefrancis	janefrancis	PROPN
aji-163	251	26	et	et	PROPN
aji-163	251	27	al	al	PROPN
aji-163	251	28	.	.	PROPN
aji-163	251	29	;	;	PUNCT
aji-163	251	30	asian	asian	PROPN
aji-163	251	31	j.	j.	PROPN
aji-163	251	32	immunol	immunol	PROPN
aji-163	251	33	.	.	PROPN
aji-163	251	34	,	,	PUNCT
aji-163	251	35	vol	vol	NOUN
aji-163	251	36	.	.	PROPN
aji-163	251	37	8	8	NUM
aji-163	251	38	,	,	PUNCT
aji-163	251	39	no	no	INTJ
aji-163	251	40	.	.	NOUN
aji-163	251	41	1	1	NUM
aji-163	251	42	,	,	PUNCT
aji-163	251	43	pp	pp	ADJ
aji-163	251	44	.	.	PUNCT
aji-163	252	1	86	86	NUM
aji-163	252	2	-	-	SYM
aji-163	252	3	96	96	NUM
aji-163	252	4	,	,	PUNCT
aji-163	252	5	2025	2025	NUM
aji-163	252	6	;	;	PUNCT
aji-163	252	7	article	article	NOUN
aji-163	252	8	no.aji.134904	no.aji.134904	VERB
aji-163	252	9	94	94	NUM
aji-163	252	10	fok	fok	NOUN
aji-163	252	11	et	et	PROPN
aji-163	252	12	al	al	PROPN
aji-163	252	13	.	.	PROPN
aji-163	252	14	,	,	PUNCT
aji-163	252	15	2019	2019	NUM
aji-163	252	16	)	)	PUNCT
aji-163	252	17	,	,	PUNCT
aji-163	252	18	how	how	SCONJ
aji-163	252	19	long	long	ADV
aji-163	252	20	and	and	CCONJ
aji-163	252	21	whether	whether	SCONJ
aji-163	252	22	these	these	DET
aji-163	252	23	changes	change	NOUN
aji-163	252	24	have	have	AUX
aji-163	252	25	sustained	sustain	VERB
aji-163	252	26	adverse	adverse	ADJ
aji-163	252	27	effects	effect	NOUN
aji-163	252	28	remains	remain	VERB
aji-163	252	29	unknown	unknown	ADJ
aji-163	252	30	.	.	PUNCT
aji-163	253	1	it	it	PRON
aji-163	253	2	is	be	AUX
aji-163	253	3	of	of	ADP
aji-163	253	4	particular	particular	ADJ
aji-163	253	5	concern	concern	NOUN
aji-163	253	6	,	,	PUNCT
aji-163	253	7	however	however	ADV
aji-163	253	8	,	,	PUNCT
aji-163	253	9	how	how	SCONJ
aji-163	253	10	excessive	excessive	ADJ
aji-163	253	11	immune	immune	ADJ
aji-163	253	12	activation	activation	NOUN
aji-163	253	13	can	can	AUX
aji-163	253	14	lead	lead	VERB
aji-163	253	15	to	to	ADP
aji-163	253	16	chronic	chronic	ADJ
aji-163	253	17	inflammation	inflammation	NOUN
aji-163	253	18	or	or	CCONJ
aji-163	253	19	autoimmunity	autoimmunity	NOUN
aji-163	253	20	(	(	PUNCT
aji-163	253	21	hajishengallis	hajishengallis	INTJ
aji-163	253	22	et	et	PROPN
aji-163	253	23	al	al	PROPN
aji-163	253	24	.	.	PROPN
aji-163	253	25	,	,	PUNCT
aji-163	253	26	2025	2025	NUM
aji-163	253	27	)	)	PUNCT
aji-163	253	28	.	.	PUNCT
aji-163	254	1	in	in	ADP
aji-163	254	2	addition	addition	NOUN
aji-163	254	3	,	,	PUNCT
aji-163	254	4	most	most	ADJ
aji-163	254	5	recent	recent	ADJ
aji-163	254	6	research	research	NOUN
aji-163	254	7	relies	rely	VERB
aji-163	254	8	on	on	ADP
aji-163	254	9	in	in	ADP
aji-163	254	10	-	-	PUNCT
aji-163	254	11	vitro	vitro	X
aji-163	254	12	models	model	NOUN
aji-163	254	13	or	or	CCONJ
aji-163	254	14	preclinical	preclinical	ADJ
aji-163	254	15	animal	animal	NOUN
aji-163	254	16	studies	study	NOUN
aji-163	254	17	without	without	ADP
aji-163	254	18	necessary	necessary	ADJ
aji-163	254	19	translation	translation	NOUN
aji-163	254	20	to	to	ADP
aji-163	254	21	human	human	ADJ
aji-163	254	22	immune	immune	ADJ
aji-163	254	23	responses	response	NOUN
aji-163	254	24	(	(	PUNCT
aji-163	254	25	xing	xing	PROPN
aji-163	254	26	et	et	PROPN
aji-163	254	27	al	al	PROPN
aji-163	254	28	.	.	PROPN
aji-163	254	29	,	,	PUNCT
aji-163	254	30	2020	2020	NUM
aji-163	254	31	)	)	PUNCT
aji-163	254	32	.	.	PUNCT
aji-163	255	1	with	with	ADP
aji-163	255	2	these	these	PRON
aji-163	255	3	,	,	PUNCT
aji-163	255	4	rigorous	rigorous	ADJ
aji-163	255	5	clinical	clinical	ADJ
aji-163	255	6	trials	trial	NOUN
aji-163	255	7	for	for	ADP
aji-163	255	8	validation	validation	NOUN
aji-163	255	9	of	of	ADP
aji-163	255	10	the	the	DET
aji-163	255	11	efficacy	efficacy	NOUN
aji-163	255	12	and	and	CCONJ
aji-163	255	13	safety	safety	NOUN
aji-163	255	14	of	of	ADP
aji-163	255	15	trained	train	VERB
aji-163	255	16	immunity	immunity	NOUN
aji-163	255	17	-	-	PUNCT
aji-163	255	18	based	base	VERB
aji-163	255	19	interventions	intervention	NOUN
aji-163	255	20	are	be	AUX
aji-163	255	21	required	require	VERB
aji-163	255	22	to	to	PART
aji-163	255	23	advance	advance	VERB
aji-163	255	24	the	the	DET
aji-163	255	25	field	field	NOUN
aji-163	255	26	.	.	PUNCT
aji-163	256	1	some	some	PRON
aji-163	256	2	of	of	ADP
aji-163	256	3	the	the	DET
aji-163	256	4	studies	study	NOUN
aji-163	256	5	have	have	AUX
aji-163	256	6	demonstrated	demonstrate	VERB
aji-163	256	7	that	that	SCONJ
aji-163	256	8	vaccination	vaccination	NOUN
aji-163	256	9	with	with	ADP
aji-163	256	10	bacillus	bacillus	NOUN
aji-163	256	11	calmetteguérin	calmetteguérin	NOUN
aji-163	256	12	(	(	PUNCT
aji-163	256	13	bcg	bcg	PROPN
aji-163	256	14	)	)	PUNCT
aji-163	256	15	and	and	CCONJ
aji-163	256	16	β	β	NOUN
aji-163	256	17	-	-	NOUN
aji-163	256	18	glucans	glucan	NOUN
aji-163	256	19	may	may	AUX
aji-163	256	20	promote	promote	VERB
aji-163	256	21	host	host	NOUN
aji-163	256	22	defense	defense	NOUN
aji-163	256	23	against	against	ADP
aji-163	256	24	heterologous	heterologous	ADJ
aji-163	256	25	infections	infection	NOUN
aji-163	256	26	(	(	PUNCT
aji-163	256	27	xing	xing	PROPN
aji-163	256	28	et	et	PROPN
aji-163	256	29	al	al	PROPN
aji-163	256	30	.	.	PROPN
aji-163	256	31	,	,	PUNCT
aji-163	256	32	2020	2020	NUM
aji-163	256	33	;	;	PUNCT
aji-163	256	34	wang	wang	PROPN
aji-163	256	35	et	et	PROPN
aji-163	256	36	al	al	PROPN
aji-163	256	37	.	.	PROPN
aji-163	256	38	,	,	PUNCT
aji-163	256	39	2024	2024	NUM
aji-163	256	40	)	)	PUNCT
aji-163	256	41	,	,	PUNCT
aji-163	256	42	but	but	CCONJ
aji-163	256	43	the	the	DET
aji-163	256	44	results	result	NOUN
aji-163	256	45	should	should	AUX
aji-163	256	46	be	be	AUX
aji-163	256	47	confirmed	confirm	VERB
aji-163	256	48	in	in	ADP
aji-163	256	49	rcts	rct	NOUN
aji-163	256	50	for	for	ADP
aji-163	256	51	various	various	ADJ
aji-163	256	52	populations	population	NOUN
aji-163	256	53	.	.	PUNCT
aji-163	257	1	in	in	ADP
aji-163	257	2	addition	addition	NOUN
aji-163	257	3	,	,	PUNCT
aji-163	257	4	clinical	clinical	ADJ
aji-163	257	5	studies	study	NOUN
aji-163	257	6	should	should	AUX
aji-163	257	7	determine	determine	VERB
aji-163	257	8	what	what	PRON
aji-163	257	9	the	the	DET
aji-163	257	10	optimal	optimal	ADJ
aji-163	257	11	dosing	dosing	NOUN
aji-163	257	12	is	be	AUX
aji-163	257	13	and	and	CCONJ
aji-163	257	14	when	when	SCONJ
aji-163	257	15	and	and	CCONJ
aji-163	257	16	with	with	ADP
aji-163	257	17	what	what	DET
aji-163	257	18	population	population	NOUN
aji-163	257	19	it	it	PRON
aji-163	257	20	does	do	AUX
aji-163	257	21	and	and	CCONJ
aji-163	257	22	does	do	AUX
aji-163	257	23	not	not	PART
aji-163	257	24	respond	respond	VERB
aji-163	257	25	,	,	PUNCT
aji-163	257	26	as	as	SCONJ
aji-163	257	27	it	it	PRON
aji-163	257	28	appears	appear	VERB
aji-163	257	29	that	that	SCONJ
aji-163	257	30	the	the	DET
aji-163	257	31	effects	effect	NOUN
aji-163	257	32	of	of	ADP
aji-163	257	33	trained	train	VERB
aji-163	257	34	immunity	immunity	NOUN
aji-163	257	35	might	might	AUX
aji-163	257	36	be	be	AUX
aji-163	257	37	affected	affect	VERB
aji-163	257	38	by	by	ADP
aji-163	257	39	age	age	NOUN
aji-163	257	40	,	,	PUNCT
aji-163	257	41	genetics	genetic	NOUN
aji-163	257	42	,	,	PUNCT
aji-163	257	43	and	and	CCONJ
aji-163	257	44	metabolic	metabolic	NOUN
aji-163	257	45	status	status	NOUN
aji-163	257	46	(	(	PUNCT
aji-163	257	47	salauddin	salauddin	NOUN
aji-163	257	48	et	et	PROPN
aji-163	257	49	al	al	PROPN
aji-163	257	50	.	.	PROPN
aji-163	257	51	,	,	PUNCT
aji-163	257	52	2024	2024	NUM
aji-163	257	53	)	)	PUNCT
aji-163	257	54	.	.	PUNCT
aji-163	258	1	large	large	ADJ
aji-163	258	2	-	-	PUNCT
aji-163	258	3	scale	scale	NOUN
aji-163	258	4	trials	trial	NOUN
aji-163	258	5	of	of	ADP
aji-163	258	6	trained	train	VERB
aji-163	258	7	immunity	immunity	NOUN
aji-163	258	8	for	for	ADP
aji-163	258	9	sepsis	sepsis	NOUN
aji-163	258	10	,	,	PUNCT
aji-163	258	11	cancer	cancer	NOUN
aji-163	258	12	immunotherapy	immunotherapy	NOUN
aji-163	258	13	,	,	PUNCT
aji-163	258	14	and	and	CCONJ
aji-163	258	15	chronic	chronic	ADJ
aji-163	258	16	infections	infection	NOUN
aji-163	258	17	would	would	AUX
aji-163	258	18	provide	provide	VERB
aji-163	258	19	crucial	crucial	ADJ
aji-163	258	20	insights	insight	NOUN
aji-163	258	21	into	into	ADP
aji-163	258	22	its	its	PRON
aji-163	258	23	therapeutic	therapeutic	ADJ
aji-163	258	24	potential	potential	NOUN
aji-163	258	25	(	(	PUNCT
aji-163	258	26	xia	xia	PROPN
aji-163	258	27	et	et	PROPN
aji-163	258	28	al	al	PROPN
aji-163	258	29	.	.	PROPN
aji-163	258	30	,	,	PUNCT
aji-163	258	31	2021	2021	NUM
aji-163	258	32	;	;	PUNCT
aji-163	258	33	capriotti	capriotti	PROPN
aji-163	258	34	&	&	CCONJ
aji-163	258	35	klase	klase	PROPN
aji-163	258	36	(	(	PUNCT
aji-163	258	37	2024	2024	NUM
aji-163	258	38	)	)	PUNCT
aji-163	258	39	.	.	PUNCT
aji-163	259	1	from	from	ADP
aji-163	259	2	the	the	DET
aji-163	259	3	perspectives	perspective	NOUN
aji-163	259	4	of	of	ADP
aji-163	259	5	ethics	ethic	NOUN
aji-163	259	6	and	and	CCONJ
aji-163	259	7	safety	safety	NOUN
aji-163	259	8	,	,	PUNCT
aji-163	259	9	there	there	PRON
aji-163	259	10	are	be	VERB
aji-163	259	11	multiple	multiple	ADJ
aji-163	259	12	concerns	concern	NOUN
aji-163	259	13	when	when	SCONJ
aji-163	259	14	manipulating	manipulate	VERB
aji-163	259	15	innate	innate	ADJ
aji-163	259	16	immune	immune	ADJ
aji-163	259	17	memory	memory	NOUN
aji-163	259	18	.	.	PUNCT
aji-163	260	1	trained	train	VERB
aji-163	260	2	immunity	immunity	NOUN
aji-163	260	3	is	be	AUX
aji-163	260	4	antigen	antigen	ADJ
aji-163	260	5	non	non	ADJ
aji-163	260	6	-	-	ADJ
aji-163	260	7	specific	specific	ADJ
aji-163	260	8	,	,	PUNCT
aji-163	260	9	as	as	SCONJ
aji-163	260	10	opposed	oppose	VERB
aji-163	260	11	to	to	ADP
aji-163	260	12	adaptive	adaptive	ADJ
aji-163	260	13	immunity	immunity	NOUN
aji-163	260	14	,	,	PUNCT
aji-163	260	15	and	and	CCONJ
aji-163	260	16	therefore	therefore	ADV
aji-163	260	17	carries	carry	VERB
aji-163	260	18	the	the	DET
aji-163	260	19	risk	risk	NOUN
aji-163	260	20	of	of	ADP
aji-163	260	21	off	off	ADP
aji-163	260	22	-	-	PUNCT
aji-163	260	23	target	target	NOUN
aji-163	260	24	effects	effect	NOUN
aji-163	260	25	,	,	PUNCT
aji-163	260	26	including	include	VERB
aji-163	260	27	inappropriate	inappropriate	ADJ
aji-163	260	28	inflammation	inflammation	NOUN
aji-163	260	29	or	or	CCONJ
aji-163	260	30	immune	immune	ADJ
aji-163	260	31	exhaustion	exhaustion	NOUN
aji-163	260	32	(	(	PUNCT
aji-163	260	33	hajishengallis	hajishengallis	INTJ
aji-163	260	34	et	et	PROPN
aji-163	260	35	al	al	PROPN
aji-163	260	36	.	.	PROPN
aji-163	260	37	,	,	PUNCT
aji-163	260	38	2025	2025	NUM
aji-163	260	39	)	)	PUNCT
aji-163	260	40	.	.	PUNCT
aji-163	261	1	intergenerational	intergenerational	ADJ
aji-163	261	2	epigenetic	epigenetic	ADJ
aji-163	261	3	inheritance	inheritance	NOUN
aji-163	261	4	is	be	AUX
aji-163	261	5	also	also	ADV
aji-163	261	6	a	a	DET
aji-163	261	7	cause	cause	NOUN
aji-163	261	8	for	for	ADP
aji-163	261	9	concern	concern	NOUN
aji-163	261	10	since	since	SCONJ
aji-163	261	11	the	the	DET
aji-163	261	12	immune	immune	ADJ
aji-163	261	13	changes	change	NOUN
aji-163	261	14	could	could	AUX
aji-163	261	15	be	be	AUX
aji-163	261	16	passed	pass	VERB
aji-163	261	17	on	on	ADP
aji-163	261	18	to	to	ADP
aji-163	261	19	a	a	DET
aji-163	261	20	generation	generation	NOUN
aji-163	261	21	,	,	PUNCT
aji-163	261	22	with	with	ADP
aji-163	261	23	uncertain	uncertain	ADJ
aji-163	261	24	consequences	consequence	NOUN
aji-163	261	25	(	(	PUNCT
aji-163	261	26	fok	fok	NOUN
aji-163	261	27	et	et	PROPN
aji-163	261	28	al	al	PROPN
aji-163	261	29	.	.	PROPN
aji-163	261	30	,	,	PUNCT
aji-163	261	31	2019	2019	NUM
aji-163	261	32	)	)	PUNCT
aji-163	261	33	.	.	PUNCT
aji-163	262	1	regulatory	regulatory	ADJ
aji-163	262	2	bodies	body	NOUN
aji-163	262	3	must	must	AUX
aji-163	262	4	construct	construct	VERB
aji-163	262	5	a	a	DET
aji-163	262	6	catalog	catalog	NOUN
aji-163	262	7	of	of	ADP
aji-163	262	8	clear	clear	ADJ
aji-163	262	9	guidelines	guideline	NOUN
aji-163	262	10	for	for	ADP
aji-163	262	11	the	the	DET
aji-163	262	12	clinical	clinical	ADJ
aji-163	262	13	medicines	medicine	NOUN
aji-163	262	14	involving	involve	VERB
aji-163	262	15	stimulated	stimulate	VERB
aji-163	262	16	immunity	immunity	NOUN
aji-163	262	17	,	,	PUNCT
aji-163	262	18	as	as	SCONJ
aji-163	262	19	the	the	DET
aji-163	262	20	use	use	NOUN
aji-163	262	21	of	of	ADP
aji-163	262	22	the	the	DET
aji-163	262	23	agents	agent	NOUN
aji-163	262	24	must	must	AUX
aji-163	262	25	be	be	AUX
aji-163	262	26	both	both	ADV
aji-163	262	27	safe	safe	ADJ
aji-163	262	28	and	and	CCONJ
aji-163	262	29	ethically	ethically	ADV
aji-163	262	30	justified	justify	VERB
aji-163	262	31	,	,	PUNCT
aji-163	262	32	and	and	CCONJ
aji-163	262	33	available	available	ADJ
aji-163	262	34	.	.	PUNCT
aji-163	263	1	to	to	PART
aji-163	263	2	make	make	VERB
aji-163	263	3	these	these	DET
aji-163	263	4	possible	possible	ADJ
aji-163	263	5	,	,	PUNCT
aji-163	263	6	tailored	tailor	VERB
aji-163	263	7	interdisciplinary	interdisciplinary	ADJ
aji-163	263	8	research	research	NOUN
aji-163	263	9	and	and	CCONJ
aji-163	263	10	robust	robust	ADJ
aji-163	263	11	clinical	clinical	ADJ
aji-163	263	12	trial	trial	NOUN
aji-163	263	13	and	and	CCONJ
aji-163	263	14	oversight	oversight	NOUN
aji-163	263	15	will	will	AUX
aji-163	263	16	need	need	VERB
aji-163	263	17	to	to	PART
aji-163	263	18	be	be	AUX
aji-163	263	19	guided	guide	VERB
aji-163	263	20	toward	toward	ADP
aji-163	263	21	the	the	DET
aji-163	263	22	translation	translation	NOUN
aji-163	263	23	of	of	ADP
aji-163	263	24	trained	train	VERB
aji-163	263	25	immunity	immunity	NOUN
aji-163	263	26	-	-	PUNCT
aji-163	263	27	based	base	VERB
aji-163	263	28	strategies	strategy	NOUN
aji-163	263	29	to	to	ADP
aji-163	263	30	practical	practical	ADJ
aji-163	263	31	and	and	CCONJ
aji-163	263	32	sustainable	sustainable	ADJ
aji-163	263	33	clinical	clinical	ADJ
aji-163	263	34	interventions	intervention	NOUN
aji-163	263	35	.	.	PUNCT
aji-163	264	1	5	5	X
aji-163	264	2	.	.	X
aji-163	264	3	conclusion	conclusion	NOUN
aji-163	264	4	trained	train	VERB
aji-163	264	5	immunity	immunity	NOUN
aji-163	264	6	has	have	VERB
aji-163	264	7	the	the	DET
aji-163	264	8	potential	potential	NOUN
aji-163	264	9	to	to	PART
aji-163	264	10	fundamentally	fundamentally	ADV
aji-163	264	11	change	change	VERB
aji-163	264	12	the	the	DET
aji-163	264	13	field	field	NOUN
aji-163	264	14	of	of	ADP
aji-163	264	15	immunology	immunology	NOUN
aji-163	264	16	by	by	ADP
aji-163	264	17	providing	provide	VERB
aji-163	264	18	novel	novel	ADJ
aji-163	264	19	information	information	NOUN
aji-163	264	20	regarding	regard	VERB
aji-163	264	21	the	the	DET
aji-163	264	22	process	process	NOUN
aji-163	264	23	by	by	ADP
aji-163	264	24	which	which	PRON
aji-163	264	25	innate	innate	ADJ
aji-163	264	26	immune	immune	ADJ
aji-163	264	27	cells	cell	NOUN
aji-163	264	28	learn	learn	VERB
aji-163	264	29	a	a	DET
aji-163	264	30	memory	memory	NOUN
aji-163	264	31	-	-	PUNCT
aji-163	264	32	like	like	ADJ
aji-163	264	33	response	response	NOUN
aji-163	264	34	in	in	ADP
aji-163	264	35	the	the	DET
aji-163	264	36	context	context	NOUN
aji-163	264	37	of	of	ADP
aji-163	264	38	epigenetic	epigenetic	ADJ
aji-163	264	39	and	and	CCONJ
aji-163	264	40	metabolic	metabolic	NOUN
aji-163	264	41	reprogramming	reprogramme	VERB
aji-163	264	42	.	.	PUNCT
aji-163	265	1	it	it	PRON
aji-163	265	2	is	be	AUX
aji-163	265	3	reviewed	review	VERB
aji-163	265	4	for	for	ADP
aji-163	265	5	its	its	PRON
aji-163	265	6	mechanisms	mechanism	NOUN
aji-163	265	7	,	,	PUNCT
aji-163	265	8	duration	duration	NOUN
aji-163	265	9	,	,	PUNCT
aji-163	265	10	and	and	CCONJ
aji-163	265	11	potential	potential	NOUN
aji-163	265	12	for	for	ADP
aji-163	265	13	therapy	therapy	NOUN
aji-163	265	14	,	,	PUNCT
aji-163	265	15	including	include	VERB
aji-163	265	16	how	how	SCONJ
aji-163	265	17	these	these	PRON
aji-163	265	18	might	might	AUX
aji-163	265	19	impact	impact	VERB
aji-163	265	20	infectious	infectious	ADJ
aji-163	265	21	diseases	disease	NOUN
aji-163	265	22	,	,	PUNCT
aji-163	265	23	cancer	cancer	NOUN
aji-163	265	24	,	,	PUNCT
aji-163	265	25	as	as	ADV
aji-163	265	26	well	well	ADV
aji-163	265	27	as	as	ADP
aji-163	265	28	inflammatory	inflammatory	ADJ
aji-163	265	29	disorders	disorder	NOUN
aji-163	265	30	.	.	PUNCT
aji-163	266	1	emerging	emerge	VERB
aji-163	266	2	strategies	strategy	NOUN
aji-163	266	3	in	in	ADP
aji-163	266	4	βglucan	βglucan	NOUN
aji-163	266	5	-	-	PUNCT
aji-163	266	6	based	base	VERB
aji-163	266	7	immunomodulation	immunomodulation	NOUN
aji-163	266	8	and	and	CCONJ
aji-163	266	9	vaccine	vaccine	NOUN
aji-163	266	10	adjuvants	adjuvant	NOUN
aji-163	266	11	are	be	AUX
aji-163	266	12	promising	promise	VERB
aji-163	266	13	,	,	PUNCT
aji-163	266	14	but	but	CCONJ
aji-163	266	15	remain	remain	VERB
aji-163	266	16	challenging	challenge	VERB
aji-163	266	17	due	due	ADJ
aji-163	266	18	to	to	ADP
aji-163	266	19	gaps	gap	NOUN
aji-163	266	20	in	in	ADP
aji-163	266	21	mechanistic	mechanistic	ADJ
aji-163	266	22	understanding	understanding	NOUN
aji-163	266	23	,	,	PUNCT
aji-163	266	24	the	the	DET
aji-163	266	25	need	need	NOUN
aji-163	266	26	for	for	ADP
aji-163	266	27	rigorous	rigorous	ADJ
aji-163	266	28	clinical	clinical	ADJ
aji-163	266	29	validation	validation	NOUN
aji-163	266	30	,	,	PUNCT
aji-163	266	31	and	and	CCONJ
aji-163	266	32	ethical	ethical	ADJ
aji-163	266	33	dilemmas	dilemma	NOUN
aji-163	266	34	of	of	ADP
aji-163	266	35	immune	immune	ADJ
aji-163	266	36	manipulation	manipulation	NOUN
aji-163	266	37	.	.	PUNCT
aji-163	267	1	future	future	ADJ
aji-163	267	2	studies	study	NOUN
aji-163	267	3	should	should	AUX
aji-163	267	4	focus	focus	VERB
aji-163	267	5	on	on	ADP
aji-163	267	6	large	large	ADJ
aji-163	267	7	size	size	NOUN
aji-163	267	8	clinical	clinical	ADJ
aji-163	267	9	trials	trial	NOUN
aji-163	267	10	,	,	PUNCT
aji-163	267	11	individualization	individualization	NOUN
aji-163	267	12	of	of	ADP
aji-163	267	13	immunomodulatory	immunomodulatory	ADJ
aji-163	267	14	approaches	approach	NOUN
aji-163	267	15	,	,	PUNCT
aji-163	267	16	and	and	CCONJ
aji-163	267	17	policies	policy	NOUN
aji-163	267	18	that	that	PRON
aji-163	267	19	can	can	AUX
aji-163	267	20	make	make	VERB
aji-163	267	21	implementation	implementation	NOUN
aji-163	267	22	safe	safe	ADJ
aji-163	267	23	and	and	CCONJ
aji-163	267	24	effective	effective	ADJ
aji-163	267	25	.	.	PUNCT
aji-163	268	1	with	with	ADP
aji-163	268	2	trained	train	VERB
aji-163	268	3	immunity	immunity	NOUN
aji-163	268	4	,	,	PUNCT
aji-163	268	5	disease	disease	NOUN
aji-163	268	6	prevention	prevention	NOUN
aji-163	268	7	and	and	CCONJ
aji-163	268	8	treatment	treatment	NOUN
aji-163	268	9	of	of	ADP
aji-163	268	10	many	many	ADJ
aji-163	268	11	diseases	disease	NOUN
aji-163	268	12	could	could	AUX
aji-163	268	13	make	make	VERB
aji-163	268	14	this	this	DET
aji-163	268	15	revolution	revolution	NOUN
aji-163	268	16	,	,	PUNCT
aji-163	268	17	bridging	bridge	VERB
aji-163	268	18	innate	innate	ADJ
aji-163	268	19	and	and	CCONJ
aji-163	268	20	adaptive	adaptive	ADJ
aji-163	268	21	immune	immune	ADJ
aji-163	268	22	strategies	strategy	NOUN
aji-163	268	23	for	for	ADP
aji-163	268	24	long	long	ADJ
aji-163	268	25	-	-	PUNCT
aji-163	268	26	term	term	NOUN
aji-163	268	27	health	health	NOUN
aji-163	268	28	benefits	benefit	NOUN
aji-163	268	29	.	.	PUNCT
aji-163	269	1	data	datum	NOUN
aji-163	269	2	availability	availability	NOUN
aji-163	269	3	:	:	PUNCT
aji-163	269	4	no	no	DET
aji-163	269	5	new	new	ADJ
aji-163	269	6	datasets	dataset	NOUN
aji-163	269	7	were	be	AUX
aji-163	269	8	generated	generate	VERB
aji-163	269	9	or	or	CCONJ
aji-163	269	10	analyzed	analyze	VERB
aji-163	269	11	in	in	ADP
aji-163	269	12	the	the	DET
aji-163	269	13	current	current	ADJ
aji-163	269	14	study	study	NOUN
aji-163	269	15	.	.	PUNCT
aji-163	270	1	concent	concent	NOUN
aji-163	270	2	and	and	CCONJ
aji-163	270	3	ethical	ethical	ADJ
aji-163	270	4	approval	approval	NOUN
aji-163	270	5	it	it	PRON
aji-163	270	6	is	be	AUX
aji-163	270	7	not	not	PART
aji-163	270	8	applicable	applicable	ADJ
aji-163	270	9	disclaimer	disclaimer	NOUN
aji-163	270	10	(	(	PUNCT
aji-163	270	11	artificial	artificial	ADJ
aji-163	270	12	intelligence	intelligence	NOUN
aji-163	270	13	)	)	PUNCT
aji-163	270	14	author(s	author(s	NOUN
aji-163	270	15	)	)	PUNCT
aji-163	270	16	hereby	hereby	ADV
aji-163	270	17	declare	declare	VERB
aji-163	270	18	that	that	SCONJ
aji-163	270	19	no	no	DET
aji-163	270	20	generative	generative	NOUN
aji-163	270	21	ai	ai	VERB
aji-163	270	22	technologies	technology	NOUN
aji-163	270	23	such	such	ADJ
aji-163	270	24	as	as	ADP
aji-163	270	25	large	large	ADJ
aji-163	270	26	language	language	NOUN
aji-163	270	27	models	model	NOUN
aji-163	270	28	(	(	PUNCT
aji-163	270	29	chatgpt	chatgpt	NOUN
aji-163	270	30	,	,	PUNCT
aji-163	270	31	copilot	copilot	NOUN
aji-163	270	32	,	,	PUNCT
aji-163	270	33	etc	etc	X
aji-163	270	34	.	.	X
aji-163	270	35	)	)	PUNCT
aji-163	270	36	and	and	CCONJ
aji-163	270	37	text	text	NOUN
aji-163	270	38	-	-	PUNCT
aji-163	270	39	to	to	ADP
aji-163	270	40	-	-	PUNCT
aji-163	270	41	image	image	NOUN
aji-163	270	42	generators	generator	NOUN
aji-163	270	43	have	have	AUX
aji-163	270	44	been	be	AUX
aji-163	270	45	used	use	VERB
aji-163	270	46	during	during	ADP
aji-163	270	47	the	the	DET
aji-163	270	48	writing	writing	NOUN
aji-163	270	49	or	or	CCONJ
aji-163	270	50	editing	editing	NOUN
aji-163	270	51	of	of	ADP
aji-163	270	52	this	this	DET
aji-163	270	53	manuscript	manuscript	NOUN
aji-163	270	54	.	.	PUNCT
aji-163	271	1	competing	compete	VERB
aji-163	271	2	interests	interest	NOUN
aji-163	271	3	authors	author	NOUN
aji-163	271	4	have	have	AUX
aji-163	271	5	declared	declare	VERB
aji-163	271	6	that	that	SCONJ
aji-163	271	7	no	no	DET
aji-163	271	8	competing	compete	VERB
aji-163	271	9	interests	interest	NOUN
aji-163	271	10	exist	exist	VERB
aji-163	271	11	.	.	PUNCT
aji-163	272	1	references	reference	NOUN
aji-163	272	2	abhimanyu	abhimanyu	PROPN
aji-163	272	3	,	,	PUNCT
aji-163	272	4	ontiveros	ontiveros	PROPN
aji-163	272	5	,	,	PUNCT
aji-163	272	6	c.	c.	PROPN
aji-163	272	7	o.	o.	PROPN
aji-163	272	8	,	,	PUNCT
aji-163	272	9	guerra	guerra	NOUN
aji-163	272	10	-	-	PUNCT
aji-163	272	11	resendez	resendez	PROPN
aji-163	272	12	,	,	PUNCT
aji-163	272	13	r.	r.	PROPN
aji-163	272	14	s.	s.	PROPN
aji-163	272	15	,	,	PUNCT
aji-163	272	16	nishiguchi	nishiguchi	NOUN
aji-163	272	17	,	,	PUNCT
aji-163	272	18	t.	t.	PROPN
aji-163	272	19	,	,	PUNCT
aji-163	272	20	ladki	ladki	PROPN
aji-163	272	21	,	,	PUNCT
aji-163	272	22	m.	m.	NOUN
aji-163	272	23	,	,	PUNCT
aji-163	272	24	hilton	hilton	PROPN
aji-163	272	25	,	,	PUNCT
aji-163	272	26	i.	i.	PROPN
aji-163	272	27	b.	b.	PROPN
aji-163	272	28	,	,	PUNCT
aji-163	272	29	...	...	PUNCT
aji-163	272	30	&	&	CCONJ
aji-163	272	31	dinardo	dinardo	PROPN
aji-163	272	32	,	,	PUNCT
aji-163	272	33	a.	a.	PROPN
aji-163	272	34	r.	r.	PROPN
aji-163	272	35	(	(	PUNCT
aji-163	272	36	2021	2021	NUM
aji-163	272	37	)	)	PUNCT
aji-163	272	38	.	.	PUNCT
aji-163	273	1	reversing	reverse	VERB
aji-163	273	2	post	post	ADJ
aji-163	273	3	-	-	ADJ
aji-163	273	4	infectious	infectious	ADJ
aji-163	273	5	epigenetic	epigenetic	ADJ
aji-163	273	6	-	-	PUNCT
aji-163	273	7	mediated	mediate	VERB
aji-163	273	8	immune	immune	ADJ
aji-163	273	9	suppression	suppression	NOUN
aji-163	273	10	.	.	PUNCT
aji-163	274	1	frontiers	frontier	NOUN
aji-163	274	2	in	in	ADP
aji-163	274	3	immunology	immunology	NOUN
aji-163	274	4	,	,	PUNCT
aji-163	274	5	12	12	NUM
aji-163	274	6	,	,	PUNCT
aji-163	274	7	688132	688132	NUM
aji-163	274	8	.	.	PUNCT
aji-163	275	1	bekkering	bekkere	VERB
aji-163	275	2	,	,	PUNCT
aji-163	275	3	s.	s.	PROPN
aji-163	275	4	,	,	PUNCT
aji-163	275	5	arts	arts	PROPN
aji-163	275	6	,	,	PUNCT
aji-163	275	7	r.	r.	PROPN
aji-163	275	8	j.	j.	PROPN
aji-163	275	9	w.	w.	PROPN
aji-163	275	10	,	,	PUNCT
aji-163	275	11	novakovic	novakovic	PROPN
aji-163	275	12	,	,	PUNCT
aji-163	275	13	b.	b.	PROPN
aji-163	275	14	,	,	PUNCT
aji-163	275	15	kox	kox	PROPN
aji-163	275	16	,	,	PUNCT
aji-163	275	17	m.	m.	NOUN
aji-163	275	18	,	,	PUNCT
aji-163	275	19	van	van	PROPN
aji-163	275	20	der	der	PROPN
aji-163	275	21	heijden	heijden	PROPN
aji-163	275	22	,	,	PUNCT
aji-163	275	23	c.	c.	PROPN
aji-163	275	24	d.	d.	PROPN
aji-163	275	25	c.	c.	PROPN
aji-163	275	26	c.	c.	PROPN
aji-163	275	27	,	,	PUNCT
aji-163	275	28	li	li	PROPN
aji-163	275	29	,	,	PUNCT
aji-163	275	30	y.	y.	PROPN
aji-163	275	31	,	,	PUNCT
aji-163	275	32	...	...	PUNCT
aji-163	275	33	&	&	CCONJ
aji-163	275	34	netea	netea	NOUN
aji-163	275	35	,	,	PUNCT
aji-163	275	36	m.	m.	NOUN
aji-163	275	37	g.	g.	PROPN
aji-163	275	38	(	(	PUNCT
aji-163	275	39	2021	2021	NUM
aji-163	275	40	)	)	PUNCT
aji-163	275	41	.	.	PUNCT
aji-163	276	1	metabolic	metabolic	ADJ
aji-163	276	2	induction	induction	NOUN
aji-163	276	3	of	of	ADP
aji-163	276	4	trained	train	VERB
aji-163	276	5	immunity	immunity	NOUN
aji-163	276	6	through	through	ADP
aji-163	276	7	the	the	DET
aji-163	276	8	mevalonate	mevalonate	ADJ
aji-163	276	9	pathway	pathway	NOUN
aji-163	276	10	.	.	PUNCT
aji-163	277	1	cell	cell	NOUN
aji-163	277	2	,	,	PUNCT
aji-163	277	3	172(1–2	172(1–2	NUM
aji-163	277	4	)	)	PUNCT
aji-163	277	5	,	,	PUNCT
aji-163	277	6	135	135	NUM
aji-163	277	7	–	–	SYM
aji-163	277	8	146	146	NUM
aji-163	277	9	.	.	PUNCT
aji-163	277	10	berendsen	berendsen	PROPN
aji-163	277	11	,	,	PUNCT
aji-163	277	12	m.	m.	PROPN
aji-163	277	13	l.	l.	PROPN
aji-163	277	14	,	,	PUNCT
aji-163	277	15	øland	øland	PROPN
aji-163	277	16	,	,	PUNCT
aji-163	277	17	c.	c.	PROPN
aji-163	277	18	b.	b.	PROPN
aji-163	277	19	,	,	PUNCT
aji-163	277	20	jensen	jensen	PROPN
aji-163	277	21	,	,	PUNCT
aji-163	277	22	k.	k.	PROPN
aji-163	277	23	j.	j.	PROPN
aji-163	277	24	,	,	PUNCT
aji-163	277	25	&	&	CCONJ
aji-163	277	26	netea	netea	NOUN
aji-163	277	27	,	,	PUNCT
aji-163	277	28	m.	m.	NOUN
aji-163	277	29	g.	g.	PROPN
aji-163	277	30	(	(	PUNCT
aji-163	277	31	2021	2021	NUM
aji-163	277	32	)	)	PUNCT
aji-163	277	33	.	.	PUNCT
aji-163	278	1	the	the	DET
aji-163	278	2	immunological	immunological	ADJ
aji-163	278	3	mechanisms	mechanism	NOUN
aji-163	278	4	underlying	underlie	VERB
aji-163	278	5	heterologous	heterologous	ADJ
aji-163	278	6	effects	effect	NOUN
aji-163	278	7	of	of	ADP
aji-163	278	8	bcg	bcg	NOUN
aji-163	278	9	vaccination	vaccination	NOUN
aji-163	278	10	.	.	PUNCT
aji-163	279	1	clinical	clinical	ADJ
aji-163	279	2	microbiology	microbiology	NOUN
aji-163	279	3	and	and	CCONJ
aji-163	279	4	infection	infection	NOUN
aji-163	279	5	,	,	PUNCT
aji-163	279	6	27(5	27(5	PROPN
aji-163	279	7	)	)	PUNCT
aji-163	279	8	,	,	PUNCT
aji-163	279	9	651	651	NUM
aji-163	279	10	–	–	PUNCT
aji-163	279	11	657	657	NUM
aji-163	279	12	.	.	PUNCT
aji-163	280	1	janefrancis	janefrancis	PROPN
aji-163	280	2	et	et	PROPN
aji-163	280	3	al	al	PROPN
aji-163	280	4	.	.	PROPN
aji-163	280	5	;	;	PUNCT
aji-163	280	6	asian	asian	PROPN
aji-163	280	7	j.	j.	PROPN
aji-163	280	8	immunol	immunol	PROPN
aji-163	280	9	.	.	PROPN
aji-163	280	10	,	,	PUNCT
aji-163	280	11	vol	vol	NOUN
aji-163	280	12	.	.	PROPN
aji-163	280	13	8	8	NUM
aji-163	280	14	,	,	PUNCT
aji-163	280	15	no	no	INTJ
aji-163	280	16	.	.	NOUN
aji-163	280	17	1	1	NUM
aji-163	280	18	,	,	PUNCT
aji-163	280	19	pp	pp	ADJ
aji-163	280	20	.	.	PUNCT
aji-163	281	1	86	86	NUM
aji-163	281	2	-	-	SYM
aji-163	281	3	96	96	NUM
aji-163	281	4	,	,	PUNCT
aji-163	281	5	2025	2025	NUM
aji-163	281	6	;	;	PUNCT
aji-163	281	7	article	article	NOUN
aji-163	281	8	no.aji.134904	no.aji.134904	VERB
aji-163	281	9	95	95	NUM
aji-163	281	10	bomans	boman	NOUN
aji-163	281	11	,	,	PUNCT
aji-163	281	12	k.	k.	PROPN
aji-163	281	13	,	,	PUNCT
aji-163	281	14	schenz	schenz	PROPN
aji-163	281	15	,	,	PUNCT
aji-163	281	16	j.	j.	PROPN
aji-163	281	17	,	,	PUNCT
aji-163	281	18	sztwiertnia	sztwiertnia	PROPN
aji-163	281	19	,	,	PUNCT
aji-163	281	20	i.	i.	PROPN
aji-163	281	21	,	,	PUNCT
aji-163	281	22	schaack	schaack	PROPN
aji-163	281	23	,	,	PUNCT
aji-163	281	24	d.	d.	PROPN
aji-163	281	25	,	,	PUNCT
aji-163	281	26	weigand	weigand	PROPN
aji-163	281	27	,	,	PUNCT
aji-163	281	28	m.	m.	NOUN
aji-163	281	29	a.	a.	PROPN
aji-163	281	30	,	,	PUNCT
aji-163	281	31	&	&	CCONJ
aji-163	281	32	uhle	uhle	PROPN
aji-163	281	33	,	,	PUNCT
aji-163	281	34	f.	f.	PROPN
aji-163	281	35	(	(	PUNCT
aji-163	281	36	2018	2018	NUM
aji-163	281	37	)	)	PUNCT
aji-163	281	38	.	.	PUNCT
aji-163	282	1	sepsis	sepsis	NOUN
aji-163	282	2	induces	induce	VERB
aji-163	282	3	a	a	DET
aji-163	282	4	long	long	ADV
aji-163	282	5	-	-	PUNCT
aji-163	282	6	lasting	last	VERB
aji-163	282	7	state	state	NOUN
aji-163	282	8	of	of	ADP
aji-163	282	9	trained	train	VERB
aji-163	282	10	immunity	immunity	NOUN
aji-163	282	11	in	in	ADP
aji-163	282	12	bone	bone	NOUN
aji-163	282	13	marrow	marrow	NOUN
aji-163	282	14	monocytes	monocyte	VERB
aji-163	282	15	.	.	PUNCT
aji-163	283	1	frontiers	frontier	NOUN
aji-163	283	2	in	in	ADP
aji-163	283	3	immunology	immunology	NOUN
aji-163	283	4	,	,	PUNCT
aji-163	283	5	9	9	NUM
aji-163	283	6	,	,	PUNCT
aji-163	283	7	2685	2685	NUM
aji-163	283	8	.	.	PUNCT
aji-163	284	1	ciarlo	ciarlo	PROPN
aji-163	284	2	,	,	PUNCT
aji-163	284	3	e.	e.	PROPN
aji-163	284	4	,	,	PUNCT
aji-163	284	5	heinonen	heinonen	PROPN
aji-163	284	6	,	,	PUNCT
aji-163	284	7	t.	t.	NOUN
aji-163	284	8	,	,	PUNCT
aji-163	284	9	théroude	théroude	ADJ
aji-163	284	10	,	,	PUNCT
aji-163	284	11	c.	c.	NOUN
aji-163	284	12	,	,	PUNCT
aji-163	284	13	asgari	asgari	PROPN
aji-163	284	14	,	,	PUNCT
aji-163	284	15	f.	f.	PROPN
aji-163	284	16	,	,	PUNCT
aji-163	284	17	le	le	PROPN
aji-163	284	18	roy	roy	PROPN
aji-163	284	19	,	,	PUNCT
aji-163	284	20	d.	d.	PROPN
aji-163	284	21	,	,	PUNCT
aji-163	284	22	netea	netea	NOUN
aji-163	284	23	,	,	PUNCT
aji-163	284	24	m.	m.	NOUN
aji-163	284	25	g.	g.	PROPN
aji-163	284	26	,	,	PUNCT
aji-163	284	27	&	&	CCONJ
aji-163	284	28	roger	roger	PROPN
aji-163	284	29	,	,	PUNCT
aji-163	284	30	t.	t.	PROPN
aji-163	284	31	(	(	PUNCT
aji-163	284	32	2020	2020	NUM
aji-163	284	33	)	)	PUNCT
aji-163	284	34	.	.	PUNCT
aji-163	285	1	trained	train	VERB
aji-163	285	2	immunity	immunity	NOUN
aji-163	285	3	confers	confer	NOUN
aji-163	285	4	broadspectrum	broadspectrum	NOUN
aji-163	285	5	protection	protection	NOUN
aji-163	285	6	against	against	ADP
aji-163	285	7	bacterial	bacterial	ADJ
aji-163	285	8	infections	infection	NOUN
aji-163	285	9	.	.	PUNCT
aji-163	286	1	the	the	DET
aji-163	286	2	journal	journal	NOUN
aji-163	286	3	of	of	ADP
aji-163	286	4	infectious	infectious	ADJ
aji-163	286	5	diseases	disease	NOUN
aji-163	286	6	,	,	PUNCT
aji-163	286	7	222(11	222(11	NUM
aji-163	286	8	)	)	PUNCT
aji-163	286	9	,	,	PUNCT
aji-163	286	10	1869	1869	NUM
aji-163	286	11	-	-	SYM
aji-163	286	12	1881	1881	NUM
aji-163	286	13	.	.	PUNCT
aji-163	287	1	duggan	duggan	PROPN
aji-163	287	2	,	,	PUNCT
aji-163	287	3	j.	j.	PROPN
aji-163	287	4	m.	m.	PROPN
aji-163	287	5	,	,	PUNCT
aji-163	287	6	siegersma	siegersma	PROPN
aji-163	287	7	,	,	PUNCT
aji-163	287	8	k.	k.	PROPN
aji-163	287	9	,	,	PUNCT
aji-163	287	10	&	&	CCONJ
aji-163	287	11	dunsmore	dunsmore	PROPN
aji-163	287	12	,	,	PUNCT
aji-163	287	13	g.	g.	PROPN
aji-163	287	14	(	(	PUNCT
aji-163	287	15	2023	2023	NUM
aji-163	287	16	)	)	PUNCT
aji-163	287	17	.	.	PUNCT
aji-163	288	1	evolutionary	evolutionary	ADJ
aji-163	288	2	conservation	conservation	NOUN
aji-163	288	3	of	of	ADP
aji-163	288	4	innate	innate	ADJ
aji-163	288	5	immune	immune	ADJ
aji-163	288	6	training	training	NOUN
aji-163	288	7	.	.	PUNCT
aji-163	289	1	trends	trend	NOUN
aji-163	289	2	in	in	ADP
aji-163	289	3	immunology	immunology	NOUN
aji-163	289	4	,	,	PUNCT
aji-163	289	5	44(3	44(3	NUM
aji-163	289	6	)	)	PUNCT
aji-163	289	7	,	,	PUNCT
aji-163	289	8	183–195	183–195	NUM
aji-163	289	9	.	.	PUNCT
aji-163	290	1	dulfer	dulfer	PROPN
aji-163	290	2	,	,	PUNCT
aji-163	290	3	s.	s.	PROPN
aji-163	290	4	,	,	PUNCT
aji-163	290	5	&	&	CCONJ
aji-163	290	6	domínguez	domínguez	NOUN
aji-163	290	7	-	-	PUNCT
aji-163	290	8	andrés	andrés	PROPN
aji-163	290	9	,	,	PUNCT
aji-163	290	10	j.	j.	PROPN
aji-163	290	11	(	(	PUNCT
aji-163	290	12	2024	2024	NUM
aji-163	290	13	)	)	PUNCT
aji-163	290	14	.	.	PUNCT
aji-163	291	1	mechanisms	mechanism	NOUN
aji-163	291	2	involved	involve	VERB
aji-163	291	3	in	in	ADP
aji-163	291	4	the	the	DET
aji-163	291	5	transmission	transmission	NOUN
aji-163	291	6	of	of	ADP
aji-163	291	7	trained	train	VERB
aji-163	291	8	immunity	immunity	NOUN
aji-163	291	9	.	.	PUNCT
aji-163	292	1	nature	nature	NOUN
aji-163	292	2	immunology	immunology	NOUN
aji-163	292	3	.	.	PUNCT
aji-163	293	1	fok	fok	PROPN
aji-163	293	2	,	,	PUNCT
aji-163	293	3	e.	e.	PROPN
aji-163	293	4	t.	t.	PROPN
aji-163	293	5	,	,	PUNCT
aji-163	293	6	davignon	davignon	PROPN
aji-163	293	7	,	,	PUNCT
aji-163	293	8	l.	l.	PROPN
aji-163	293	9	,	,	PUNCT
aji-163	293	10	fanucchi	fanucchi	PROPN
aji-163	293	11	,	,	PUNCT
aji-163	293	12	s.	s.	PROPN
aji-163	293	13	,	,	PUNCT
aji-163	293	14	&	&	CCONJ
aji-163	293	15	mhlanga	mhlanga	PROPN
aji-163	293	16	,	,	PUNCT
aji-163	293	17	m.	m.	NOUN
aji-163	293	18	m.	m.	NOUN
aji-163	293	19	(	(	PUNCT
aji-163	293	20	2019	2019	NUM
aji-163	293	21	)	)	PUNCT
aji-163	293	22	.	.	PUNCT
aji-163	294	1	the	the	DET
aji-163	294	2	lncrna	lncrna	NOUN
aji-163	294	3	connection	connection	NOUN
aji-163	294	4	between	between	ADP
aji-163	294	5	cellular	cellular	ADJ
aji-163	294	6	metabolism	metabolism	NOUN
aji-163	294	7	and	and	CCONJ
aji-163	294	8	epigenetics	epigenetic	NOUN
aji-163	294	9	in	in	ADP
aji-163	294	10	trained	train	VERB
aji-163	294	11	immunity	immunity	NOUN
aji-163	294	12	.	.	PUNCT
aji-163	295	1	frontiers	frontier	NOUN
aji-163	295	2	in	in	ADP
aji-163	295	3	immunology	immunology	NOUN
aji-163	295	4	,	,	PUNCT
aji-163	295	5	9	9	NUM
aji-163	295	6	,	,	PUNCT
aji-163	295	7	3184	3184	NUM
aji-163	295	8	.	.	PUNCT
aji-163	296	1	gee	gee	INTJ
aji-163	296	2	,	,	PUNCT
aji-163	296	3	s.	s.	PROPN
aji-163	296	4	,	,	PUNCT
aji-163	296	5	mohr	mohr	PROPN
aji-163	296	6	,	,	PUNCT
aji-163	296	7	c.	c.	PROPN
aji-163	296	8	,	,	PUNCT
aji-163	296	9	&	&	CCONJ
aji-163	296	10	felger	felger	PROPN
aji-163	296	11	,	,	PUNCT
aji-163	296	12	j.	j.	PROPN
aji-163	296	13	c.	c.	PROPN
aji-163	296	14	(	(	PUNCT
aji-163	296	15	2021	2021	NUM
aji-163	296	16	)	)	PUNCT
aji-163	296	17	.	.	PUNCT
aji-163	297	1	epigenetic	epigenetic	ADJ
aji-163	297	2	mechanisms	mechanism	NOUN
aji-163	297	3	of	of	ADP
aji-163	297	4	trained	train	VERB
aji-163	297	5	innate	innate	ADJ
aji-163	297	6	immunity	immunity	NOUN
aji-163	297	7	and	and	CCONJ
aji-163	297	8	its	its	PRON
aji-163	297	9	implications	implication	NOUN
aji-163	297	10	for	for	ADP
aji-163	297	11	neuroimmune	neuroimmune	NOUN
aji-163	297	12	disorders	disorder	NOUN
aji-163	297	13	.	.	PUNCT
aji-163	298	1	neuropsychopharmacology	neuropsychopharmacology	NOUN
aji-163	298	2	,	,	PUNCT
aji-163	298	3	46(4	46(4	NOUN
aji-163	298	4	)	)	PUNCT
aji-163	298	5	,	,	PUNCT
aji-163	298	6	990	990	NUM
aji-163	298	7	–	–	PUNCT
aji-163	298	8	1001	1001	NUM
aji-163	298	9	.	.	PUNCT
aji-163	299	1	hao	hao	PROPN
aji-163	299	2	,	,	PUNCT
aji-163	299	3	d.	d.	PROPN
aji-163	299	4	,	,	PUNCT
aji-163	299	5	mcbride	mcbride	PROPN
aji-163	299	6	,	,	PUNCT
aji-163	299	7	m.	m.	NOUN
aji-163	299	8	a.	a.	PROPN
aji-163	299	9	,	,	PUNCT
aji-163	299	10	bohannon	bohannon	PROPN
aji-163	299	11	,	,	PUNCT
aji-163	299	12	j.	j.	PROPN
aji-163	299	13	k.	k.	PROPN
aji-163	299	14	,	,	PUNCT
aji-163	299	15	hernandez	hernandez	PROPN
aji-163	299	16	,	,	PUNCT
aji-163	299	17	a.	a.	PROPN
aji-163	299	18	,	,	PUNCT
aji-163	299	19	klein	klein	PROPN
aji-163	299	20	,	,	PUNCT
aji-163	299	21	b.	b.	PROPN
aji-163	299	22	,	,	PUNCT
aji-163	299	23	williams	williams	PROPN
aji-163	299	24	,	,	PUNCT
aji-163	299	25	d.	d.	PROPN
aji-163	299	26	l.	l.	PROPN
aji-163	299	27	,	,	PUNCT
aji-163	299	28	&	&	CCONJ
aji-163	299	29	sherwood	sherwood	PROPN
aji-163	299	30	,	,	PUNCT
aji-163	299	31	e.	e.	PROPN
aji-163	299	32	r.	r.	PROPN
aji-163	299	33	(	(	PUNCT
aji-163	299	34	2025	2025	NUM
aji-163	299	35	)	)	PUNCT
aji-163	299	36	.	.	PUNCT
aji-163	300	1	metabolic	metabolic	NOUN
aji-163	300	2	adaptations	adaptation	NOUN
aji-163	300	3	driving	drive	VERB
aji-163	300	4	innate	innate	ADJ
aji-163	300	5	immune	immune	ADJ
aji-163	300	6	memory	memory	NOUN
aji-163	300	7	:	:	PUNCT
aji-163	300	8	mechanisms	mechanism	NOUN
aji-163	300	9	and	and	CCONJ
aji-163	300	10	therapeutic	therapeutic	ADJ
aji-163	300	11	implications	implication	NOUN
aji-163	300	12	.	.	PUNCT
aji-163	301	1	journal	journal	NOUN
aji-163	301	2	of	of	ADP
aji-163	301	3	leukocyte	leukocyte	NOUN
aji-163	301	4	biology	biology	NOUN
aji-163	301	5	,	,	PUNCT
aji-163	301	6	qiaf037	qiaf037	PROPN
aji-163	301	7	.	.	PUNCT
aji-163	302	1	jentho	jentho	PROPN
aji-163	302	2	,	,	PUNCT
aji-163	302	3	e.	e.	PROPN
aji-163	302	4	,	,	PUNCT
aji-163	302	5	ruiz	ruiz	PROPN
aji-163	302	6	-	-	PUNCT
aji-163	302	7	moreno	moreno	PROPN
aji-163	302	8	,	,	PUNCT
aji-163	302	9	c.	c.	PROPN
aji-163	302	10	,	,	PUNCT
aji-163	302	11	novakovic	novakovic	PROPN
aji-163	302	12	,	,	PUNCT
aji-163	302	13	b.	b.	PROPN
aji-163	302	14	,	,	PUNCT
aji-163	302	15	kourtzelis	kourtzelis	PROPN
aji-163	302	16	,	,	PUNCT
aji-163	302	17	i.	i.	PROPN
aji-163	302	18	,	,	PUNCT
aji-163	302	19	megchelenbrink	megchelenbrink	PROPN
aji-163	302	20	,	,	PUNCT
aji-163	302	21	w.	w.	PROPN
aji-163	302	22	l.	l.	PROPN
aji-163	302	23	,	,	PUNCT
aji-163	302	24	martins	martins	PROPN
aji-163	302	25	,	,	PUNCT
aji-163	302	26	r.	r.	PROPN
aji-163	302	27	,	,	PUNCT
aji-163	302	28	...	...	PUNCT
aji-163	302	29	&	&	CCONJ
aji-163	302	30	weis	weis	PROPN
aji-163	302	31	,	,	PUNCT
aji-163	302	32	s.	s.	PROPN
aji-163	302	33	(	(	PUNCT
aji-163	302	34	2021	2021	NUM
aji-163	302	35	)	)	PUNCT
aji-163	302	36	.	.	PUNCT
aji-163	303	1	trained	train	VERB
aji-163	303	2	innate	innate	ADJ
aji-163	303	3	immunity	immunity	NOUN
aji-163	303	4	,	,	PUNCT
aji-163	303	5	long	long	ADV
aji-163	303	6	-	-	PUNCT
aji-163	303	7	lasting	last	VERB
aji-163	303	8	epigenetic	epigenetic	ADJ
aji-163	303	9	modulation	modulation	NOUN
aji-163	303	10	,	,	PUNCT
aji-163	303	11	and	and	CCONJ
aji-163	303	12	skewed	skewed	ADJ
aji-163	303	13	myelopoiesis	myelopoiesis	NOUN
aji-163	303	14	by	by	ADP
aji-163	303	15	heme	heme	NOUN
aji-163	303	16	.	.	PUNCT
aji-163	304	1	proceedings	proceeding	NOUN
aji-163	304	2	of	of	ADP
aji-163	304	3	the	the	DET
aji-163	304	4	national	national	PROPN
aji-163	304	5	academy	academy	PROPN
aji-163	304	6	of	of	ADP
aji-163	304	7	sciences	sciences	PROPN
aji-163	304	8	,	,	PUNCT
aji-163	304	9	118(42	118(42	NUM
aji-163	304	10	)	)	PUNCT
aji-163	304	11	,	,	PUNCT
aji-163	304	12	e2102698118	e2102698118	PROPN
aji-163	304	13	.	.	PUNCT
aji-163	305	1	katzmarski	katzmarski	PROPN
aji-163	305	2	,	,	PUNCT
aji-163	305	3	n.	n.	NOUN
aji-163	305	4	,	,	PUNCT
aji-163	305	5	domínguez	domínguez	NOUN
aji-163	305	6	-	-	PUNCT
aji-163	305	7	andrés	andrés	NOUN
aji-163	305	8	,	,	PUNCT
aji-163	305	9	j.	j.	PROPN
aji-163	305	10	,	,	PUNCT
aji-163	305	11	cirovic	cirovic	PROPN
aji-163	305	12	,	,	PUNCT
aji-163	305	13	b.	b.	PROPN
aji-163	305	14	,	,	PUNCT
aji-163	305	15	renieris	renieris	PROPN
aji-163	305	16	,	,	PUNCT
aji-163	305	17	g.	g.	PROPN
aji-163	305	18	,	,	PUNCT
aji-163	305	19	mertes	mertes	PROPN
aji-163	305	20	,	,	PUNCT
aji-163	305	21	m.	m.	NOUN
aji-163	305	22	m.	m.	NOUN
aji-163	305	23	,	,	PUNCT
aji-163	305	24	cavallari	cavallari	PROPN
aji-163	305	25	,	,	PUNCT
aji-163	305	26	g.	g.	PROPN
aji-163	305	27	,	,	PUNCT
aji-163	305	28	...	...	PUNCT
aji-163	305	29	&	&	CCONJ
aji-163	305	30	netea	netea	NOUN
aji-163	305	31	,	,	PUNCT
aji-163	305	32	m.	m.	NOUN
aji-163	305	33	g.	g.	PROPN
aji-163	305	34	(	(	PUNCT
aji-163	305	35	2021	2021	NUM
aji-163	305	36	)	)	PUNCT
aji-163	305	37	.	.	PUNCT
aji-163	306	1	transmission	transmission	NOUN
aji-163	306	2	of	of	ADP
aji-163	306	3	trained	train	VERB
aji-163	306	4	immunity	immunity	NOUN
aji-163	306	5	and	and	CCONJ
aji-163	306	6	heterologous	heterologous	ADJ
aji-163	306	7	resistance	resistance	NOUN
aji-163	306	8	to	to	ADP
aji-163	306	9	infections	infection	NOUN
aji-163	306	10	across	across	ADP
aji-163	306	11	generations	generation	NOUN
aji-163	306	12	.	.	PUNCT
aji-163	307	1	nature	nature	NOUN
aji-163	307	2	immunology	immunology	NOUN
aji-163	307	3	,	,	PUNCT
aji-163	307	4	22(12	22(12	NUM
aji-163	307	5	)	)	PUNCT
aji-163	307	6	,	,	PUNCT
aji-163	307	7	1382–1390	1382–1390	NUM
aji-163	307	8	.	.	PUNCT
aji-163	308	1	kaufmann	kaufmann	PROPN
aji-163	308	2	,	,	PUNCT
aji-163	308	3	e.	e.	PROPN
aji-163	308	4	,	,	PUNCT
aji-163	308	5	sanz	sanz	PROPN
aji-163	308	6	,	,	PUNCT
aji-163	308	7	j.	j.	PROPN
aji-163	308	8	,	,	PUNCT
aji-163	308	9	dunn	dunn	PROPN
aji-163	308	10	,	,	PUNCT
aji-163	308	11	j.	j.	PROPN
aji-163	308	12	l.	l.	PROPN
aji-163	308	13	,	,	PUNCT
aji-163	308	14	khan	khan	PROPN
aji-163	308	15	,	,	PUNCT
aji-163	308	16	n.	n.	NOUN
aji-163	308	17	,	,	PUNCT
aji-163	308	18	mendonça	mendonça	PROPN
aji-163	308	19	,	,	PUNCT
aji-163	308	20	l.	l.	PROPN
aji-163	308	21	e.	e.	PROPN
aji-163	308	22	,	,	PUNCT
aji-163	308	23	pacis	pacis	PROPN
aji-163	308	24	,	,	PUNCT
aji-163	308	25	a.	a.	NOUN
aji-163	308	26	,	,	PUNCT
aji-163	308	27	...	...	PUNCT
aji-163	308	28	&	&	CCONJ
aji-163	308	29	netea	netea	NOUN
aji-163	308	30	,	,	PUNCT
aji-163	308	31	m.	m.	NOUN
aji-163	308	32	g.	g.	PROPN
aji-163	308	33	(	(	PUNCT
aji-163	308	34	2022	2022	NUM
aji-163	308	35	)	)	PUNCT
aji-163	308	36	.	.	PUNCT
aji-163	309	1	bcg	bcg	PROPN
aji-163	309	2	educates	educate	VERB
aji-163	309	3	hematopoietic	hematopoietic	ADJ
aji-163	309	4	stem	stem	NOUN
aji-163	309	5	cells	cell	NOUN
aji-163	309	6	to	to	PART
aji-163	309	7	generate	generate	VERB
aji-163	309	8	protective	protective	ADJ
aji-163	309	9	innate	innate	ADJ
aji-163	309	10	immunity	immunity	NOUN
aji-163	309	11	.	.	PUNCT
aji-163	310	1	cell	cell	NOUN
aji-163	310	2	,	,	PUNCT
aji-163	310	3	184(1	184(1	NUM
aji-163	310	4	)	)	PUNCT
aji-163	310	5	,	,	PUNCT
aji-163	310	6	297–311	297–311	NUM
aji-163	310	7	.	.	PUNCT
aji-163	311	1	keating	keating	PROPN
aji-163	311	2	,	,	PUNCT
aji-163	311	3	s.	s.	PROPN
aji-163	311	4	t.	t.	PROPN
aji-163	311	5	,	,	PUNCT
aji-163	311	6	groh	groh	PROPN
aji-163	311	7	,	,	PUNCT
aji-163	311	8	l.	l.	PROPN
aji-163	311	9	,	,	PUNCT
aji-163	311	10	van	van	PROPN
aji-163	311	11	der	der	PROPN
aji-163	311	12	heijden	heijden	PROPN
aji-163	311	13	,	,	PUNCT
aji-163	311	14	c.	c.	PROPN
aji-163	311	15	d.	d.	PROPN
aji-163	311	16	,	,	PUNCT
aji-163	311	17	rodriguez	rodriguez	PROPN
aji-163	311	18	,	,	PUNCT
aji-163	311	19	h.	h.	PROPN
aji-163	311	20	,	,	PUNCT
aji-163	311	21	dos	do	VERB
aji-163	311	22	santos	santos	PROPN
aji-163	311	23	,	,	PUNCT
aji-163	311	24	j.	j.	PROPN
aji-163	311	25	c.	c.	PROPN
aji-163	311	26	,	,	PUNCT
aji-163	311	27	fanucchi	fanucchi	PROPN
aji-163	311	28	,	,	PUNCT
aji-163	311	29	s.	s.	PROPN
aji-163	311	30	,	,	PUNCT
aji-163	311	31	...	...	PUNCT
aji-163	311	32	&	&	CCONJ
aji-163	311	33	riksen	riksen	PROPN
aji-163	311	34	,	,	PUNCT
aji-163	311	35	n.	n.	PROPN
aji-163	311	36	p.	p.	PROPN
aji-163	311	37	(	(	PUNCT
aji-163	311	38	2020	2020	NUM
aji-163	311	39	)	)	PUNCT
aji-163	311	40	.	.	PUNCT
aji-163	312	1	the	the	DET
aji-163	312	2	set7	set7	PROPN
aji-163	312	3	lysine	lysine	NOUN
aji-163	312	4	methyltransferase	methyltransferase	NOUN
aji-163	312	5	regulates	regulate	VERB
aji-163	312	6	plasticity	plasticity	NOUN
aji-163	312	7	in	in	ADP
aji-163	312	8	oxidative	oxidative	ADJ
aji-163	312	9	phosphorylation	phosphorylation	NOUN
aji-163	312	10	necessary	necessary	ADJ
aji-163	312	11	for	for	ADP
aji-163	312	12	trained	train	VERB
aji-163	312	13	immunity	immunity	NOUN
aji-163	312	14	induced	induce	VERB
aji-163	312	15	by	by	ADP
aji-163	312	16	β	β	NOUN
aji-163	312	17	-	-	NOUN
aji-163	312	18	glucan	glucan	NOUN
aji-163	312	19	.	.	PUNCT
aji-163	313	1	cell	cell	NOUN
aji-163	313	2	reports	report	NOUN
aji-163	313	3	,	,	PUNCT
aji-163	313	4	31(3	31(3	NUM
aji-163	313	5	)	)	PUNCT
aji-163	313	6	.	.	PUNCT
aji-163	314	1	lajqi	lajqi	ADJ
aji-163	314	2	,	,	PUNCT
aji-163	314	3	t.	t.	PROPN
aji-163	314	4	,	,	PUNCT
aji-163	314	5	köstlin	köstlin	PROPN
aji-163	314	6	-	-	PUNCT
aji-163	314	7	gille	gille	NOUN
aji-163	314	8	,	,	PUNCT
aji-163	314	9	n.	n.	NOUN
aji-163	314	10	,	,	PUNCT
aji-163	314	11	&	&	CCONJ
aji-163	314	12	gille	gille	PROPN
aji-163	314	13	,	,	PUNCT
aji-163	314	14	c.	c.	PROPN
aji-163	314	15	(	(	PUNCT
aji-163	314	16	2024	2024	NUM
aji-163	314	17	)	)	PUNCT
aji-163	314	18	.	.	PUNCT
aji-163	315	1	trained	train	VERB
aji-163	315	2	innate	innate	ADJ
aji-163	315	3	immunity	immunity	NOUN
aji-163	315	4	in	in	ADP
aji-163	315	5	pediatric	pediatric	ADJ
aji-163	315	6	infectious	infectious	ADJ
aji-163	315	7	diseases	disease	NOUN
aji-163	315	8	.	.	PUNCT
aji-163	316	1	the	the	DET
aji-163	316	2	pediatric	pediatric	ADJ
aji-163	316	3	infectious	infectious	ADJ
aji-163	316	4	disease	disease	NOUN
aji-163	316	5	journal	journal	NOUN
aji-163	316	6	,	,	PUNCT
aji-163	316	7	43(2	43(2	NUM
aji-163	316	8	)	)	PUNCT
aji-163	316	9	,	,	PUNCT
aji-163	316	10	e57	e57	NOUN
aji-163	316	11	–	–	PUNCT
aji-163	316	12	e59	e59	NOUN
aji-163	316	13	.	.	PUNCT
aji-163	316	14	mulder	mulder	PROPN
aji-163	316	15	,	,	PUNCT
aji-163	316	16	w.	w.	PROPN
aji-163	316	17	j.	j.	PROPN
aji-163	316	18	m.	m.	PROPN
aji-163	316	19	,	,	PUNCT
aji-163	316	20	ochando	ochando	PROPN
aji-163	316	21	,	,	PUNCT
aji-163	316	22	j.	j.	PROPN
aji-163	316	23	,	,	PUNCT
aji-163	316	24	joosten	joosten	VERB
aji-163	316	25	,	,	PUNCT
aji-163	316	26	l.	l.	PROPN
aji-163	316	27	a.	a.	PROPN
aji-163	316	28	b.	b.	PROPN
aji-163	316	29	,	,	PUNCT
aji-163	316	30	fayad	fayad	PROPN
aji-163	316	31	,	,	PUNCT
aji-163	316	32	z.	z.	PROPN
aji-163	316	33	a.	a.	PROPN
aji-163	316	34	,	,	PUNCT
aji-163	316	35	&	&	CCONJ
aji-163	316	36	netea	netea	NOUN
aji-163	316	37	,	,	PUNCT
aji-163	316	38	m.	m.	NOUN
aji-163	316	39	g.	g.	PROPN
aji-163	317	1	(	(	PUNCT
aji-163	317	2	2019	2019	NUM
aji-163	317	3	)	)	PUNCT
aji-163	317	4	.	.	PUNCT
aji-163	318	1	therapeutic	therapeutic	ADJ
aji-163	318	2	targeting	targeting	NOUN
aji-163	318	3	of	of	ADP
aji-163	318	4	trained	train	VERB
aji-163	318	5	immunity	immunity	NOUN
aji-163	318	6	.	.	PUNCT
aji-163	319	1	nature	nature	NOUN
aji-163	319	2	reviews	review	VERB
aji-163	319	3	drug	drug	NOUN
aji-163	319	4	discovery	discovery	NOUN
aji-163	319	5	,	,	PUNCT
aji-163	319	6	18(9	18(9	NOUN
aji-163	319	7	)	)	PUNCT
aji-163	319	8	,	,	PUNCT
aji-163	319	9	553–566	553–566	NUM
aji-163	319	10	.	.	PUNCT
aji-163	320	1	netea	netea	NOUN
aji-163	320	2	,	,	PUNCT
aji-163	320	3	m.	m.	NOUN
aji-163	320	4	g.	g.	PROPN
aji-163	320	5	,	,	PUNCT
aji-163	320	6	joosten	joosten	VERB
aji-163	320	7	,	,	PUNCT
aji-163	320	8	l.	l.	PROPN
aji-163	320	9	a.	a.	PROPN
aji-163	320	10	,	,	PUNCT
aji-163	320	11	latz	latz	NOUN
aji-163	320	12	,	,	PUNCT
aji-163	320	13	e.	e.	PROPN
aji-163	320	14	,	,	PUNCT
aji-163	320	15	mills	mill	NOUN
aji-163	320	16	,	,	PUNCT
aji-163	320	17	k.	k.	PROPN
aji-163	320	18	h.	h.	PROPN
aji-163	320	19	,	,	PUNCT
aji-163	320	20	natoli	natoli	PROPN
aji-163	320	21	,	,	PUNCT
aji-163	320	22	g.	g.	PROPN
aji-163	320	23	,	,	PUNCT
aji-163	320	24	stunnenberg	stunnenberg	PROPN
aji-163	320	25	,	,	PUNCT
aji-163	320	26	h.	h.	PROPN
aji-163	320	27	g.	g.	PROPN
aji-163	320	28	,	,	PUNCT
aji-163	320	29	...	...	PUNCT
aji-163	320	30	&	&	CCONJ
aji-163	320	31	xavier	xavier	PROPN
aji-163	320	32	,	,	PUNCT
aji-163	320	33	r.	r.	PROPN
aji-163	320	34	j.	j.	PROPN
aji-163	320	35	(	(	PUNCT
aji-163	320	36	2020	2020	NUM
aji-163	320	37	)	)	PUNCT
aji-163	320	38	.	.	PUNCT
aji-163	321	1	trained	train	VERB
aji-163	321	2	immunity	immunity	NOUN
aji-163	321	3	:	:	PUNCT
aji-163	321	4	a	a	DET
aji-163	321	5	program	program	NOUN
aji-163	321	6	of	of	ADP
aji-163	321	7	innate	innate	ADJ
aji-163	321	8	immune	immune	ADJ
aji-163	321	9	memory	memory	NOUN
aji-163	321	10	in	in	ADP
aji-163	321	11	health	health	NOUN
aji-163	321	12	and	and	CCONJ
aji-163	321	13	disease	disease	NOUN
aji-163	321	14	.	.	PUNCT
aji-163	322	1	science	science	NOUN
aji-163	322	2	,	,	PUNCT
aji-163	322	3	367(6481	367(6481	NUM
aji-163	322	4	)	)	PUNCT
aji-163	322	5	,	,	PUNCT
aji-163	322	6	eaay1916	eaay1916	PROPN
aji-163	322	7	.	.	PUNCT
aji-163	323	1	saeed	saeed	PROPN
aji-163	323	2	,	,	PUNCT
aji-163	323	3	s.	s.	PROPN
aji-163	323	4	,	,	PUNCT
aji-163	323	5	quintin	quintin	PROPN
aji-163	323	6	,	,	PUNCT
aji-163	323	7	j.	j.	PROPN
aji-163	323	8	,	,	PUNCT
aji-163	323	9	kerstens	kerstens	PROPN
aji-163	323	10	,	,	PUNCT
aji-163	323	11	h.	h.	PROPN
aji-163	323	12	h.	h.	PROPN
aji-163	323	13	,	,	PUNCT
aji-163	323	14	rao	rao	PROPN
aji-163	323	15	,	,	PUNCT
aji-163	323	16	n.	n.	PROPN
aji-163	323	17	a.	a.	PROPN
aji-163	323	18	,	,	PUNCT
aji-163	323	19	aghajanirefah	aghajanirefah	VERB
aji-163	323	20	,	,	PUNCT
aji-163	323	21	a.	a.	NOUN
aji-163	323	22	,	,	PUNCT
aji-163	323	23	matarese	matarese	PROPN
aji-163	323	24	,	,	PUNCT
aji-163	323	25	f.	f.	PROPN
aji-163	323	26	,	,	PUNCT
aji-163	323	27	...	...	PUNCT
aji-163	323	28	&	&	CCONJ
aji-163	323	29	netea	netea	NOUN
aji-163	323	30	,	,	PUNCT
aji-163	323	31	m.	m.	NOUN
aji-163	323	32	g.	g.	PROPN
aji-163	323	33	(	(	PUNCT
aji-163	323	34	2014	2014	NUM
aji-163	323	35	)	)	PUNCT
aji-163	323	36	.	.	PUNCT
aji-163	324	1	epigenetic	epigenetic	ADJ
aji-163	324	2	programming	programming	NOUN
aji-163	324	3	of	of	ADP
aji-163	324	4	monocyte	monocyte	NOUN
aji-163	324	5	-	-	PUNCT
aji-163	324	6	to	to	ADP
aji-163	324	7	-	-	PUNCT
aji-163	324	8	macrophage	macrophage	NOUN
aji-163	324	9	differentiation	differentiation	NOUN
aji-163	324	10	and	and	CCONJ
aji-163	324	11	trained	train	VERB
aji-163	324	12	immunity	immunity	NOUN
aji-163	324	13	.	.	PUNCT
aji-163	325	1	science	science	NOUN
aji-163	325	2	,	,	PUNCT
aji-163	325	3	345(6204	345(6204	NUM
aji-163	325	4	)	)	PUNCT
aji-163	325	5	,	,	PUNCT
aji-163	325	6	1251086	1251086	NUM
aji-163	325	7	.	.	PUNCT
aji-163	326	1	sallusto	sallusto	PROPN
aji-163	326	2	,	,	PUNCT
aji-163	326	3	f.	f.	PROPN
aji-163	326	4	,	,	PUNCT
aji-163	326	5	geginat	geginat	PROPN
aji-163	326	6	,	,	PUNCT
aji-163	326	7	j.	j.	PROPN
aji-163	326	8	,	,	PUNCT
aji-163	326	9	&	&	CCONJ
aji-163	326	10	lanzavecchia	lanzavecchia	PROPN
aji-163	326	11	,	,	PUNCT
aji-163	326	12	a.	a.	NOUN
aji-163	326	13	(	(	PUNCT
aji-163	326	14	2010	2010	NUM
aji-163	326	15	)	)	PUNCT
aji-163	326	16	.	.	PUNCT
aji-163	327	1	central	central	ADJ
aji-163	327	2	memory	memory	NOUN
aji-163	327	3	and	and	CCONJ
aji-163	327	4	effector	effector	NOUN
aji-163	327	5	memory	memory	NOUN
aji-163	327	6	t	t	PROPN
aji-163	327	7	cell	cell	NOUN
aji-163	327	8	subsets	subset	NOUN
aji-163	327	9	:	:	PUNCT
aji-163	327	10	function	function	NOUN
aji-163	327	11	,	,	PUNCT
aji-163	327	12	generation	generation	NOUN
aji-163	327	13	,	,	PUNCT
aji-163	327	14	and	and	CCONJ
aji-163	327	15	maintenance	maintenance	NOUN
aji-163	327	16	.	.	PUNCT
aji-163	328	1	annual	annual	ADJ
aji-163	328	2	review	review	NOUN
aji-163	328	3	of	of	ADP
aji-163	328	4	immunology	immunology	NOUN
aji-163	328	5	,	,	PUNCT
aji-163	328	6	22	22	NUM
aji-163	328	7	,	,	PUNCT
aji-163	328	8	745–763	745–763	NUM
aji-163	328	9	.	.	PUNCT
aji-163	329	1	sánchez	sánchez	NOUN
aji-163	329	2	-	-	PUNCT
aji-163	329	3	ramón	ramón	PROPN
aji-163	329	4	,	,	PUNCT
aji-163	329	5	s.	s.	PROPN
aji-163	329	6	,	,	PUNCT
aji-163	329	7	conejero	conejero	PROPN
aji-163	329	8	,	,	PUNCT
aji-163	329	9	l.	l.	PROPN
aji-163	329	10	,	,	PUNCT
aji-163	329	11	netea	netea	NOUN
aji-163	329	12	,	,	PUNCT
aji-163	329	13	m.	m.	NOUN
aji-163	329	14	g.	g.	PROPN
aji-163	329	15	,	,	PUNCT
aji-163	329	16	sancho	sancho	PROPN
aji-163	329	17	,	,	PUNCT
aji-163	329	18	d.	d.	PROPN
aji-163	329	19	,	,	PUNCT
aji-163	329	20	palomares	palomare	NOUN
aji-163	329	21	,	,	PUNCT
aji-163	329	22	ó	ó	PROPN
aji-163	329	23	.	.	PROPN
aji-163	329	24	,	,	PUNCT
aji-163	329	25	&	&	CCONJ
aji-163	329	26	subiza	subiza	PROPN
aji-163	329	27	,	,	PUNCT
aji-163	329	28	j.	j.	PROPN
aji-163	329	29	l.	l.	PROPN
aji-163	329	30	(	(	PUNCT
aji-163	329	31	2018	2018	NUM
aji-163	329	32	)	)	PUNCT
aji-163	329	33	.	.	PUNCT
aji-163	330	1	trained	train	VERB
aji-163	330	2	immunity	immunity	NOUN
aji-163	330	3	-	-	PUNCT
aji-163	330	4	based	base	VERB
aji-163	330	5	vaccines	vaccine	NOUN
aji-163	330	6	:	:	PUNCT
aji-163	330	7	a	a	DET
aji-163	330	8	new	new	ADJ
aji-163	330	9	paradigm	paradigm	NOUN
aji-163	330	10	for	for	ADP
aji-163	330	11	the	the	DET
aji-163	330	12	development	development	NOUN
aji-163	330	13	of	of	ADP
aji-163	330	14	broad	broad	ADJ
aji-163	330	15	-	-	PUNCT
aji-163	330	16	spectrum	spectrum	NOUN
aji-163	330	17	anti	anti	ADJ
aji-163	330	18	-	-	ADJ
aji-163	330	19	infectious	infectious	ADJ
aji-163	330	20	formulations	formulation	NOUN
aji-163	330	21	.	.	PUNCT
aji-163	331	1	frontiers	frontier	NOUN
aji-163	331	2	in	in	ADP
aji-163	331	3	immunology	immunology	NOUN
aji-163	331	4	,	,	PUNCT
aji-163	331	5	9	9	NUM
aji-163	331	6	,	,	PUNCT
aji-163	331	7	2936	2936	NUM
aji-163	331	8	.	.	PUNCT
aji-163	332	1	shad	shad	PROPN
aji-163	332	2	,	,	PUNCT
aji-163	332	3	r.	r.	PROPN
aji-163	332	4	,	,	PUNCT
aji-163	332	5	&	&	CCONJ
aji-163	332	6	doris	doris	PROPN
aji-163	332	7	,	,	PUNCT
aji-163	332	8	l.	l.	PROPN
aji-163	332	9	(	(	PUNCT
aji-163	332	10	n.d	n.d	PROPN
aji-163	332	11	.	.	PROPN
aji-163	332	12	)	)	PUNCT
aji-163	332	13	.	.	PUNCT
aji-163	333	1	innate	innate	ADJ
aji-163	333	2	immune	immune	ADJ
aji-163	333	3	memory	memory	NOUN
aji-163	333	4	:	:	PUNCT
aji-163	333	5	understanding	understanding	NOUN
aji-163	333	6	trained	train	VERB
aji-163	333	7	immunity	immunity	NOUN
aji-163	333	8	and	and	CCONJ
aji-163	333	9	its	its	PRON
aji-163	333	10	implications	implication	NOUN
aji-163	333	11	for	for	ADP
aji-163	333	12	future	future	ADJ
aji-163	333	13	vaccine	vaccine	NOUN
aji-163	333	14	design	design	NOUN
aji-163	333	15	.	.	PUNCT
aji-163	334	1	sun	sun	PROPN
aji-163	334	2	,	,	PUNCT
aji-163	334	3	j.	j.	PROPN
aji-163	334	4	c.	c.	PROPN
aji-163	334	5	,	,	PUNCT
aji-163	334	6	&	&	CCONJ
aji-163	334	7	lanier	lanier	PROPN
aji-163	334	8	,	,	PUNCT
aji-163	334	9	l.	l.	PROPN
aji-163	334	10	l.	l.	PROPN
aji-163	334	11	(	(	PUNCT
aji-163	334	12	2021	2021	NUM
aji-163	334	13	)	)	PUNCT
aji-163	334	14	.	.	PUNCT
aji-163	335	1	natural	natural	ADJ
aji-163	335	2	killer	killer	NOUN
aji-163	335	3	cell	cell	NOUN
aji-163	335	4	memory	memory	NOUN
aji-163	335	5	in	in	ADP
aji-163	335	6	immunity	immunity	NOUN
aji-163	335	7	and	and	CCONJ
aji-163	335	8	disease	disease	NOUN
aji-163	335	9	.	.	PUNCT
aji-163	336	1	nature	nature	NOUN
aji-163	336	2	reviews	review	VERB
aji-163	336	3	immunology	immunology	NOUN
aji-163	336	4	,	,	PUNCT
aji-163	336	5	21(3	21(3	NUM
aji-163	336	6	)	)	PUNCT
aji-163	336	7	,	,	PUNCT
aji-163	336	8	200	200	NUM
aji-163	336	9	–	–	PUNCT
aji-163	336	10	213	213	NUM
aji-163	336	11	.	.	PUNCT
aji-163	337	1	wang	wang	PROPN
aji-163	337	2	,	,	PUNCT
aji-163	337	3	w.	w.	PROPN
aji-163	337	4	,	,	PUNCT
aji-163	337	5	ma	ma	PROPN
aji-163	337	6	,	,	PUNCT
aji-163	337	7	l.	l.	PROPN
aji-163	337	8	,	,	PUNCT
aji-163	337	9	liu	liu	PROPN
aji-163	337	10	,	,	PUNCT
aji-163	337	11	b.	b.	PROPN
aji-163	337	12	,	,	PUNCT
aji-163	337	13	&	&	CCONJ
aji-163	337	14	ouyang	ouyang	PROPN
aji-163	337	15	,	,	PUNCT
aji-163	337	16	l.	l.	PROPN
aji-163	337	17	(	(	PUNCT
aji-163	337	18	2024	2024	NUM
aji-163	337	19	)	)	PUNCT
aji-163	337	20	.	.	PUNCT
aji-163	338	1	the	the	DET
aji-163	338	2	role	role	NOUN
aji-163	338	3	of	of	ADP
aji-163	338	4	trained	train	VERB
aji-163	338	5	immunity	immunity	NOUN
aji-163	338	6	in	in	ADP
aji-163	338	7	sepsis	sepsis	NOUN
aji-163	338	8	.	.	PUNCT
aji-163	339	1	frontiers	frontier	NOUN
aji-163	339	2	in	in	ADP
aji-163	339	3	immunology	immunology	NOUN
aji-163	339	4	,	,	PUNCT
aji-163	339	5	15	15	NUM
aji-163	339	6	,	,	PUNCT
aji-163	339	7	1449986	1449986	NUM
aji-163	339	8	.	.	PUNCT
aji-163	340	1	xia	xia	PROPN
aji-163	340	2	,	,	PUNCT
aji-163	340	3	l.	l.	PROPN
aji-163	340	4	,	,	PUNCT
aji-163	340	5	oyang	oyang	PROPN
aji-163	340	6	,	,	PUNCT
aji-163	340	7	l.	l.	PROPN
aji-163	340	8	,	,	PUNCT
aji-163	340	9	lin	lin	PROPN
aji-163	340	10	,	,	PUNCT
aji-163	340	11	j.	j.	PROPN
aji-163	340	12	,	,	PUNCT
aji-163	340	13	tan	tan	PROPN
aji-163	340	14	,	,	PUNCT
aji-163	340	15	s.	s.	PROPN
aji-163	340	16	,	,	PUNCT
aji-163	340	17	han	han	PROPN
aji-163	340	18	,	,	PUNCT
aji-163	340	19	y.	y.	PROPN
aji-163	340	20	,	,	PUNCT
aji-163	340	21	wu	wu	PROPN
aji-163	340	22	,	,	PUNCT
aji-163	340	23	n.	n.	NOUN
aji-163	340	24	,	,	PUNCT
aji-163	340	25	yi	yi	PROPN
aji-163	340	26	,	,	PUNCT
aji-163	340	27	p.	p.	PROPN
aji-163	340	28	,	,	PUNCT
aji-163	340	29	tang	tang	PROPN
aji-163	340	30	,	,	PUNCT
aji-163	340	31	l.	l.	PROPN
aji-163	340	32	,	,	PUNCT
aji-163	340	33	pan	pan	PROPN
aji-163	340	34	,	,	PUNCT
aji-163	340	35	q.	q.	PROPN
aji-163	340	36	,	,	PUNCT
aji-163	340	37	rao	rao	PROPN
aji-163	340	38	,	,	PUNCT
aji-163	340	39	s.	s.	PROPN
aji-163	340	40	,	,	PUNCT
aji-163	340	41	&	&	CCONJ
aji-163	340	42	liang	liang	PROPN
aji-163	340	43	,	,	PUNCT
aji-163	340	44	j.	j.	PROPN
aji-163	340	45	(	(	PUNCT
aji-163	340	46	2021	2021	NUM
aji-163	340	47	)	)	PUNCT
aji-163	340	48	.	.	PUNCT
aji-163	341	1	the	the	DET
aji-163	341	2	cancer	cancer	NOUN
aji-163	341	3	metabolic	metabolic	NOUN
aji-163	341	4	janefrancis	janefrancis	PROPN
aji-163	341	5	et	et	PROPN
aji-163	341	6	al	al	PROPN
aji-163	341	7	.	.	PROPN
aji-163	341	8	;	;	PUNCT
aji-163	341	9	asian	asian	PROPN
aji-163	341	10	j.	j.	PROPN
aji-163	341	11	immunol	immunol	PROPN
aji-163	341	12	.	.	PROPN
aji-163	341	13	,	,	PUNCT
aji-163	341	14	vol	vol	NOUN
aji-163	341	15	.	.	PROPN
aji-163	341	16	8	8	NUM
aji-163	341	17	,	,	PUNCT
aji-163	341	18	no	no	INTJ
aji-163	341	19	.	.	NOUN
aji-163	341	20	1	1	NUM
aji-163	341	21	,	,	PUNCT
aji-163	341	22	pp	pp	ADJ
aji-163	341	23	.	.	PUNCT
aji-163	342	1	86	86	NUM
aji-163	342	2	-	-	SYM
aji-163	342	3	96	96	NUM
aji-163	342	4	,	,	PUNCT
aji-163	342	5	2025	2025	NUM
aji-163	342	6	;	;	PUNCT
aji-163	342	7	article	article	NOUN
aji-163	342	8	no.aji.134904	no.aji.134904	VERB
aji-163	342	9	96	96	NUM
aji-163	342	10	reprogramming	reprogramming	ADJ
aji-163	342	11	and	and	CCONJ
aji-163	342	12	immune	immune	ADJ
aji-163	342	13	response	response	NOUN
aji-163	342	14	.	.	PUNCT
aji-163	343	1	molecular	molecular	ADJ
aji-163	343	2	cancer	cancer	NOUN
aji-163	343	3	,	,	PUNCT
aji-163	343	4	20	20	NUM
aji-163	343	5	,	,	PUNCT
aji-163	343	6	1–21	1–21	PROPN
aji-163	343	7	.	.	PUNCT
aji-163	344	1	xing	xing	PROPN
aji-163	344	2	,	,	PUNCT
aji-163	344	3	z.	z.	PROPN
aji-163	344	4	,	,	PUNCT
aji-163	344	5	afkhami	afkhami	PROPN
aji-163	344	6	,	,	PUNCT
aji-163	344	7	s.	s.	PROPN
aji-163	344	8	,	,	PUNCT
aji-163	344	9	bavananthasivam	bavananthasivam	PROPN
aji-163	344	10	,	,	PUNCT
aji-163	344	11	j.	j.	PROPN
aji-163	344	12	,	,	PUNCT
aji-163	344	13	fritz	fritz	PROPN
aji-163	344	14	,	,	PUNCT
aji-163	344	15	d.	d.	PROPN
aji-163	344	16	k.	k.	PROPN
aji-163	344	17	,	,	PUNCT
aji-163	344	18	d’agostino	d’agostino	PROPN
aji-163	344	19	,	,	PUNCT
aji-163	344	20	m.	m.	NOUN
aji-163	344	21	r.	r.	PROPN
aji-163	344	22	,	,	PUNCT
aji-163	344	23	vaseghishanjani	vaseghishanjani	PROPN
aji-163	344	24	,	,	PUNCT
aji-163	344	25	m.	m.	NOUN
aji-163	344	26	,	,	PUNCT
aji-163	344	27	...	...	PUNCT
aji-163	344	28	&	&	CCONJ
aji-163	344	29	jeyanathan	jeyanathan	PROPN
aji-163	344	30	,	,	PUNCT
aji-163	344	31	m.	m.	NOUN
aji-163	344	32	(	(	PUNCT
aji-163	344	33	2020	2020	NUM
aji-163	344	34	)	)	PUNCT
aji-163	344	35	.	.	PUNCT
aji-163	345	1	innate	innate	ADJ
aji-163	345	2	immune	immune	ADJ
aji-163	345	3	memory	memory	NOUN
aji-163	345	4	of	of	ADP
aji-163	345	5	tissue	tissue	NOUN
aji-163	345	6	-	-	PUNCT
aji-163	345	7	resident	resident	NOUN
aji-163	345	8	macrophages	macrophage	NOUN
aji-163	345	9	and	and	CCONJ
aji-163	345	10	trained	train	VERB
aji-163	345	11	innate	innate	ADJ
aji-163	345	12	immunity	immunity	NOUN
aji-163	345	13	:	:	PUNCT
aji-163	345	14	re	re	VERB
aji-163	345	15	-	-	VERB
aji-163	345	16	vamping	vamping	ADJ
aji-163	345	17	vaccine	vaccine	NOUN
aji-163	345	18	concept	concept	NOUN
aji-163	345	19	and	and	CCONJ
aji-163	345	20	strategies	strategy	NOUN
aji-163	345	21	.	.	PUNCT
aji-163	346	1	journal	journal	NOUN
aji-163	346	2	of	of	ADP
aji-163	346	3	leukocyte	leukocyte	NOUN
aji-163	346	4	biology	biology	NOUN
aji-163	346	5	,	,	PUNCT
aji-163	346	6	108(3	108(3	NUM
aji-163	346	7	)	)	PUNCT
aji-163	346	8	,	,	PUNCT
aji-163	346	9	825–834	825–834	NUM
aji-163	346	10	.	.	PUNCT
aji-163	347	1	disclaimer	disclaimer	ADJ
aji-163	347	2	/	/	SYM
aji-163	347	3	publisher	publisher	NOUN
aji-163	347	4	’s	’s	PART
aji-163	347	5	note	note	NOUN
aji-163	347	6	:	:	PUNCT
aji-163	347	7	the	the	DET
aji-163	347	8	statements	statement	NOUN
aji-163	347	9	,	,	PUNCT
aji-163	347	10	opinions	opinion	NOUN
aji-163	347	11	and	and	CCONJ
aji-163	347	12	data	datum	NOUN
aji-163	347	13	contained	contain	VERB
aji-163	347	14	in	in	ADP
aji-163	347	15	all	all	DET
aji-163	347	16	publications	publication	NOUN
aji-163	347	17	are	be	AUX
aji-163	347	18	solely	solely	ADV
aji-163	347	19	those	those	PRON
aji-163	347	20	of	of	ADP
aji-163	347	21	the	the	DET
aji-163	347	22	individual	individual	ADJ
aji-163	347	23	author(s	author(s	PROPN
aji-163	347	24	)	)	PUNCT
aji-163	347	25	and	and	CCONJ
aji-163	347	26	contributor(s	contributor(s	NOUN
aji-163	347	27	)	)	PUNCT
aji-163	347	28	and	and	CCONJ
aji-163	347	29	not	not	PART
aji-163	347	30	of	of	ADP
aji-163	347	31	the	the	DET
aji-163	347	32	publisher	publisher	NOUN
aji-163	347	33	and/or	and/or	CCONJ
aji-163	347	34	the	the	DET
aji-163	347	35	editor(s	editor(s	NOUN
aji-163	347	36	)	)	PUNCT
aji-163	347	37	.	.	PUNCT
aji-163	348	1	this	this	DET
aji-163	348	2	publisher	publisher	NOUN
aji-163	348	3	and/or	and/or	CCONJ
aji-163	348	4	the	the	DET
aji-163	348	5	editor(s	editor(s	NOUN
aji-163	348	6	)	)	PUNCT
aji-163	348	7	disclaim	disclaim	VERB
aji-163	348	8	responsibility	responsibility	NOUN
aji-163	348	9	for	for	ADP
aji-163	348	10	any	any	DET
aji-163	348	11	injury	injury	NOUN
aji-163	348	12	to	to	ADP
aji-163	348	13	people	people	NOUN
aji-163	348	14	or	or	CCONJ
aji-163	348	15	property	property	NOUN
aji-163	348	16	resulting	result	VERB
aji-163	348	17	from	from	ADP
aji-163	348	18	any	any	DET
aji-163	348	19	ideas	idea	NOUN
aji-163	348	20	,	,	PUNCT
aji-163	348	21	methods	method	NOUN
aji-163	348	22	,	,	PUNCT
aji-163	348	23	instructions	instruction	NOUN
aji-163	348	24	or	or	CCONJ
aji-163	348	25	products	product	NOUN
aji-163	348	26	referred	refer	VERB
aji-163	348	27	to	to	ADP
aji-163	348	28	in	in	ADP
aji-163	348	29	the	the	DET
aji-163	348	30	content	content	NOUN
aji-163	348	31	.	.	PUNCT
aji-163	349	1	_	_	PUNCT
aji-163	350	1	_	_	PUNCT
aji-163	351	1	_	_	PUNCT
aji-163	352	1	_	_	PUNCT
aji-163	353	1	_	_	PUNCT
aji-163	354	1	_	_	PUNCT
aji-163	355	1	_	_	PUNCT
aji-163	356	1	_	_	PUNCT
aji-163	357	1	_	_	PUNCT
aji-163	358	1	_	_	PUNCT
aji-163	359	1	_	_	PUNCT
aji-163	360	1	_	_	PUNCT
aji-163	361	1	_	_	PUNCT
aji-163	362	1	_	_	PUNCT
aji-163	363	1	_	_	PUNCT
aji-163	364	1	_	_	PUNCT
aji-163	365	1	_	_	PUNCT
aji-163	366	1	_	_	PUNCT
aji-163	367	1	_	_	PUNCT
aji-163	368	1	_	_	PUNCT
aji-163	369	1	_	_	PUNCT
aji-163	370	1	_	_	PUNCT
aji-163	371	1	_	_	PUNCT
aji-163	372	1	_	_	PUNCT
aji-163	373	1	_	_	PUNCT
aji-163	374	1	_	_	PUNCT
aji-163	375	1	_	_	PUNCT
aji-163	376	1	_	_	PUNCT
aji-163	377	1	_	_	PUNCT
aji-163	378	1	_	_	PUNCT
aji-163	379	1	_	_	PUNCT
aji-163	380	1	_	_	PUNCT
aji-163	381	1	_	_	PUNCT
aji-163	382	1	_	_	PUNCT
aji-163	383	1	_	_	PUNCT
aji-163	384	1	_	_	PUNCT
aji-163	385	1	_	_	PUNCT
aji-163	386	1	_	_	PUNCT
aji-163	387	1	_	_	PUNCT
aji-163	388	1	_	_	PUNCT
aji-163	389	1	_	_	PUNCT
aji-163	390	1	_	_	PUNCT
aji-163	391	1	_	_	PUNCT
aji-163	392	1	_	_	PUNCT
aji-163	393	1	_	_	PUNCT
aji-163	394	1	_	_	PUNCT
aji-163	395	1	_	_	PUNCT
aji-163	396	1	_	_	PUNCT
aji-163	397	1	_	_	PUNCT
aji-163	398	1	_	_	PUNCT
aji-163	399	1	_	_	PUNCT
aji-163	400	1	_	_	PUNCT
aji-163	401	1	_	_	PUNCT
aji-163	402	1	_	_	PUNCT
aji-163	403	1	_	_	PUNCT
aji-163	404	1	_	_	PUNCT
aji-163	405	1	_	_	PUNCT
aji-163	406	1	_	_	PUNCT
aji-163	407	1	_	_	PUNCT
aji-163	408	1	_	_	PUNCT
aji-163	409	1	_	_	PUNCT
aji-163	410	1	_	_	PUNCT
aji-163	411	1	_	_	PUNCT
aji-163	412	1	_	_	PUNCT
aji-163	413	1	_	_	PUNCT
aji-163	414	1	_	_	PUNCT
aji-163	415	1	_	_	PUNCT
aji-163	416	1	_	_	PUNCT
aji-163	417	1	_	_	PUNCT
aji-163	418	1	_	_	PUNCT
aji-163	419	1	_	_	PUNCT
aji-163	420	1	_	_	PUNCT
aji-163	421	1	_	_	PUNCT
aji-163	422	1	_	_	PUNCT
aji-163	423	1	_	_	PUNCT
aji-163	424	1	_	_	PUNCT
aji-163	425	1	_	_	PUNCT
aji-163	426	1	_	_	PUNCT
aji-163	427	1	_	_	PUNCT
aji-163	428	1	_	_	PUNCT
aji-163	429	1	_	_	PUNCT
aji-163	430	1	©	©	PRON
aji-163	430	2	copyright	copyright	NOUN
aji-163	430	3	(	(	PUNCT
aji-163	430	4	2025	2025	NUM
aji-163	430	5	):	):	PUNCT
aji-163	430	6	author(s	author(s	NOUN
aji-163	430	7	)	)	PUNCT
aji-163	430	8	.	.	PUNCT
aji-163	431	1	the	the	DET
aji-163	431	2	licensee	licensee	NOUN
aji-163	431	3	is	be	AUX
aji-163	431	4	the	the	DET
aji-163	431	5	journal	journal	PROPN
aji-163	431	6	publisher	publisher	NOUN
aji-163	431	7	.	.	PUNCT
aji-163	432	1	this	this	PRON
aji-163	432	2	is	be	AUX
aji-163	432	3	an	an	DET
aji-163	432	4	open	open	ADJ
aji-163	432	5	access	access	NOUN
aji-163	432	6	article	article	NOUN
aji-163	432	7	distributed	distribute	VERB
aji-163	432	8	under	under	ADP
aji-163	432	9	the	the	DET
aji-163	432	10	terms	term	NOUN
aji-163	432	11	of	of	ADP
aji-163	432	12	the	the	DET
aji-163	432	13	creative	creative	ADJ
aji-163	432	14	commons	common	NOUN
aji-163	432	15	attribution	attribution	NOUN
aji-163	432	16	license	license	NOUN
aji-163	432	17	(	(	PUNCT
aji-163	432	18	http://creativecommons.org/licenses/by/4.0	http://creativecommons.org/licenses/by/4.0	NOUN
aji-163	432	19	)	)	PUNCT
aji-163	432	20	,	,	PUNCT
aji-163	432	21	which	which	PRON
aji-163	432	22	permits	permit	VERB
aji-163	432	23	unrestricted	unrestricted	ADJ
aji-163	432	24	use	use	NOUN
aji-163	432	25	,	,	PUNCT
aji-163	432	26	distribution	distribution	NOUN
aji-163	432	27	,	,	PUNCT
aji-163	432	28	and	and	CCONJ
aji-163	432	29	reproduction	reproduction	NOUN
aji-163	432	30	in	in	ADP
aji-163	432	31	any	any	DET
aji-163	432	32	medium	medium	NOUN
aji-163	432	33	,	,	PUNCT
aji-163	432	34	provided	provide	VERB
aji-163	432	35	the	the	DET
aji-163	432	36	original	original	ADJ
aji-163	432	37	work	work	NOUN
aji-163	432	38	is	be	AUX
aji-163	432	39	properly	properly	ADV
aji-163	432	40	cited	cite	VERB
aji-163	432	41	.	.	PUNCT
aji-163	433	1	peer	peer	NOUN
aji-163	433	2	-	-	PUNCT
aji-163	433	3	review	review	NOUN
aji-163	433	4	history	history	NOUN
aji-163	433	5	:	:	PUNCT
aji-163	433	6	the	the	DET
aji-163	433	7	peer	peer	NOUN
aji-163	433	8	review	review	NOUN
aji-163	433	9	history	history	NOUN
aji-163	433	10	for	for	ADP
aji-163	433	11	this	this	DET
aji-163	433	12	paper	paper	NOUN
aji-163	433	13	can	can	AUX
aji-163	433	14	be	be	AUX
aji-163	433	15	accessed	access	VERB
aji-163	433	16	here	here	ADV
aji-163	433	17	:	:	PUNCT
aji-163	433	18	https://pr.sdiarticle5.com/review-history/134904	https://pr.sdiarticle5.com/review-history/134904	PRON
aji-163	433	19	https://pr.sdiarticle5.com/review-history/134904	https://pr.sdiarticle5.com/review-history/134904	VERB